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Increased delay discounting (DD) has been associated with and is theorized to 
contribute to alcoholism and substance abuse. It is also been associated with numerous 
other mental disorders and is believed to be a trans-disease process (i.e., a process that 
occurs in and contributes to multiple different pathologies). Consequently insights gained 
from studying DD are likely to apply to many different diseases. Studies on the 
neurobiological underpinnings of DD have two main interpretations. The first 
interpretation is that two different neurobehavioral systems exist, one favoring delayed 
rewards (executive system) and one favoring immediate rewards (impulsive system), and 
the system with the greater relative activation determines choice made by an individual. 
Alternatively, a single valuation system may exist. This system integrates different 
information about outcomes and generates a value signal that then guides decision 
making. Preclinical investigations have steered clear of these two different interpretations 
and rather focused on the role of individual structures in DD. One such structure, the rat 
mPFC, may generate an outcome representation of delayed rewards that is critically 
involved in attributing value to delayed rewards. Moreover, there is evidence indicating 
the rat mPFC may correspond to the primate dlPFC, an executive system structure.  
The current body of work set about testing the hypotheses that the mPFC is 
necessary for attributing value to delayed rewards and that decreasing the activity in an 
executive system area, and thus the executive system, shifts inter-temporal preference 
towards immediate rewards. To this end the rat mPFC was inactivated using an hM4Di 
inhibitory designer receptor exclusively activated by designer drugs (DREADD; 
experiment 1) or microinjections of tetrodotoxin (TTX; experiment 2) while animals 
completed an adjusting amount DD task. Activation of the hM4Di inhibitory DREADD 
receptor caused a decrease in DD, opposite of what was predicted. Electrophysiological 
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recordings revealed a subpopulation of neurons actually increased their firing in response 
to hM4Di receptor activation, potentially explaining the unpredicted results. 
Microinjections of TTX to completely silence neural activity in the mPFC failed to 
produce a change in DD. Together both results indicate that mPFC activity is capable of 
manipulating but is not necessary for DD and the attribution of value to the delayed 
reward. Consequently, a secondary role for the rat mPFC in DD is proposed in line with 
single valuation system accounts of DD. Further investigations determining the primary 
structures responsible for sustaining delayed reward valuation and how manipulating the 
mPFC may be a means to decrease DD are warranted, and continued investigation that 
delineates the neurobiological processes of delayed reward valuation may provide 
valuable insight to both addiction and psychopathology. 
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INTRODUCTION 
Impulsivity, Delay Discounting, and Psychopathology 
Poorly controlled and/or conceived behavior is often described as being 
impulsive. However the construct of “Impulsivity” does not appear to exist as a unitary 
entity. Rather the term describes a constellation of related but distinct behaviors all 
characterized as a lack of optimal behavioral control.  Different operational definitions of 
impulsivity, both self-report and lab task, do not inter-correlate strongly (Cyders & 
Coskunpinar, 2011). Furthermore in a seminal review by Evenden (1999), it was 
demonstrated that different behavioral measures of impulsivity are pharmacologically 
dissociable. 
One operational definition of impulsivity is high levels of delay discounting (DD). 
DD refers to the rate at which individuals devalue or discredit delayed outcomes. While 
attributing less value to delayed rewards is normally an adaptive process, it can become 
maladaptive. Exhibiting a strong preference for immediate gratification over later gains 
and rewards, even though the immediate rewards are considerably smaller or less 
desirable, constitutes acting without regard for future consequences and is often 
detrimental in the long term. As such, increased levels of DD are considered to be 
“Impulsive” (Ainslie, 1975).  
As evidence of increased DD being maladaptive, it has been associated with a 
variety of psychopathologies. Indeed Bickel et al. (2012) have described high levels of 
DD as “trans-disease process.” Greater discounting of delayed rewards and reinforcers is 
seen in case-control comparison studies for disorders such as depression (Puluc et al., 
2014), schizophrenia (Heerey et al., 2007), and attention deficit hyperactivity disorder 
(Demurie et al., 2012; Wilson et al., 2011). It has also been linked to greater levels of 
social anxiety (Rounds et al., 2007). Interestingly too little DD may also be problematic. 
Steinglass et al. (2012) recently found that the restricting subtype of anorexia nervosa is 
associated with decreased DD. 
Increased DD has also been repeatedly associated with addiction and is theorized 
to play a causal role in substance abuse pathology (Perry & Carroll, 2008). From a 
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conceptual perspective, individuals are choosing immediate rewards and reinforcement 
(e.g., rush, euphoria, escape) in lieu of greater but delayed ones (e.g. better health, 
financial stability, improved interpersonal relationships, etc.). Case-control comparison 
studies have consistently shown that substance abusing individuals exhibit elevated levels 
of DD. This pattern has been demonstrated across multiple classes of substances from 
alcohol (Mitchell et al., 2005; Petry et al., 2001; Vuchinich & Simpson, 1998) and 
cocaine (Washio et al., 2011) to nicotine (Bickel et al., 1999; Mitchell & Wilson 2012) 
and heroin (Kirby & Petry, 2004). Across studies and classes of substances, the 
difference in DD from cases to controls has a moderate effect size, and inclusion of 
nonclinical samples (e.g. heavy versus light social drinkers, recreational illicit drug users 
versus abstainers, etc.) does not abolish this effect (MacKillop et al., 2011). Moreover, 
levels of DD are positively associated with other alcohol use and risky drinking variables 
that are continuous in nature (Claus et al., 2011; Kollins, 2003). Longitudinal studies 
have shown increased DD predicts later levels of smoking (Drain-McGovern et al., 
2009), and mediates the protective effects of both working memory and religiousness on 
later alcohol and substance use respectively (Khurana et al., 2012; Kim-Spoon et al., 
2015).  In sum, DD has been shown time and time again to be related to substance abuse 
in correlational studies, and longitudinal evidence suggests increased DD occurs before 
substance use.  
Preclinical studies have also demonstrated that these elevated levels of DD are 
present in drug naïve animals before exposure and predict greater abuse liability. Higher 
levels of prior DD predict greater operant self-administration of cocaine and nicotine 
(Anker et al., 2009; Broos et al., 2012; Diergaarde et al., 2008; Koffarnus & Woods., 
2011). In addition, rodent lines selectively bred for high intake and preference of alcohol 
show increased levels of DD (Linsenbardt et al., 2017; Oberlin & Grahame, 2009; Perkel 
et al., 2015; Wilhelm & Mitchell, 2008). Though discordant results for the selected lines 
exist (Wilhelm & Mitchell, 2012; Wilhelm et al., 2007), this disagreement is likely due to 
high levels of home cage intake and preference of alcohol being a pleiotropic phenotype. 
All of the possible gene networks underlying intake and preference may or may not be 
recruited in a given selection, and DD may only be influenced by a subset of those gene 
networks (Mitchell, 2011). The gene network underlying increased appetitive drive, is 
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one such candidate network. Indeed increased DD in alcohol naïve animals tracks with 
later seeking of alcohol, but not its consumption (Beckwith & Czackowski, 2014; Stein et 
al., 2015). Hence the preclinical literature builds on human correlational and longitudinal 
studies by demonstrating increased DD is indeed present before increased self-
administration and is likely to be a genetically correlated trait with high levels of alcohol 
intake and preference.  
There is also evidence to suggest exposure to drugs of abuse increases DD as 
well, but the evidence is not as congruent across different substances. In preclinical 
models, cocaine exposure increases DD (Dandy & Gatch, 2009; Mitchell et al., 2014; 
Paine et al., 2003; Roesch et al., 2007; Simon et al., 2007). Heroin and nicotine both have 
(Dallery & Loecy, 2005; Schippers et al., 2012) and have not (Anderson & Diller 2010; 
Counotte et al., 2009; Hart et al., 2011) been sufficient to increase DD with possible 
differences in exposure paradigms (contingent vs. non-contingent) and rate-dependent 
effects being possible moderators. Ethanol’s effects are similarly mixed (Evenden & 
Ryan, 1999; Mejia-Tober et al., 2014; Olmstead et al., 2006; Pouls et al., 1998; Richards 
et al., 1999). Regardless, substance use causing an increase in DD is not mutually 
exclusive with DD causing increased abuse liability. Indeed if DD is both a risk factor 
and a consequence of substance abuse, then a potential positive feedback loop may be 
set-up. It is possible that DD confers risk for substance abuse, is increased by usage, and 
then confers additional risk for increased use.  
There are undoubtedly more processes involved in psychopathology and addictive 
disorders than DD. Just to name several factors, religious affiliation, peers, and family 
relations are all thought to be involved in the development of substance abuse (Stone et 
al., 2012). That being said, it is clear DD is an important piece to the puzzle based on the 
reviewed correlational, longitudinal, and preclinical research. Given a disease such as 
alcoholism’s large economic ($223.5 billion in 2006; Bouchery et al., 2011) and public 
heath impact (98,334 alcohol-attributable deaths from 2001-2005; CDC, 2011) multiple 
different approaches are warranted. Hence, developing interventions targeting DD is 
important, even though DD is not the end-all and be-all of addiction and 
psychopathology. In order to foster the development of these interventions, an 
understanding of the neurobiology of DD is needed. This knowledge is especially 
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important given the advent of new treatment strategies such as deep brain stimulation and 
site specific viral gene therapy. For example, LeWitt et al. (2011) used an adeno-
associated virus (AAV) to overexpress glutamic acid decarboxylase (GAD) in the 
subthalamic nucleus of Parkinson’s patients and saw improvement at 3 and 6 months 
without any major complications. 
Delay Discounting as Decision Making & Mathematical Models 
While DD is formally defined as a discounting of outcome value as a function of 
the delay to its occurrence, it is often conceptualized and considered a form of decision 
making. Human and animal tasks assessing DD are based on a choice between two 
different events that differ in the time at which they occur. Indeed descriptions such as 
preferring a sooner-smaller reward over a larger-later one imply a choice. The discounted 
value of a delayed reward is typically expressed in units of the same commodity provided 
immediately. Value itself is an abstract construct often used to compare two different 
goods/outcomes in a common currency. A related term that is frequently used 
synonymously to DD is inter-temporal choice. Inter-temporal choice specifically refers to 
how time influences choices between outcomes which differ in time. As 
conceptualization and measurement of DD is so intimately intertwined to decision 
making, conceptualizations of decision making become pertinent. 
In both psychology and economics as well as their intersection, behavioral 
economics, there is a rich history of studying decision making. Models of decision 
making generally fall into two broad categories, normative and descriptive. Normative, 
also known as proscriptive, models specify what an individual should choose (Anderson, 
1990). In other words if a person is a rational agent, what choice should they make. By 
contrast descriptive models do not make assumptions about what factors make the best 
alternative. Rather as their name implies, they simply describe observed patterns of 
behavior (Anderson, 1990). Mathematical models of DD are no exception and can be 
categorized as normative or descriptive.  
The earliest models of DD, or rather inter-temporal choice, were normative and 
derived from economics. These models are based upon a discounted utility model. The 
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utility1 of an outcome declines at a constant rate as a function of time due to a constant 
hazard rate (Samuelson, 1937; Strotz, 1956; Hull, 1943). In other words, for each unit of 
time there is a constant probability that the delayed outcome will no longer occur. 
Consequently, the decline in subjective value, or utility as it is defined, decreases at an 
exponential rate as a function of time. The equation below is Hull’s model where V is the 
value/utility, A is the amount, K is the discount rate, and D is the delay to the outcome.  
𝑉 = 𝐴𝑒−𝐾𝐷 
However, simple exponential models are unable to account for “preference 
reversals” (Ainslie, 1975)2.  When individuals are faced with a choice between two 
different delayed outcomes they typically will choose the larger delayed one. However, 
as the time to receipt comes closer and the sooner outcome essentially becomes 
immediate, they will change their choice to the sooner-smaller outcome. Put a different 
way, individuals have inconsistent preferences over time (Ainslie, 1974; Rachlin & 
Green 1972; Green et al., 1981). Quasi-hyperbolic models, have attempted to account for 
this dynamic inconsistency in choice. Laibson (1997) proposed a model where DD results 
from two competing systems. The first corresponds to an impulsive β system that 
discounts rewards faster than the actual decline in subjective value. This system attempts 
to capture the extra preference for immediate rewards via quasi-hyperbolic discounting. 
The second system, the δ system, is the rational system that discounts at a slower rate 
than is actually observed. In its simplest form3, the model is below where u is the 
undiscounted value of the outcome and t is the delay (McClure et al., 2004). 
𝑉 = 𝛽𝛿𝑡𝑢 
One of the most prevalent models in psychology is the hyperbolic model proposed 
by James Mazur (1987). This is a purely descriptive model that was worked out in 
pigeons via testing predictions about the delays needed to equate the value of two 
different rewards. Mazur’s hyperbolic model has since been seen to hold across species 
and explain more variance in DD than other equations (Ainslie, 1992; Green et al, 1994;  
                                                 
1 The satisfaction acquired from a good or service.  
2 Myerson & Green (1995) make the argument that exponential models can actually account for 
preference reversals once one accounts for magnitude effects on the rate of discounting. 
3 Both β and δ have been simplified.  
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Rachlin et al., 1991; but see Kable and Glimcher 2010; Myerson & Green 1995). Below 
V corresponds to the subjective value of the delayed reward, A the amount of the reward, 
k is the discount parameter, and D is the delay. 
𝑉 =
𝐴
1 + 𝑘𝐷
 
Ho et al. (1999) formally proposed another model that has been influential on 
neuroscience research, the multiplicative hyperbolic model. This model is often used in 
preclinical studies seeking to manipulate DD because in theory it allows one to 
disentangle differing effects of sensitivity to reward magnitude, probability discounting, 
and DD all of which may alter choice behavior. This model postulates that the value of a 
reward is a function of hyperbolic delay, magnitude, and probability discount functions 
that are multiplicatively combined. This is expressed mathematically below where q is 
the reward magnitude, Q is a discounting parameter for magnitude, d is the reward delay, 
K is the discount parameter for delay, θ is the odds-against ratio ([1/p]-1), and H is the 
discount parameter for the odds against ratio (Ho et al., 1999). 
𝑉 =
1
1 + 𝑄 𝑞⁄
∙
1
1 + 𝐾𝑑
∙
1
1 + 𝐻𝜃
 
Using a series of null equations based on when two rewards (A & B) have equal value, 
this model predicts a linear relationship between the delay to the sooner-smaller reward 
and the delay to the larger-later reward needed to equalize the value of the two rewards 
(da Costa Araujo et al., 2009; Ho et al., 1999; Kheramin et al., 2002). Below dB(50) is the 
“indifference delay” when the larger-later reward (B) has an equal subjective value to the 
sooner-smaller reward (A) delivered after a given delay (dA). 
𝑑𝐵(50) = 𝑑𝐴 [
1 + 𝑄 𝑞𝐴⁄
1 + 𝑄 𝑞𝐵⁄
] + [
1
𝐾
1 (1 + 𝑄 𝑞𝐵) − 1 (1 + 𝑄 𝑞𝐴)⁄⁄⁄⁄
1 (1 + 𝑄 𝑞𝐴)⁄⁄
] 
In this linear relationship, K, the discounting parameter for delay, only effects the y 
intercept; increases in K decrease the intercept. However the sensitivity to reward 
magnitude, Q, effects both the slope and intercept; increases in Q cause increases in both 
the slope and intercept.  
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Neurobiology of Delay Discounting  
Human Neuroimaging Research 
The different mathematical models of DD have had a distinct influence on 
research into and our understanding of the neurobiology of DD. This influence is 
especially apparent in human neuroimaging studies using functional magnetic resonance 
imaging (fMRI) and psychometric-neurometric comparisons. In this literature, two 
system accounts are the most prominent interpretations of the neurobiology of DD, and 
they bear a striking parallel to Laibson’s (1997) semi-normative, quasi-hyperbolic model 
proposing an impulsive β system and a rational δ system. As such, these two system 
accounts posit the existence of two competing systems: a hot, impulsive system versus a 
cool, reflective, executive system. This concept is not new to the field of neuroscience 
and experimental psychology. Metcalfe and Mischel (1999) proposed that “a cool, 
cognitive ‘know’ system and a hot, emotional ‘go’ system” underlie performance on their 
delay of gratification paradigm. More specifically the balance and interaction of these 
two systems is critical. One system eventually wins out over the other, and as a result, 
behavior is either controlled or “impulsive.”  
These dual process approaches have been adopted to explain both addiction and 
DD (Bechera, 2005; Bickel et al., 2007). The competing neurobehavioral decisions 
systems theory (CNDS) is one recent conceptualization. This theory postulates the 
existence of two different neurobehavioral systems: an executive system consisting of the 
prefrontal cortex (dorsolateral & ventromedial; PFC), insula, and hippocampus and an 
impulsive system mainly comprised by limbic regions (Bechara 2005; Bickel et al., 
2007). The relative activation of these two neural systems during a given decision 
determines the choice made by an individual. Extending to addiction, Bickel et al. (2007) 
make the argument that drugs of abuse alter executive system regions adversely 
explaining why addiction is associated with increased DD. Moreover, Bickel et al. (2007) 
suggest that increased DD and/or addiction may result from either an overactive 
impulsive system or an underactive executive system. Along similar lines, Bechara  
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(2005) proposed that drugs may trigger the bottom-up impulsive system and may bias or 
“hijack the goal-driven cognitive resources needed for the normal operation of the 
reflective system.”4 
McClure, Laibson, Loewen, and Cohen (2004) looked for evidence of these two 
separate neural systems based on Laibson’s (1997) impulsive β and conservative δ 
mathematical model of quasi-hyperbolic discounting. Using fMRI blood oxygenation 
level dependent signal (BOLD) as a measure of neural activity while participants 
performed a DD task, they examined neural activation across choices when either an 
immediate or delayed reward was chosen. The ventral striatum (VS), medial orbital 
frontal cortex (mOFC) and medial PFC (mPFC) were identified as showing greater 
activation during choices when an immediate reward was chosen and were ascribed to the 
impulsive β system. Conversely they identified δ system areas by whether they were 
activated during choices regardless of the chosen outcome. Also, δ system areas activity 
level had to be correlated with decision difficulty (to exclude sensory and motor 
processing areas). This δ system included the intraparietal cortex, dorsolateral PFC 
(dlPFC), the ventrolateral PFC (vlPFC), and the lateral OFC (lOFC; McClure et al., 
2004).  
Next they tested whether these two systems might be competing with each other 
by determining if the relative activation of the two systems during a trial predicted the 
chosen option. Indeed when participants chose the delayed reward, the δ system showed 
greater BOLD signal than the β system. Conversely, the β system showed greater activity 
compared to the δ system when an immediate option was chosen (McClure et al., 2004). 
Individual choices tracking with the neural activation in these two systems has been taken 
as evidence that these two different neurobehavioral systems exist and are competing 
with each other (Bickel et al., 2007).  
This differential pattern of activation has additional support from studies looking 
at the executive/δ system. Increased BOLD signal in the left dlPFC has been 
independently replicated to be greater when a delayed reward is chosen (Hare et al., 
2014). Also transcranial magnetic stimulation (TMS) used to disrupt activity in the dlPFC 
has been seen to increase the rate of DD. Although some lateralization exists as only 
                                                 
4 Bechara (2005) terms the cool, executive system the “reflective system.” 
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inhibition of the left, but not right, dlPFC increased selection of the immediate reward5 
(Figner et al., 2010). Transcranial direct current stimulation (DCS) of the dlPFC also 
affects DD. Left dlPFC stimulation/right dlPFC inhibition, but not the reverse, (i.e., 
anode over the left and cathode over the right) increases immediate reward selection as 
well (Hecht et al., 2013). Finally, increased DD is related to decreased activity in the 
dlPFC and lOFC after feedback in a card guessing task (Hariri et al., 2006). 
There is also independent evidence supporting the hot, impulsive β system. In the 
above mentioned card guessing game, VS reactivity to feedback was positivity correlated 
with DD rate. The activity in the mPFC, another β system area, displayed the same 
relationship with increased activity being related to increased DD (Hariri et al., 2006). 
Furthermore, choices that involve an immediate reward caused increase activation in the 
VS, anterior cingulate cortex (ACC), and mPFC. Furthermore this effect does not occur 
when the choice is being made for another person, suggesting the impulsive β system is 
not engaged when making choices for another individual (Albrect et al., 2011). This is an 
interesting finding considering individuals tend to be less impulsive (decreased DD) 
when choosing for another person versus for themselves, and the rate of discounting 
decreases with increased social and genetic distance (Ziegler & Tunney, 2012). The β 
system not being sufficiently activated when making choices and/or valuing rewards for 
other individuals such that the δ systems drives behavior could explain this phenomena. 
DD has fairly clear and well replicated age dependent effects across species that 
can be explained by two system accounts as well. DD tends to decrease with increases in 
age (Eppinger et al., 2011; Green et al., 1994; Reimers et al., 2009; Simon et al., 2010). 
Adolescence, one particular high period for DD, is characterized by a dopaminergic 
overdrive in the mesolimbic dopamine (DA) system and incomplete prefrontal 
development (Spear, 2000). Therefore in adolescence key executive system areas may 
lack functionality, and impulsive β system areas may have increased influence on DD. In 
line with this hypothesis, the greater DD seen in younger individuals is correlated with 
increased VS activation in response to immediate rewards, and this increased VS 
activation was positively related to the rate of DD (Eppinger et al., 2011). This finding 
                                                 
5 TMS did not disrupt value judgments or affect decisions involving two different delayed 
rewards.  
10 
 
was replicated by another cross-sectional study that found age related decreases in DD 
are associated with decreased VS activation during a DD task (Christakou et al., 2011). 
Seemingly against this grain, another β system area, the vmPFC, showed increased 
activation was related to decreases in DD. However, the age related changes in DD were 
also associated with increased vmPFC activation coupling with δ system areas (dlPFC, 
insula, and inferior parietal cortex) suggesting the development of top down control over 
the β system with age (Christakou et al., 2011). Also the increased BOLD signal seen in 
the vmPFC may actually correspond to neural inhibition and not activation. On a related 
behavior, risky decision making, adults have more activation in the vlPFC and dorsal 
ACC than adolescents supporting the notion of decreased executive system function 
during adolescence as well (Eshel et al., 2006). Combining these results suggest that age 
related differences in DD may be explained by an overactive hot, impulsive system and 
an impaired executive system in younger individuals, specifically adolescents.  
In 2007, McClure et al. replicated their β-δ system findings and extended them. 
Previously participants made their choices based on hypothetical monetary rewards with 
a timescale of weeks (McClure et al., 2004). Now individuals chose between actually 
delivered primary rewards (fruit juice or water) delayed by minutes. In this new context, 
they again found the limbic β areas (NAcc, mOFC, PCC, precuneus, aubgenual cingulate 
cortex) were preferentially activated for immediate rewards, δ areas (PCC, posterior 
parietal cortex, anterior insula, dlPFC) for all choices, and the relative activation of these 
two systems predicted the choice an individual would make. However, when both options 
were delayed by an additional ten minutes, the β system did not appear to be recruited. 
Suggesting that in this case, only the δ system weights rewards, but this is problematic to 
interpret via two system theories. As the two systems compete with each other and the δ 
system is processing and valuing both, what is it competing with? Moreover, a direct 
neuromeric-psychometric comparison did not yield the expected results. Specifically, the 
β term was fit to β system area’s BOLD signal and the δ term was fit to δ areas BOLD 
signal. The fitted parameters were compared to their counterparts when the model was fit 
to the behavioral data. While the δ terms from both models showed good correspondence, 
the β terms did not display such a quantitative match. Both of these findings can be 
interpreted away by proposing primary rewards are only given special weight via the β 
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system when truly immediate and β system areas also perform other functions disrupting 
the psychometric-neurometric comparison. Never-the-less, these minor inconsistencies 
foreshadow a different trend in the literature. 
NAcc/VS BOLD signal has been seen to track the subjective value of rewards, 
and not immediate reward choice. Ballard & Knutson (2009) used a DD task which 
presented individual components of each alternative in sequence. Combined with event 
related fMRI, separate BOLD signals were detected for reward delay and magnitude. 
Increases in delayed reward magnitude were related to increases in NAcc BOLD signal. 
According to the two system accounts, increases in NAcc activity should favor the 
immediate option. However, increases in delayed reward magnitude impart greater value, 
and increases in delayed reward magnitude cause discounting to occur at a slower rate 
(Baker et al., 2003). Furthermore, individuals who discounted at a greater rate should 
have greater NAcc activation. Rather these participants had the smallest increase in NAcc 
BOLD in relation to reward magnitude. While this makes intuitive sense that steeper 
discounters would have less of a neural response to a delayed reward, the two system 
explanations would predict this diminished response to occur in an executive system 
structure and not in the NAcc.  
Consistent with Ballard & Knutson’s (2009) findings, direct psychometric-
neurometric comparisons show the NAcc/VS tracks the subjective value of the reward 
regardless of whether or not it is delayed. NAcc as well as left vmPFC neural activation 
in adolescents during a DD task is positively correlated to the subjective value of the 
delayed reward (Schneider et al., 2014). Interestingly, this measurement occurred in the 
context of a longitudinal experiment, and the same relationship was found at both time 
points. Moreover, same-sex parental reward inconsistency6 assessed at the first timepoint 
not only predicted increased DD but decreased NAcc activation at the second time point. 
This finding suggests factors that increase the rate of DD also decrease this possible 
subjective value encoding of the delayed reward (Schneider et al., 2014). In adults, the 
VS, mPFC, and PCC have been seen to exhibit positive correlations with subjective value 
as well (Kable & Glmicher, 2007).  Additionally, the k values obtained from fitting the 
                                                 
6 Parental reward inconsistency was measured by items such as “my father promises me a reward 
and then forgets about it” (Schneider et al., 2014). 
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hyperbolic equation to the behavior and the BOLD signal in each of these regions of 
interest (ROI), did not differ. However, when the β-δ model was used, none of the ROI’s 
neural β or δ terms matched with the behavioral data (Kable & Glmicher, 2007).   
One critique of the above studies is that the immediate option was fixed in terms 
of both the time of presentation as well as its amount. Kable & Glimcher (2010) followed 
up and added variation in these domains, and the mPFC, VS, and PCC still showed 
correlations with subjective value. Specifically, BOLD signal in these areas was 
positively related to the absolute subjective value of both rewards, as opposed to the 
relative difference between the two options or only a single option (Kable & Glimcher, 
2010). In separate correlations, the subjective value of both the immediate and the 
delayed reward was related to BOLD signal in these areas. The ROI analysis however 
could not determine which relationship was the strongest (i.e., BOLD with  sum of 
absolute values, only the value of the larger-later reward, or only the value of the chosen 
reward; Kable & Glimcher, 2010). Finally they looked for direct evidence of separate β 
and δ systems by seeing if the dlPFC and PPC, two δ system areas, exhibited increased 
BOLD on choices where the delayed reward was chosen. They did not find the increased 
activity predicted by two system models, but rather activity in these regions increased 
with the difficulty7 of the choices (Kable & Glimcher, 2010). Moreover the VS, mPFC, 
and PCC did not show increased levels of BOLD on immediate reward choices separate 
from subjective value.  
These results led Kable & Glimcher (2010) to propose a single system 
interpretation of DD. In their “As soon as possible” single system model, they propose 
that rather than two competing systems there are several valuation areas that integrate 
different information about options. These areas then serve as a final common pathway 
which creates a value signal that is inversely related to delay (Kable & Glmicher; 2010). 
This value signal generated by a single system, then serves to guide choices.  
Separate from single and two system accounts, diffusion tensor imaging (DTI) 
and functional connectivity studies also provide a unique insight into the biological basis 
of DD. Specifically they highlight that how strongly areas are interconnected may be 
important. Resting state functional connection intensity (rsFCI) between areas whose 
                                                 
7 Choice latency was used as an index of difficulty.  
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activation during a DD is positively correlated with reward magnitude (vmPFC, striatum, 
PPC, hippocampus, parahippocampus) has been seen to be directly related to DD rate. 
Moreover, the rsFCI between these magnitude areas and areas whose activation is 
negatively correlated with delay (aPFC, SFG, dlPFC, IFG, vmPFC, dmPFC, IPL) was 
negatively correlated with DD rates (Li et al., 2013). Also, functional coupling between 
the ACC and the hippocampus/amygdala predicts the degree to which episodic future 
event cues decrease DD (Peters & Büchel, 2010). Frontostriatal white matter integrity 
(WMI) has been shown to be negatively correlated with the rate of DD such that 
decreased WMI is related to increased DD (Peper et al., 2013). Similarly increased 
structural and functional connectivity between the dlPFC and the striatum, assessed via 
DTI and fMRI BOLD, is associated with decreased DD and increases in the connectivity 
are related to the decrease in DD with age (van den Bos et al., 2014; 2015). Hampton et 
al. (in press) looked to dissociate ventral versus dorsal frontostriatal white matter 
connectivity to DD. They found that the strength of the connection between the vmPFC 
and VS was related to increased DD, and the strength of the connection between the 
dorsal striatum and the dlPFC was similarly related to increased DD as well (Hampton et 
al., in press). Finally, longitudinally frontostriatal white matter development predicts 
future DD rate (Achterberg, 2016). Hence, the connectivity between regions, perhaps 
particularly the dlPFC to the striatum, has an influence on DD as well.  
Two of the most commonly identified areas in both event related fMRI and 
connectivity studies are the VS/NAcc and the dlPFC. While the VS/NAcc may be 
implicated in encoding the subjective value of the delayed reward and a β system area in 
two system accounts, exactly how the dlPFC is been implicated has varied from study to 
study. It was identified as a δ system area by McClure et al., (2004; 2007). Disruption by 
TMS and DCS has increased DD (Finger et al., 2010; Hecht et al., 2012). Ballard & 
Knutson (2009) founds its activity level to be inversely correlated with delay, and Kable 
& Glimcher, (2010) found its activity tended to increase with increases in choice 
difficulty. Its connectivity to the VS/NAcc is also related to DD (Li et al., 2013; Van den 
Bos, 2014; 2015; Achterberg, 2016). Never-the-less the precise role of the dlPFC in DD 
is not certain based on these studies beyond that it appears to be important for delaying 
gratification and is a “cooler” area involved in executive functions.  
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 Additional insight into the role of the dlPFC may be provided by studies 
examining variation in catechol-O-methyltransferase (COMT) genotype in relation to 
DD.  One common single nucleotide polymorphism, rs4680, is a G to A substitution that 
results in a valine (val) as opposed to a methionine (met) at codon 158 (val158met). The 
val allele is associated with increased metabolism of DA and higher protein levels of 
COMT (Chen et al., 2004). As COMT is responsible for the majority of DA clearance in 
the PFC, the val158met substitution results in large differences in the levels of PFC DA 
(Käenmäki et al., 2010). The val allele, which should result in a hypodopaminergic state 
in the PFC, and thus the dlPFC, is associated with increased DD. Boettiger et al. (2007) 
found that individuals homozygous for the val allele showed increased levels of DD, and 
moreover during the DD task these individuals showed increased BOLD signal in the 
dorsal PFC.  This effect was later replicated with individuals heterozygous for the val 
allele displaying an intermediate phenotype (i.e., increased DD was associated with an 
increased val allele count; Gianotti et al., 2012). Furthermore, dorsal PFC (BA 9/10) 
resting state electroencephalogram (EEG) measurements (beta3 activity) were related to 
both DD and val allele count, and a mediation analysis found the resting state activity 
fully mediated the relationship between COMT genotype and DD. Taken together, these 
results suggest possession of the high activity val allele leads to a hypodopaminergic state 
in the dorsal PFC that causes increased DD. 
However the exact opposite result has been observed as well; the met/met 
genotype has been associated with increased levels of DD (Paloyelis et al., 2010). 
Critically, this observation was in adolescent boys. Subsequent studies found that age 
moderated the effect of COMT genotype on DD (Smith and Boettiger, 2012). Adolescent 
val/val homozygotes show decreased DD compared to met/met homozygotes and val/met 
heterozygotes. In adulthood this pattern is reversed with the val/val homozygotes 
showing increased DD compared to the other genotypes. Smith and Boettiger (2012) 
interpreted these results in the context of an inverted U dose response function for DA in 
the PFC. The high activity val allele normalized the high levels of mesocortical DA seen 
in adolescence (Spear, 2000),  but in adulthood the val/val genotype resulted in too little 
DA. Conversely, the met allele carriers had experienced an excess of dopamine in 
adolescence, but the optimal amount in adulthood.  
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Finally, administration of tolcapone, a COMT inhibitor, decreased DD having the 
greatest effect in impulsive individuals (Kayser et al., 2012). Tolcapone also increased 
BOLD signal in the dm- & dlPFC and decreased BOLD signal in default mode network 
cortical areas. The tolcapone mediated decrease in DD was inversely correlated with the 
change in BOLD signal in the striatum and anterior insula. Some caution is warranted as 
COMT is not solely expressed in the PFC. However, EEG and fMRI results support PFC, 
specifically dorsal PFC, involvement in COMT’s relationship with DD coupled with 
downstream effects in areas such as the striatum (Gianotti et al., 2012; Boettiger et al., 
2007; Kayser et al., 2012).  
Preclinical Investigations 
Preclinical investigations of the neurobiology of DD have looked at several 
interconnected areas including the NAcc, OFC, mPFC, and the basolateral nucleus of the 
amygdala (BLA). Unlike human neuroimaging studies, the involvement of a single 
structure is typically examined in isolation. What is lost in being able to examine the 
entire human brain simultaneously is made up for by the use of experimental as opposed 
to correlational designs and more precise measures than fMRI BOLD.  
Preclinally, DD is examined using various discrete choice8 tasks (DCT) where 
subjects make individual distinct choices between two alternatives (as opposed to having 
two concurrently available schedules that one can switch back and forth between at will). 
They are typically set up on a trial by trial basis where subjects are presented with two 
different (free choice) or 1 (forced choice) response options that yield a specific outcome 
when completed on each trial. Completion of one response, precludes execution of the 
other. One key implication is that with the use of an inter-trial interval animals are not 
able to earn a greater relative rate of reinforcement by earning multiple sooner-smaller 
rewards in the span of time it would take to earn a single delayed reward.  
In rodents there are five main DCT paradigms, although others exist, that are 
commonly used to measure DD. One of the first means to assess DD utilized a T-Maze. 
One arm of the “T” always contained a small reward available immediately and the other 
                                                 
8 In the current document a discrete choice is defined by when subjects are forced to choose 
between a finite set of alternatives in a trial by trial basis. 
16 
 
a large reward delivered after a delay. The delay to the large reward is typically 
implemented by detaining rats in the delayed arm using guillotine doors prior to reward 
delivery. Several trials are given per day. After several days the delay to the large reward 
is increased. The main dependent variable is percent choice of each arm. Greater choice 
of the small reward arm when delays are present on the larger reward indicate increased 
DD. 
The adjusting delay (AD) paradigm was developed by James Mazur (1987). It is a 
psychometric titration procedure that derives an “indifference delay” for two rewards that 
differ in magnitude. On one lever (or response key as was the case for Mazur) a small 
reward is delivered immediately with no delay. On the other lever a large reward is 
delivered after a variable delay. The delay to the larger reward is adjusted based upon the 
subject’s choices. Forced choice trials, in which only one lever has any programed 
consequences, are used to ensure subjects are acquainted with the changing delays. The 
sessions are divided into 4 trial blocks, 2 forced choice trials (one on each lever) followed 
by two free choice trials. If a subject chooses the larger delayed reward twice in a block, 
the delay is increased by one second in the next block of trials. If they choose the 
immediate reward twice it would decrease. Across one session to the next the delay is 
carried over. Once there is no change in the mean adjusted delay (MAD) across sessions, 
the MAD is inferred to be the delay to the larger reward necessary to equalize the value 
of the two rewards (i.e., the indifference delay)9. Longer MADs correspond, to decreased 
DD as longer delays are needed to sufficiently discount the value of the larger reward to 
achieve indifference. 
In 1996, Evenden and Ryan described a different operant DD procedure wherein 
several delays would be utilized within a session. On each trial the rat responded on 
either a lever associated with one pellet delivered immediately or 3 or 5 pellets (pending 
experiment) delivered after a delay. The delay to the large reward started at 0 and it 
increased every 12 trials. In this fashion each session consisted of 5 blocks of 12 trials 
each with a different delay. The principle variable of interest was percent choice of the 
delayed reinforcer with decreased percent choice of the delayed option corresponding to 
                                                 
9 Note: for acute pharmacological investigations typically only a single session’s MAD score is 
used versus an average of several sessions.  
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increased DD. Also, an indifference delay can be derived via interpolation. One notable 
procedural variation of this paradigm is to decrease the delay across blocks versus 
increases them (i.e., start at a 60 second delay and work to 0). Later studies included 2 
forced choice trials at the start of each block, one on each lever, to signal the changing 
delays. This task is often referred to as the delayed reward task (DRT). 
A consideration with the DRT is within session carry over effects and the 
influence of increased behavioral perseveration. Increased behavioral perseveration 
would in theory cause the rat to continue to respond on the initially more reinforcing 
outcome in spite of the changing delay. These concerns and the effect they can have is 
demonstrated by Tanno et al. (2014) who found the effects of systemic amphetamine 
administration on a DRT depended on the order of delay presentation (ascending versus 
descending). Specifically, when ascending delays were used systemic amphetamine 
decreased DD. Conversely when descending delays were used, systemic amphetamine 
increased DD. Tanno et al. (2014) interpreted these results as amphetamine increasing 
behavioral perseveration on the initially more valued option (the delayed reward in 
ascending delays and the immediate reward with descending delays). However, the exact 
nature of the increase in behavioral flexibility needed to cause such a false positive is not 
clear. Lesions of the vHPC cause increased perseverative responding on a 5 choice serial 
reaction time task, but also increased DD on a DRT (Abela & Chudasama, 2013; Abela et 
al., 2012). Regardless, interpreting any decrease in DD or null result when only 
ascending delays are used is extremely difficult. An observed change in choice behavior 
may, or may not, actually be a result of underlying processes presumed to govern DD. 
Put another way, when only ascending delays are used (which is majority of cases) the 
DRT is susceptible to false positives for decreases in DD and false negatives for having 
any effect10.  
Considering the converse situation, decreased behavioral perseveration, additional 
factors come into play. It could be argued that decreasing behavioral perseveration would 
cause increased DD in a DRT with ascending delays as subjects would be better able to 
track the changing reward values. However this argument assumes that under baseline 
                                                 
10 The vast majority of studies only use ascending delays. Unless it is specifically stated otherwise 
in this document, ascending delays are implied.  
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conditions without pharmacological manipulations, subjects are not already tracking the 
reward values optimally. While this situation is possible, it is not likely. The AD 
paradigm, in which perseveration is not a major concern, shows concurrent validity with 
the DRT suggesting that the DRT does provide valid measurement under baseline 
conditions. The concurrent validity of these two paradigms is evidenced by indifference 
delays derived from these two paradigms (derived via interpolation in a DRT and by 
MAD scores in an AD paradigm) inter-correlating very strongly (Spearman’s ρ = .71; 
Craig et al., 2014). Accordingly, at least under baseline conditions the DRT may not be 
confounded by behavioral perseveration.  
The adjusting amount (AA) DD task was developed by Richards et al. (1997) and 
is akin to the AD procedure in that it utilizes a titration schedule. However as its name 
indicates the magnitude/amount of the immediate reinforcer is adjusted as opposed to the 
delay. On each trial the subject chooses between one response yielding a standard reward 
after a delay and an adjusting alternative reward delivered immediately. If the subject 
chooses the standard reward, the adjusting alternative reward’s magnitude adjusts up on 
the next trial and vice versa if the adjusting alternative reward was chosen. The exact 
degree of titration varies from lab to lab, some utilizing a percent of the adjusting 
alternative reward and others using a fixed amount.  The median adjusting amount of the 
last 20-30 trials is taken as a measure of indifference. These indifference points are taken 
as a measure of the subjective value of the delayed standard reward in units of the 
immediate reward. Lower indifference points correspond to increased DD as subjects are 
willing to settle for less immediate reward in lieu of the delayed reward. 
The quantitative analysis (QA; Kheramin et al., 2002) method is not really a 
different paradigm. Rather it is a different approach to examining and analyzing DD data 
with a small, but meaningful procedural variation. The QA approach uses either a DRT or 
AD task to derive a series of indifference delays to the larger-later reward as a function of 
the multiple different delays to sooner-smaller reward. Then the QA paradigm applies the 
multiplicative hyperbolic model11. The relationship between the delay to the sooner-
smaller reward and the indifference delay to the larger-later reward is linear with its slope 
affected by Q (magnitude sensitivity parameter) and its y intercept by both K and Q. K is 
                                                 
11 Discussed above under Delay Discounting as Decision Making & Mathematical Models. 
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inversely related to only the intercept, and Q is directly related to both the slope and 
intercept. Differences in the slope and intercept of the indifference delays (in addition to 
fitting the model directly) are then used to make inferences about the rate of DD. In this 
fashion one is able to disentangle sensitivity to reward size from sensitivity to reward 
delay.  
There are also variations within and across the different methods of assessing DD 
in rodents that are important to consider. The lengths of the delay to the larger reward 
varies wildly across (and within) the different paradigms from several seconds (Acheson 
et al., 2006) to over a hundred (Pardey et al., 2012; Bezzina et al., 2007). Different delay 
lengths may require different processes and recruit different neural structures to delay 
gratification. Also, there is variability in what cues are used. Some studies use explicit 
discriminative stimuli (DS) to signal the available options others do not.  
Using a cued delay period (CDP) has also been shown to moderate the effect of 
manipulations on DD and affect the rate of DD in general (Zeeb et al., 2010). A CDP is 
when an explicit stimulus is presented after the selection of the delayed alternative and 
remains until the reward is delivered. For example, after pressing the delayed reward 
lever, a stimulus light comes on or flashes until the delayed reward is presented. 
Increasing the delay between response and reinforcement decreases the strength of the 
resulting response-reward association. Signaling the duration of the delay with a cue can 
facilitate learning and increase the effective value of the delayed reward, as the cue 
acquires some of the affective properties of the reward and may act as a conditioned 
reinforcer (Mazur 1997; Williams and Dunn 1991). Indeed it has been proposed that 
animals are actually choosing between the immediate reward and a conditioned reinforcer 
(Mazur, 1997).  
Each of these methods and procedural variations has their own strengths and 
weakness. The DRT allows one to test all delays inside a single session easily allowing 
one to see if an effect only occurs at specific delays or causes animals to no longer value 
the larger reward when there is no delay. However this is also its major limitation as 
impairments in animals’ ability to adapt to these within session shifts can lead to false 
positives for decreasing DD (Tanno et al., 2014). The AA and AD procedure do not have 
this drawback, but they only assess one delay for acute manipulations and make strong 
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assumptions about animals’ ability to track changing reward values on a trial by trial 
basis. The QA method can provide additional information, but it takes longer to complete 
by orders of magnitude as one is essentially repeating the other paradigms multiple times. 
In lesion studies this can raise concern about the development of compensatory 
mechanisms, and it precludes the use of acute pharmacological manipulations.  
 However, given the differing limitations of each, converging evidence from 
multiple different paradigms is particularly valuable. Fortunately, studies looking into the 
concurrent validity of these tasks suggest that they are measuring the same construct.  As 
was mentioned before, the indifference delays derived via an AD and DRT in the same 
rats correlate very strongly with each other (Craig et al., 2014). Also the AA and AD 
tasks show convergence on the same construct as well. Both the AA and AD procedures 
are equally well fit by Mazur’s (1987) hyperbolic equation, and yield values of the 
discount parameter (k) that are not different when derived in the same subjects using both 
paradigms (Green et al., 2007). As the different paradigms display concurrent validity 
with each other and have their own unique caveats, the ideal evidence of a change in DD 
is congruent evidence across multiple different paradigms. In this fashion, the caveats of 
an individual task can be excluded as an alternative interpretation.  
The following sections review the brain site specific investigations of DD. The 
overall goal is to attempt to distil the structures and connections important for DD and 
what role they may subserve. While some of these studies examine the role of a 
neurotransmitter system in a specific structure in DD, the overall roles of a given 
neurotransmitter system will not be examined here. While they are undoubtedly 
important and influential, comprehensively reviewing the literature on systemic 
neurotransmitter manipulations would be a separate massive undertaking fraught with its 
own challenges. Accordingly, such a discussion has been deemed to be beyond the scope 
of the current document.  
Nucleus Accumbens 
The NAcc has long been considered an interface between the limbic and motor 
system (Morgenson, 1980) in addition to proposed roles including reward processing and 
associative learning (Wise, 1980; 2004; 2005), incentive salience attribution (Berridge & 
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Robinson, 1998; Berridge, 2007), and invigorating and directing behavior (Cardnial et al., 
2002). It has also been put forth that the NAcc represents different outcomes 
simultaneously and acts as a mechanism of action selection (Nicola, 2007; Floresco, 
2015). The NAcc’s limbic afferents and direct and indirect efferent connections to the 
basal ganglia and brain stem motor nuclei are central to the NAcc acting as a limbic 
motor interface involved in action selection (Basar et al., 2010; Floresco, 2015; Nicola, 
2007).  
The NAcc receives inputs from a number of different areas and is situated to serve 
as an integration site. The core subregion has afferent connections with the anterior end 
of the BLA, dorsal prelimbic cortex, cingulate cortex, parahippocamapl cortex, as well as 
the caudal midline and intralaminar nuclei of the thalamus (Berendse et al., 1992; 
Berendse and Groenewegen, 1990; Brog et al., 1993; Wright et al., 1996). The shell of 
the NAcc is innervated by the posterior BLA, infralimbic cortex, ventral prelimbic 
cortex, hippocampus (subiculum & CA1), ventral tegmental area (VTA), and dorsal 
raphe (Berendse et al., 1992; Brog et al., 1993; Heidbreder and Groenewegen, 2003; 
Berendse and Groenewegan, 1990; Wright et al., 1996; Groenewegen et al., 1987; 
Ikemoto, 2007; Berridge et al., 1997).  
In contrast to its inputs, the NAcc tends to project to the basal ganglia and other 
subcortical structures. The NAcc core’s efferent connections include the ventral pallidum 
(VP), endopeduncular nucleus (human Globus palidus intera), and the substantia nigra 
pars reticulate (SNpr; Deniau et al., 1994; Haver et al., 1990; Heimer et al., 1991; 
Groenewegen and Berendse, 1990; Alexander et al., 1990; Ferry et al., 2000; 
Groenewegen et al., 1993; Groenewegen et al., 1996; Zaham and Brog, 1992). The shell 
projects to the VP as well, but also the lateral hypothalamus, pedunculopontine nucleus, 
VTA, and SN pars compacta. (SNpc; Groenewegen et al., 1993; Groenewegen et al., 
1999a; Groenewegen et al., 1996; Zaham and Brog 1992; Gerfen, 2004).  
Interestingly, the VP projects to some the same regions as the NAcc, namely the 
endopeduncular nucleus, VTA, SNpc, SNpr, and lateral hypothalamus (Nicola, 2007). As 
a result, activation of NAcc projections, which are GABAergic MSNs (Chang & Kitai, 
1985; Ikemoto et al., 2015; Preston et al., 1980), can directly inhibit areas, or disinhibit 
them via inhibiting the VP’s GABAergic projections (Ikemoto et al., 2015; Nicola, 2007; 
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Zahm, 1987; 1996). This potential parallel processing of information and 
inhibition/disinhibition mechanism is central to Nicola’s (2007) conceptualization of 
NAcc’s potential role in action selection. It is important to note that subserving this 
function is not necessarily incompatible with other proposed functions for the NAcc.  
Looking at DD specifically, a number of studies report core lesions increase DD. 
One of the earliest of these reports was by Cardinal and colleagues (2001). Animals 
completed a DRT without DS or a CDP and with ascending delays. Excitotoxic lesions 
decreased selection of the large reward compared to sham lesioned animals (Cardinal et 
al., 2001). However the lesions did so at all delays, with the mean section of the larger-
later reward at just above 25% when no delay was present. While omitting or including 
all delays on alternate sessions did show NAcc core lesioned animals were still sensitive 
to delay, it did not restore a preference for the larger reinforcer with no delay. 
Consequently while an increased selection of the immediate reward was present, animals’ 
ability to discriminate between rewards of different magnitudes may have been impaired 
by the NAcc core lesions.   
Cardinal and Cheung (2005) followed up on whether NAcc core lesions affect 
sensitivity to reward magnitude. They tested whether excitotoxic NAcc core lesions 
would affect generalized matching behavior to two concurrent random interval 60 
schedules. The schedules differed only in the magnitude of the reinforcer. While both 
groups undermatched, NAcc core lesioned rats more closely approximated perfect 
matching behavior comparted to sham animals. Cardinal and Cheung (2005) inferred 
based upon this finding that NAcc core lesioned animals actually were more sensitive to 
reward magnitude. However, this finding of increased sensitivity to reinforcer magnitude 
conflicts with their earlier study (Cardinal et al., 2001) where animals displayed lack of 
preference, nearing an aversion, for a larger magnitude reward versus a short one when 
no delay was present. Their interpretation also downplays the possibility that core 
lesioned animals may process reward magnitude differently than sham animals.  
Other studies have followed up on and attempted to account for this possible 
change in the sensitivity to reinforcer magnitude seen by Cardinal et al. (2001). These 
experiments have utilized the QA paradigm with either a shortened version of the DRT or 
an AD task to derive indifference delays. Bezzina et al., (2007) used an abbreviated DRT 
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with a CDP, and varied the delay to the receipt of the sooner-smaller reward. Excitotoxic 
lesions of the NAcc core decreased the intercept, but not the slope, of the indifference 
delays as a function of the delay to the sooner reward. This result indicated that the 
discount parameter for delay, K, but not magnitude, Q, was affected by the lesion. 
Specifically, the lesion increased the rate of DD. da Costa Araújo et al. (2009) used the 
QA method with an AD paradigm to derive indifference delays while they varied the 
magnitude of the sooner-smaller reward. They found that the ratio of the indifference 
delays between different magnitudes of the sooner-smaller reinforcer were unchanged 
between an excitotoxic lesion and sham lesion group, but the overall level of the 
indifference delays was lower in the lesioned animals. The multiplicative hyperbolic 
model predicts that this change occurs when the sensitivity to magnitude is unaffected 
but, DD is increased (da Costa Araújo et al., 2009). The same group of researchers also 
subsequently replicated12 this effect (Valencia-Torres et al., 2012). As a whole, the 
research with the QA paradigm indicates that excitotoxic lesions of the NAcc core 
increase DD but do not affect sensitivity to magnitude.  
Galtress & Kirkpatrick (2010) also found evidence that the NAcc core is involved 
in DD with a choice link procedure. In their choice link procedure, the first link had 
animals chose the schedule they would respond on with an FR1. The two options were a 
FI60 or a progressive interval (PI) schedule. The PI schedule started at 0s and increased 
by 15s with every selection of the PI schedule. Once the animal chose the FI60s schedule 
the PI interval reset to 0 seconds. The main dependent variable was the “changeover 
time,” the mean interval on the PI schedule at which animals chose the FI60 schedule. 
They found that when the FI60 schedule was reinforced with 4 pellets and the PI 
schedule with 1, animals with an excitotoixc lesion of the NAcc core had an increased 
changeover time. This result suggests increased DD because a longer delay to the 1 pellet 
reward is needed to equalize the value of the 4 pellet reward which has been discounted 
to a greater extent due to the longer delay13. 
                                                 
12 Valencia-Torres et al. (2012) was an almost exact replication of da Costa Araújo et al. (2009). 
They changed the amounts of reward magnitudes such that there were specific proportional relationships 
between the sooner-smaller and larger-later rewards. This allowed them to simplify some of the null 
equations and test additoinal mathematical predictions that are beyond the scope of this document.  
13 Assuming the quasi-hyperbolic model of Mazur (1987),  k=.1, a fixed delay of 60 seconds to a 
reward with a magnitude of 4, and an alternate reward magnitude of 1, a delay of 7.5 seconds to the 
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Galtress & Kirkpatrick’s (2010) also used an incentive contrast procedure to 
examine if animals ability to process reward magnitude was disrupted. In this task, 
animals responded on two different levers each reinforced with a single sucrose pellet on 
a VI30s schedule. Only one lever was extended into the chamber at a time in a pseudo-
random order and there were no explicit DSs. After animals exhibited a stable baseline 
and equal levels of responding for each lever, one lever, the induction lever, had its 
reinforcer increased to 4 pellets. The other lever’s reinforcer stayed at 1 pellet (contrast 
lever). NAcc core sham lesioned animals showed the predicted increase in responding on 
the induction lever and a decrease on the contrast lever. However, core lesioned animals 
only showed the decreased responding on the contrast lever. These results suggest, at 
least to some degree, that core lesions disrupt normal processing and/or adaptation to 
reinforcer magnitude.  
To avoid potential problems with magnitude perception, Pothuizen and collegeus 
(2005) used a choice procedure that had rewards that differed in terms of both delay and 
probability (as opposed to magnitude). One option provided continuous reinforcement 
that was associated with a delayed 1 pellet reward, and the other option yield partial 
reinforcement, p(reward)=.25, for an immediate 1 pellet reward. The delay was changed 
across days (2-5 days at each delay) in a pseudorandom order with 0 second delay 
conditions in place before and between all other delays. Before training animals received 
excitotoxic NAcc core, shell, or sham lesions. Initially, no differences were seen under 
any-delay condition. However, after extended re-testing at the longest delay, core 
                                                 
alternate reward is needed to equalize the value of the two rewards (to three digits to the left of the decimal 
place).  
𝑉1 =
4
1 + .1(60)
= 𝑉2 =
1
1 + .1(7.5)
= 0.571 
 
Conversely when k=.4, a delay of 13.1 seconds to the alternate reward is needed to equalize the reward 
values.  
𝑉3 =
4
1 + .4(60)
=  𝑉4 =
1
1 + .4(13.1)
= 0.16 
 
As a result, the relationship between k and the change over point in Galtress & Kirkpatrick’s (2010) choice 
link task takes on a positive decelerating function. This pattern, at least mathematically, occurs because as k 
increases it discounts both the smaller and larger rewards faster hence while the larger-later reward is 
discounted more and needing more of a delay, smaller reward is discounted more and more needing less of 
a delay to equalize the values. Consequently, at higher levels of k the power to detect differences with this 
procedure is actually substantially reduced.  
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lesioned animals developed a greater preference for the immediate reward relative to 
sham lesioned animals. This result may suggest that core lesions increased DD14, and 
critically this was observed when the two rewards had equal magnitudes as core lesions 
may disrupt animals’ ability to distinguish reward magnitudes. 
Alternatively, Pothuizen and colleagues’ (2005) core lesioned animals may have 
slowly extinguished delayed lever responding. This interpretation is supported by the 
deficit only being seen with extended testing, and Cardinal and Cheung (2005) found that 
NAcc core lesions impaired learning a response with a delayed, but not immediate, 
reinforcer. Specifically pretraining NAcc core excitotoxic lesions impaired acquisition of 
and rate of responding (ROR) for delayed rewards in a free operant schedule with no 
explicit cues. Post-training lesions disrupted responding for a delayed, but not immediate, 
reinforcer, and responding for a delayed 20 second reinforcer was no longer different 
from responding on the inactive lever.   
While the majority of studies have found disrupting the NAcc causes an increase 
in DD, two have found the opposite effect. In a DRT with DS but no CDP, partial 
inactivation of the NAcc core with a low dose of microinjected baclophen and musimcol 
resulted in increased preference of the delayed reward (Moschak & Mitchell, 2014). 
Interestingly this effect was driven by individuals who were already low discounters at 
baseline. Steep discounters displayed no change. The second study to find an increase in 
DD characterized the effects of complete (core and shell) NAcc excitotoixic lesions. In an 
AA task with both DS and a CDP, post-training lesions increased indifference points at a 
delay of 8 seconds (but not 4), and increased k values (Mazur, 1987) indicative of 
decreased DD (Acheson et al., 2006).  
 Acheson et al.’s (2006) study also found that whole NAcc lesions decreased the 
model fit (R2) for Mazur’s (1987) hyperbolic equation. Concerned that the lesion 
disrupted animals ability to adapt to changes in delay, they then retrained animals at a 
delay of 4 seconds and the switched them to a delay of 2 or 8 seconds. In this test, they 
                                                 
14 One potential caveat to this interpretation is whether core lesions alter probability discounting. 
Acheson et al. (2006) did not find whole NAcc lesions affected discounting. Cardinal & Howes (2005) 
found core lesioned animals to be risk aversive. If the NAcc core is necessary to promote choice of 
uncertain rewards, it adds strength to Pothuizen et al.’s (2005) findings as lesioned animals developed a 
preference for the immediate reward based on delay aversion despite an increase in probability discounting.  
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found that lesioned animals had greater indifference points at the 8 second delay. 
Acheson et al., (2006) argue that this was evidence of lesioned animals being less 
sensitive to changes in delay. However, they did not observe the corresponding result 
with a delay of two seconds (decreased indifference points). Indeed, this test truly only 
replicated their prior results of no difference at the 4 second delay and increased 
indifference points at the 8 second delay. Consequently, there may not be sufficient 
evidence to assuredly make the inference that animals were less sensitive to changes in 
delay as a decrease in DD is still a plausible explanation for their results.  
Two other studies have also attempted to assess if lesioning the NAcc core makes 
animals less able to adapt to changing delays. da Costa Araújo et al. (2009) and Valencia-
Torres et al. (2012; discussed above) used a Fourier transform on the adjusting delays in 
an AD task to conduct a power spectrum analysis. If animals ability to perceive and adapt 
to the changing delays was impaired, then they would continually “over and under shoot” 
during their titration of the adjusting delay. In theory, this in turn would lead to more trial 
blocks per oscillation in adjusting delays and a greater peak to trough difference in 
oscillations of the adjusting delay. Thus if animals’ ability to adapt to and perceive 
changing delays was impaired, then the both dominate frequency band and its power 
would be expected to be greater. However, they found that the dominate frequency band, 
and the power in said band, did not differ as a function of the lesion group suggesting 
animals ability to adapt to the changing delays was not impaired.  
Dopamine neurotransmission in the NAcc appears to be involved in DD as well. 
Day et al. (2010) performed fast scan voltammetry in the NAcc core and shell while 
animals completed a DCT where stimulus lights cued the available rewards for 5 seconds 
before lever extension. Then animals chose between two equal magnitude rewards, only 
one of which was delayed. On all trials, a phasic dopamine signal was observed in the 
core that occurred with cue onset. On forced choice trials where only one alternative was 
cued and available, the high value (no delay) cue was associated with a greater phasic 
dopamine release that the low value cue. On free choice trials when both cues were 
presented concurrently, there was no difference in the phasic DA signal between trials  
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where the low or high value alternative was selected. In the NAcc shell, a phasic 
dopamine signal was observed with cue onset, but it did not differ based on the type of 
forced choice trial or free trial choice.  
Day et al.,(2010) interpreted this as indicating that phasic dopamine release in the 
NAcc core, but not shell, encodes the value of rewards, and on free choice trials it 
encoded the value of the greater value reward regardless of the eventually chosen option. 
While this is a plausible explanation, especially as the DA signal occurred before animals 
reach the point of no return for their choice (the lever press), they did not parametrically 
vary either of the reward values and correlate the DA signal with the options (and their 
combination) on each free choice trial. Consequently, alternative explanations, such as 
the DA signal encoding a combination of the two rewards values, cannot be ruled out.  
Manipulation of this dopamine signal affects DD as well. Adrianai et al. (2009) 
transfected the NAcc of male wistar rats with a lenti-virus causing overexpression of 
DAT, silencing of DAT, or expression of green fluorescent protein (GFP). Animals 
completed a DCT where either an immediate, low magnitude (1 pellet) reward was pitted 
against a delayed, larger magnitude (5 pellets) reward. The delay increased across 
sessions and was constant within given session, and a CDP was used. Compared to GFP 
controls, both silencing and overexpression of DAT in the NAcc caused increased 
selection of an immediate, low magnitude reward (Adriani et al., 2009).  
However, 6-OHDA lesions, which selectively target dopamine innervation, have 
not been demonstrated to affect DD. Winstanley et al. (2005) found that such lesions of 
the entire NAcc did not affect choice behavior on a DRT with ascending delays and no 
CDP or DS. A conference abstract by Richards et al. (2002) reports a similar null effect 
with an AA procedure (based on the group the procedure would have had DS and a 
CDP). Never-the-less, both of these reports do not differentiate between the core and 
shell and did not completely ablate dopamine levels (~70% reduction reported by both).  
Additional light may be shed by microinjections of d-amphetamine into the 
nucleus accumbens. In DRT without DS or a CDP, d-amphetaine in the NAcc (core & 
shell) caused increased selection of the delayed reward when ascending delays were used 
and the opposite pattern when descending delays were used (Orsini et al., 2017). This 
finding is the same pattern seen by Tanno et al., (2014) and is indicative of a behavioral 
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flexibility deficit which confounds the measurement of DD. One key caveat that Orisini 
et al. (2017) point out is that there is evidence suggesting acute changes in DA release 
may play a role, and not a change in overall DA levels as would have resulted from 
amphetamine microinjection.  
The activity of the NAcc during inter-temproal choice tasks has also been the 
subject of multiple investigations. Increased c-fos expression has been seen in the NAcc 
core after completing a DCT where animals are required to process different delay 
lengths to reward receipt but not after a magnitude based task (da Costa Araújo et al., 
2010). In the delay based task one option yield either a sucrose solution reward after a 
delay of 2 or 18 seconds (equal probability of each) and the other an equal magnitude 
reward after a delay that adjusted pending the subjects choices. The magnitude based task 
had one option that yielded either a 20ul or 180ul sucrose solution reward while the other 
option an adjusting magnitude reward. Compared to a control task which had two options 
that yield rewards with no delay and equal magnitudes, an increase in c-fos positive cells 
was seen in the Nacc core after the delay, but not the magnitude, based task suggesting 
the NAcc core is involved in processing delayed rewards. 
The NAcc core appears to exhibit neural activity that tracks with reward value. 
Gutman & Taha (2016) had animals complete a delay or a magnitude based DCT. In both 
tasks, stimulus lights acted as DS, and there was no was no CDP.   The delay task had 
animals chose between two equal magnitude rewards one of which was delivered after a 
delay. In the magnitude task, the two rewards were both delivered immediately and had 
different magnitudes. They only recorded from forced choice trials and found increased 
firing time locked to both DS, and the lever press. For firing associated with DS, there 
was a greater response with the more valuable reward. However firing that occurred just 
before the lever press was unrelated to reward value. Moreover, much of this firing was 
directionally selective (only occurring when only the right or left lever was pressed; 
rewards were repeatedly changed between the two levers in both tasks). This pattern held 
for both tasks, suggesting that the NAcc core has neural activity related to reward value 
derived from both reward delay and magnitude in response to predictive cues (Gutman & 
Taha, 2016). 
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Another study found that neural activity immediately preceding response 
selection in the VS tracked reward value. This activity was selective for the chosen 
alternative on free choice trials and was directionally selective (Roesch et al., 2009). 
Single unit recordings were taken while animals completed a DCT where different odors 
signaled a forced choice on either the right or left nosepoke or a free choice. Across 
blocks of trials the delay and magnitude of the reinforcers for each option were varied. 
Animals chose between an equal magnitude reward that was delayed or given 
immediately and between two rewards of unequal magnitude both of which were 
provided immediately. Inside each session, both the left and right option were associated 
with each outcome. On forced choice trials, neurons displayed a greater firing rate just 
before the response for high (immediate & large magnitude) versus low (delayed and low 
magnitude) value rewards, but only when the option was in the neurons’ preferred 
direction (left versus right). On free choice trials a similar pattern was observed, but the 
activity was selective for the eventually chosen option.  Further indicating that these 
signals encoded outcome value, the level of activity was also negatively correlated with 
response latency. It is important to note that free choice trials were signaled by a third 
odor. Consequently, directional specific firing cannot be attributed to the DS, but rather 
to the direction of the movement/spatial location of the subsequent nosepoke. Roesch et 
al. (2009), also found that after selection of a delayed reward there was continued firing 
after the response. Consequently, the NAcc may encode and represent the value of a 
selected choice immediately before its execution, and it may subserve another function as 
well based upon the activity during the delay period. 
In summary, lesion, microinjection, electrochemical, and electrophysiological 
studies all indicate the NAcc, primarily the core, is involved in DD. Lesions of the core 
tend to increase DD and disrupt learning with delayed reinforcers (Cardinal et al., 2001; 
Pothuizen et al., 2005; Cardinal & Cheung, 2005; Bezzina et al., 2007; da Costa Araújo et 
al., 2009; Valencia-Torres et al., 2012; Galtress & Kirkpatrick, 2010). However, partial 
inactivation’s of the core (Moschak & Mitchell) and lesions of the entire NAcc have been 
seen to decrease DD (Acheson et al., 2006). DA release to DS for choices tracks reward 
value (Day et al., 2010), and NAcc single unit activity scales with reward value as a 
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function of both delay and magnitude (Gutman & Taha, 2016; Roesch et al., 2009). All of 
these converging lines of evidence indicate NAcc, specifically core, is involved in DD.  
 
Table 1: Preclinical Nucleus Accumbens DD Studies. 
    Cues   
Study Site Technique Paradigm DS Delay DL(s) Finding 
Cardinal et al., 2001 Core Post-T. ETL DRT   0, 10, 20, 40, 60 ↑DD; MD 
Pothuizen et al., 2005 Core Pre-T ETL DCT  Yes 0, 10, 15, 20 ↑DD  
 Shell Pre-T ETL DCT  Yes 0, 10, 15, 20 No effect 
Cardinal & Cheung, 2005 Core Post-T. ETL FO   0, 10, 20 ↓ROR w/ D 
 Core Pre-T. ETL FO   0, 10, 20 ↓ ROR w/ D 
Bezzina et al., 2007 Core Pre-T. ETL QA w/ DRT Yes Yes da (.5-12) db(0-
128) 
↑DD 
da Costa Araujo et al., 2009 Core Pre-T. ETL QA w/ AD Yes Yes 0-60 ↑DD 
Valencia-Torres et al., 2012 Core Pre-T. ETL QA w/ AD Yes Yes 0-60 ↑DD 
Acheson et al., 2006 Whole Post-T. ETL AA Yes Yes 0, 2, 4, 8 ↓DD 
da Costa Araujo et al., 2010 Core c-fos  AD  Yes 2-18 ↑ c-fos 
 Core c-fos AM  Yes NA No effect 
Galtress & Kirkpatrick., 2010 Core Post-T. ETL CC   60s vs 0-∞ ↑DD 
Moschak & Mitchell, 2014 Core LDBM DRT Yes  0, 2.5, 5, 10, 20 ↓DD 
Winstanley et al., 2005 Whole Post-T. OHDA DRT   0, 10, 20, 40, 60 No Effect 
Richards et al., 2002 Whole Post-T. OHDA AA Yes Yes 1, 3, 9 No Effect 
Orsini et al., 2017 Whole d-amph DRT   0, 4, 8, 16, 32 ↓DD 
 Whole d-amph DRT   32, 16, 8, 4, 0 ↑DD 
Adriani et al., 2016 Whole DAT ↑ DCT  Yes 0, 5, 10, 20, 30, 
45, 60, 75 
↑DD 
 Whole DAT ↓ DCT  Yes 0, 5, 10, 20, 30, 
45, 60, 75 
↑DD 
Day et al., 2010 Core FSCV DCT Yes  5s ↑DA at cue 
Roesch et al., 2009 Whole Single Unit 
Recordings 
   3-7 Directionally 
selective activity 
that tracks value 
and chosen option  
Gutman & Taha, 2016 Core Single Unit 
Recordings 
   10 ↑firing at cue 
onset that tracks 
value & ↑firing 
before response 
*Note: Abbreviations: DL(s)= delay length seconds; Post-T=Post-training; Pre-T=Pre-training; FO=Free operant; 
MD=magnitude discrimination disruption; CC=concurrent choice; AM=adjusting magnitude; FSCV=fast scan cyclic 
voltammetry; LDBM=low dose baclophen mucimol partial inactivation; d-amph=d-amphetamine microinjections. 
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There is some discordance about whether disrupting the core causes disruptions in 
animals’ ability to accurately perceive reward magnitude, potentially complicating  
interpretations of any DD effects. One study indicates a severe disruption (Cardinal et al., 
2001). Several others suggest the sensitivity to reward magnitude remains unaffected (da 
Costa Araújo et al., 2009; Valencia-Torres et al., 2012). Examinations of whether animals 
conform to the generalized matching law suggest core lesioned animals are actually better 
at discriminating based on magnitude (Cardinal & Cheung, 2005), but core lesioned 
animals have a mild deficit in an incentive contrast procedure (Galtress & Kirkpatrick, 
2010). Electrophysiological studies indicated that NAcc activity is sensitive to both delay 
and magnitude (Roesch et al., 2009). Interestingly studies which show a change in 
magnitude sensitivity with lesions do not utilize any predictive cues (Cardinal et al., 
2001; Cardinal & Cheung, 2005; Galtress & Kirkpatrick, 2010), and studies that show 
magnitude sensitivity is unaffected do use such cues (da Costa Araújo et al., 2009; 
Valencia-Torres et al., 2012). It is possible that while the NAcc core is involved in 
processing magnitude, the use of predictive cues engages a secondary mechanism which 
is able to compensate for any loss of function with core disruption. Critically for 
interpretations of DD, Pothuizen et al. (2005) found increased DD with two choices with 
equal magnitudes, only one of which was delayed. 
It is possible that the NAcc, specifically the core, serves as a final common 
pathway where value information from several different sources summates. Eventually, 
the chosen option’s representation wins out and the NAcc serves to help initiate the motor 
pattern necessary for execution of this response. This is evidenced by multiple different 
areas projecting to the NAcc that have been implicated in DD (Berendse et al., 1992; 
Brinley-Reed et al, 1995; Brog et al., 1993; Hoover et al., 2011), the NAcc core’s role in 
learning/maintaining operant responding for delayed reinforcers (Cardinal & Cheung, 
2005), response linked neural activity that is directionally selective and appears to encode 
the value of rewards associated with specific actions (Rosesch et al., 2009; Gutman & 
Taha, 2016), and DA neurotransimission directly related to reward value that is 
temporally congruent with predictive cues (Day et al., 2010).  
The lesion studies are a little bit more difficult to fit in with this interpretation. If 
the NAcc core is a general valuation and action selection center, a lesion or inactivation 
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might be expected to produce a general disruption of behavior that is not specific to either 
delayed or immediate options. However, the NAcc is not necessary to maintain operant 
responding (Cardinal & Cheung, 2005), and the NAcc may be specifically necessary for 
action selection when rewards and reinforcers are unpredictable either due to being 
probabilistic or delayed (Nicola, 2007; Floresco, 2015). By contrast when the 
reward/reinforcer is certain, the dorsal striatum is able to facilitate selection and action 
initiation. Hence, the lesion studies may have had the functional effect of disrupting the 
main mechanism by which delayed rewards are selected, but not immediate ones.  
Orbital Frontal Cortex 
The OFC has been implicated in multiple different decision making tasks 
(Floresco et al., 2008a). It has been shown to encode reward value (Padoa-Schioppa & 
Assad, 2006) as well as be involved in stimulus-outcome representations and associations 
(Ostlund & Balleine, 2007). More specifically, the OFC may signal the desirability of 
expected outcomes (Schoenbaum et al., 2006) and generates a common currency value 
signal of those expected outcomes (Kringelback, 2005; Montague and Berns, 2002). 
Coincidentally (or perhaps not), the OFC is heavily implicated in addictive disorders 
(Koob & Volkow, 2010; Goldstein & Volkow, 2002; Volkow & Fowler, 2000) for which 
DD is a risk factor (MacKillop et al., 2011; Mitchell, 2011).  
Anatomically, the OFC projects to other areas which likely affect DD. It is 
reciprocally connected with the BLA (Krettek and Price, 1997; McDonald, 1991; Cassell 
& Wright 1986) as well as the mPFC (Sesack et al., 1986), and the hippocampus 
(Burwell & Amaral 1989; Jay & Witter 1991). The OFC sends projections to the NAcc 
(Hoover et al., 2011). It also receives projections from the VTA (Dunnett and Robbins 
1992; Oades and Halliday, 1987). In the rat the OFC is typically divided into medial 
(mOFC), ventral (vOFC), lateral (lOFC) and dorsolateral (dlOFC) regions. These 
different regions have been seen to have a different efferent connections, particularly the 
mOFC (Schilman et al., 2008). The mOFC is heavily interconnected with the mPFC, and 
its projections have been reported to be more akin to the rat mPFC. In part, this 
differential connection pattern has led to the suggestion that the mOFC may be a 
functional link between the mPFC and the more lateral areas of the OFC (Hoover & 
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Vertes, 2011; Hoover et al., 2011). In sum, among the OFC’s many connections are areas 
implicated in DD in preclinical studies, and it can be divided into several distinct 
anatomical subregions.  
There is evidence indicating the OFC is critical for valuing the delayed rewards.  
One of the first lesion studies of OFC involvement in DD used a DCT with a CDP but no 
DS (Mobini et al., 2002). Delays to a larger reward progressed across multiple sessions 
(20-30 sessions) in ascending order. A pre-training excitotoxic lesion of the whole OFC 
(wOFC) comprising medial (mOFC), ventral (vOFC), and lateral OFC (lOFC) 
subregions, caused an increased preference for the sooner-smaller reward as the delays 
increased but not a difference when there was no or minimal delays to the larger reward. 
OFC lesions causing increased DD was later replicated. In a T-maze task vlOFC lesioned 
rats displayed increased choice of a sooner-smaller reward compared to sham animals 
(Rudebeck et al., 2006). Hence, there is evidence that lesioning the OFC increases DD.  
However, not all lesion studies show an increase in DD. Using a DRT without DS 
or a CDP Winstanley et al. (2004) found post-training excitotoxic lesions of the vlOFC 
caused a decrease in DD. However, given the OFC lesioned subjects tend exhibit 
perseverative behaviors (Chudasama & Robbins, 2003), a confounding increase in 
behavioral perseveration underling these results is a concern (Tanno et al., 2014).  
A number of other studies have also found no effect of OFC manipulation on DD. 
In a cued, non-spatially dependent T-maze task the sooner-smaller and larger-later 
rewards alternated locations but were always associated with either grey or black and 
white painted walls, floor, and guillotine doors. vlOFC lesions did not affect DD relative 
to sham animals (Mariano et al. 2009). Male Long Evans rats in a touchscreen version of 
the DRT with DS and ascending delays did not exhibit a change in DD after vlOFC pre-
training excitotoxic lesions (Abela & Chudasama, 2013). While the behavioral 
perseveration confound is a concern with this study as well, probability discounting was 
also performed with the same paradigm, and it did not prevent a decreased selection of a 
larger uncertain reward in later trial blocks. Using a six arm maze with each arm 
associated with either a small immediate reward or larger delayed one, wOFC lesions 
also caused no change in preference for immediate over delayed arms (Jo et al., 2013). 
Another study found mOFC reversible inactivations with baclofen/musimol 
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microinjections had no effect on DD in a DRT with ascending delays, no DS, and no 
CDP (Stopper et al., 2014). Finally in a T-maze task in which animals had to wait outside 
the goal arm for 15 seconds while not collecting the immediate reward, lOFC inactivation 
with baclophen/musimol did not cause an increase in DD (Churchwell et al., 2009). In 
sum, a number of studies show no effect of OFC lesions on DD.  
Several studies have tried to resolve the discordant literature on OFC involvement 
in DD. They have tested whether anatomical location or the use of a CDP are moderators, 
and if OFC lesions alter sensitivity to reward magnitude. Hypothesizing that the specific 
OFC subregion is a moderator, Mar and colleagues (2011) performed excitotoxic lesions 
in either the wOFC, mOFC, or lOFC in animals performing a DRT without DS or a CDP 
and ascending delays (primarily). wOFC lesions transiently “flattened” percent choice of 
the delayed lever by decreasing it at the 0 second delay and increasing it at later delays. 
After several more sessions, normal DD behavior was restored and no difference in 
preference was seen between the sham controls, even when they removed the delay to the 
larger reward. However, reversing the levers, such that the delayed lever now became the 
immediate and vise versa, showed wOFC lesioned rats were slower to adapt to the 
change than shams. Finally, Mar et al., (2011) reversed the order of delay presentation, 
such that delays were presented in descending order, and found no difference from 
shams. mOFC lesions initially displayed no effect on DD, but after several more sessions 
showed decreased DD. Removing the delays, no difference was observed with sham 
animals. Upon restoring the delays, the decreased DD in mOFC animals was observed 
again. When the levers were reversed, mOFC animals actually adapted more quickly than 
sham animals. By contrast, lOFC lesions displayed increased DD paired with a slower 
adaptation to a lever reversal. To summarize, anatomical subregion appears to moderate 
the effects of OFC lesions. wOFC lesions transiently disrupted choice behavior overall 
but did not change DD. mOFC lesions caused a decrease in DD that developed over 
several sessions, and lOFC increased DD.  
These findings are particularly interesting as one would expect the opposite 
pattern based on the results of Tanno et al. (2014).  Animals that show inflexible behavior 
and adapt more slowly to the lever reversal, might be expected to also be impaired when 
there are within sessions shifts in reinforcer contingencies. This would be represented by 
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decreased DD on a DRT with ascending delays as was seen by Tanno et al. (2014). Yet 
Mar et al. (2011) found the opposite pattern: increased DD with a slower adaptation to 
the lever reversal and decreased DD with a faster adaption to the lever reversal15. One 
potential implication is that not all forms of behavioral inflexibility confound the DRT 
and may not necessarily obscure effects on choice behavior. Regardless, it highlights that 
using both ascending and descending orders of delay presentation in a DRT is strongly 
advisable. Doing so constitutes a best practice because without both orders of delay, 
presentation of a null effect or effect congruent with an increase in behavioral 
perseveration is very difficult to clearly interpret.  
Whether the OFC is also involved in the processing of sensitivity to reward 
magnitude in addition to DD has also been examined. In a QA paradigm with a DRT 
using a CDP to derive indifferences delays, pre-training, excitotoxic lesions of the vlOFC 
increased the slope, but not the intercept, of the indifference delays as a function of the 
delay to the sooner-smaller option (Kheramin et al., 2002). This result suggests the 
sensitivity to reinforcer size and DD are both increased. The sensitivity to reinforcer size, 
Q, increases both the slope and intercept of indifference delays. The DD parameter, K, 
decreases the intercept. Therefore an increase in slope has to be due to an increase in Q, 
but Q should also increase the intercept unless an increase in K drives it back down (Ho 
et al., 1999). One implication of this finding is that, pending the delay, overall size of 
reinforcers used, and the ratio of the two reward sizes, one could observe either increased 
or decreased preference for delayed rewards (Kheramin et al., 2002). The same group 
repeated this experiment using a sooner-uncertain reward of equal magnitude versus a 
delayed certain reward (i.e., used probability to reduce the value of the immediate reward 
versus magnitude). Again an increase in the DD parameter, K, was found indicating 
increased DD along with an increase in the probability discounting parameter, H 
(Kheramin et al., 2003). Accordinly, discordance in OFC lesion studies may also be due 
to other processes in addition to DD, such as magnitude sensitivity being altered.  
Specific aspects of DD tasks, namely the use of a CDP, also appear to alter the 
effects of OFC manipulations. Zeeb et al. (2010) had Long Evans rats complete two 
                                                 
15 Mar et al. (2011) only performed a “delay reversal” where delays are presented in descending 
order on wOFC lesioned and sham animals, not mOFC or lOFC lesioned animals and shams.  
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different versions of a DRT with ascending delays. The only difference between the two 
tasks was whether or not a CDP was used. When there was no CDP, baclophen/musimol 
microinjections into the lOFC caused a decrease in DD in high discounting subjects (but 
not low). However when a CDP was used, the opposite pattern was seen; inactivation 
increased DD in subjects with low levels of DD. Accordingly, the effects of OFC 
disruptions on DD are also moderated by the use of a CDP as well as showing some rate 
dependent effects.   
Microinjections of DA antagonists also demonstrated that a CDP is critical 
moderator of lOFC involvement in DD. When no cue was present, microinjections of 
eticlopride (D2 antagonist) and SCH 23390 (D1 antagonist) had no effect, but when a 
CDP was used, eticlopride increased DD and SCH 23390 trended towards the same 
effect. Zeeb et al. (2010) note that these effects appeared to be rate dependent based on 
the level of DD (low discounters increasing DD), but the effect was not significant (or 
shown).  
The results of these DA manipulation have been replicated. In another DRT with 
ascending delays and a CDP, SCH 23390 and racolpride microinjections into the lOFC 
trended towards and increased DD respectively (Pardey et al., 2013). In a QA paradigm 
with CDPs, 6-OHDA lesions of dopaminergic innervation in the vlOFC caused both 
increased DD behavior as well as increased sensitivity to large magnitude rewards 
(Kheramin et al., 2004). Against this grain, mRNA transcript levels of DA receptors (D1-
D5) and DA related signaling molecules in the OFC, quantified via real-time polymerase 
chain reaction (RT-PCR), are not related to DD assessed using a DRT with DS and a 
CDP (Loos et al., 2013), but mRNA transcript levels do not necessarily relate to protein 
levels nor availability of the ligand.  
The lack of OFC DA effects when no CDP is used have also been replicated. 
Neither OFC microinjections of reuptake inhibitors with actions on the dopamine 
transporter (amphetamine; methylphenidate; atomoxetine), the D1 agonist SKF81297, the 
D1 antagonist SCH 23390, the D2 agonist quinpirole, or the D2 antagonist eticlopride 
had any effect on DD behavior in an AD paradigm without a CDP (Yates et al., 2014). 
Similarly, Simon et al. (2013) used in situ hybridization to examine D2 receptor mRNA 
levels in the OFC and found no relationship to DD behavior on a DRT without DS or a 
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CDP. Although the quantitative as opposed to qualitative utility of in situ hybridization is 
questionable. Rats performing a DRT without DS or a CDP exhibit increases in DA’s 
main metabolite, DOPAC, in the OFC16, but DA levels were below the threshold for 
detection by microdialysis (Winstanley et al., 2006).  
Exactly why a CDP is a moderator for OFC DA manipulations has not been 
directly examined, but it may be related the activation of the meso-cortical DA system to 
conditioned cues and reinforecers. Studies examining moderation of systemic 
dopaminergic drugs’ effects on DD by the use of a CDP have not been consistent 
(Cardinal et al., 2000; Slezak & Anderson, 2009; van Gaalen et al., 2006).  One possible 
reason a CDP matters specifically for OFC microinjections of dopaminergic drugs 
centers around the cue predicting reward and becoming a conditioned reinforcer. Cues 
paired with rewards have been shown to activate the mesolimbic and mesocortico-limbic 
DA system (Schultz et al., 1997). This activation would cause an increase in DA in the 
OFC. Without the increased levels of DA from activation of the meso-cortical DA 
system, there may not be sufficient DA neurotransmission for the antagonists to block. 
Winstanley et al.’s (2006) finding that OFC DA levels were too low to detect via 
microdialysis and HPLC is in line with this possibility as they did not use a CDP or DS.  
Hence, DA antagonists microinjected into the OFC may only have an effect when a CDP 
activates the meso-cortical DA system.  
However the above rationale does not account for why DA agonists do not have 
any effect when microinjected into the OFC. The reason for this pattern of results may be 
due to dopamine’s role as a neuromodulator. DA release in the OFC during the presence 
of a cue could be facilitating glutamatergic neurotransmission encoding a representation 
of a cue by various mechanisms (Seamans & Yang, 2004). In this instance, simply adding 
DA or a DA agonist to the OFC when no cue is being encoded by fast synaptic 
transmission is not likely to have any overt effect as there is no encoded representation to 
facilitate. With this interpretation in mind, an important line of future research will be to 
investigate what will happen when a DA agonist is applied to the OFC when a cue is 
                                                 
16 No increase in OFC DOPAC was seen for rats in two different yoked control groups: one 
controlling simply for reward presentation (in chambers and presented with the same rewards earned by the 
master rat), and one controlling for operant responding for rewards (in chambers completing the task, but 
only forced choice trials defined by the choices of the master rat). 
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present. DA agonists could further facilitate the encoding of the cue, functionally 
decreasing impulsive choice, or have the opposite effect by disrupting the representation 
of the cue and functionally increasing impulsive choice.    
With regards to the weak and inconsistent effects of D1 antagonists microinjected 
into the OFC when a cue is present, Kheramin et al.’s (2004) results offer a possible 
explanation. Kheramin et al. (2004) found that in addition to 6-OHDA lesions of the OFC 
increasing DD, the lesions also increased the sensitivity to large magnitude rewards. If 
D1 antagonism in the OFC is having a similar effect both increasing DD and increasing 
the sensitivity to large magnitude rewards, then in DD paradigms not designed to 
disentangle these two factors one could see a weak or null effect. This pattern would be 
seen because the value of the larger-later reward starts out at a higher point, and it would 
have to be discounted to a greater degree to even result in the same pattern of choice 
behavior prior to the manipulation, let alone increased “impulsive choice.” 
Serotonin function in the OFC also appears to be involved in modulating cue 
processing, but there is limited evidence. In an AD paradigm with DS but no CDP, the 5-
HT1A agonist 8-OH-DPAT decreased DD (Yates et al., 2014). As the 5-HT1A receptor is 
thought of as an autoreceptor (Albert et al., 1996), 8-OH-DPAT may actually decrease 5-
HT neurotransmission, suggesting 5-HT in the OFC promotes impulsive choice. 
However, DOI (5-HT2A/2C agonist), Way-100635 (5-HT1A antagonist) and Ketanserin (5-
HT2A antagonist) had no effects (Yates et al., 2014). Moreover, Winstanley et al., 2006 
found that there were no task specific increases in 5-HT or its metabolite 5-HIAA during 
DRT without DS or a CDP. However, in a T-maze task, DOI infusions increased DD, and 
this increase was blocked when LY379268 (mGlu2/3 agonist) was coadminstered 
systemically despite LY379268 having no independent effect (Wischhof et al., 2011). 
Given the limited evidence, it is tough to decipher exactly what role serotonin may be 
playing with regards to the OFC and DD. As neither Yates et al., (2014) nor Winstanley 
et al., (2006) used a CDP and enclosing an animal in the goal arm in a T-maze could be 
argued to be a CDP, 5-HT may be important for modulating glutamate neurotransmission 
in the OFC involved in processing the CDP.  
In a DCT with DS but not a CDP in which rewards differed by either magnitude 
or delay, two different populations of neurons sensitive to reward delay and a third 
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associated with magnitude were found (Roesch et al., 2006). In the first population, 
neurons responded more to an immediate reward choice. Their activity increased briefly 
after responding for an immediate or a delayed reward, and then a second increase in 
activity was seen at the delivery of the delayed reward. This immediate response activity 
was greater than the combined activity for delayed reward. Furthermore, the strength of 
this response was correlated with choice behavior on free choice trials. The second 
population of neurons in the OFC fired more in response to a delayed reward choice 
(Roesch et al., 2006). For both rewards, the increase in activity began immediately 
following the response, but the delayed reward activity continued to increase throughout 
the delay, peaking just prior to reward delivery. Activity in these first two populations of 
neurons did not show differential activity to large versus small magnitude rewards. 
Rather a third population of neurons showed differential activity based on magnitude 
upon reward delivery. The activity in the reward magnitude encoding population was 
unrelated to reward delay.   
A “dual role” for the OFC has been proposed where it both discounts delayed 
rewards and supports their learning and thus their selection (Schoenbaum & Roesch, 
2005; Roesch et al., 2006). Examining all of the literature reviewed here, a ternary if not 
quaternary role may be also be the case. There is evidence that the OFC is involved in 
discounting the delayed reward, encodes an expectancy signal for the delayed reward, 
and processes cues associated with the delayed reward. Disrupting the OFC causes a 
decrease in DD when no CDP is used (Winstanley et al., 2004b; Zeeb et al., 2010). In this 
situation the “discounting” process may be the most prominent and outweigh the 
influence of reward magnitude and a possible outcome expectancy signal. By contrast 
when a CDP is used, the addition of a “common currency” value signal for a conditioned 
reinforcer may tip the balance of OFC involvement towards favoring delayed rewards. 
Accordingly when a CDP is used, OFC disruptions tend to increase DD (Mobini et al., 
2002; Zeeb et al., 2010; Kheramin et al., 2002; 2003).   
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Table 2: Preclinical Orbital Frontal Cortex DD Studies 
    Cues   
Study Site Technique Paradigm DS CDP DL(s) Finding 
Mobini et al., 2002 wOFC Pre-T. ETL DCT  Y 1, 2, 4, 8, 12, 16, 
20, 30, 1 
↑DD 
Rubeck et al., 2006 vlOFC Post-T. ETL T-maze  Y 15 ↑DD 
Winstanley et al., 2004b wOFC Post-T. ETL DRT   0, 10, 20, 40, 60 ↓DD 
Mariano et al., 2009 vlOFC Post-T. ETL Cued T-
Maze 
  15 No Change 
Abela & Chudasama, 2013 wOFC Pre-T. ETL DRT Y  0, 8, 16, 32 No Change 
Jo et al., 2013 wOFC Post-T. ETL 6 arm 
Maze 
  0, 3, 6, 9, 12 No Change 
Stopper et al., 2014 mOFC Baclofen/Musimol DRT  Y 0,15, 30, 45 No Change 
Churchwell et al., 2009  Musimol T-Maze   15 No Change 
Mar et al., 2011 wOFC 
wOFC 
mOFC 
vlOFC 
Post-T. ETL DRT   0, 20, 40, 60 
60, 40, 20, 0 
0, 20, 40, 60 
0, 20, 40, 60 
No Change 
No Change 
↓DD 
↑DD 
Kheramin et al., 2002 vlOFC Pre-T. ETL QA w/ 
DRT 
 Y 0-75 ↑DD 
Kheramin et al., 2003 vlOFC Pre-T. ETL QA w/ 
DRT 
 Y 0-~100 ↑DD 
 Zeeb et al., 2010 lOFC Baclofen/Musimol 
 
SCH 23390 
 
Electropride 
 
DRT  Y 
 
Y 
 
Y 
0, 15, 30, 45 ↑DD  
↓DD 
↑DD  
No Change 
↑DD 
No Change 
Yates et al., 2014 vlOFC MPH 
AMPH 
ATO 
SKF81297 
SCH 23390 
Quinpirole 
Eticlopride 
8-OH-DPAT 
Way-100635 
Ketanserin 
AD Y  0-45 No Change 
No Change 
No Change 
No Change 
No Change 
No Change 
No Change 
↓DD 
No Change 
No Change 
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Table 2 continued 
    Cues   
Study Site Technique Paradigm DS CDP DL(s) Finding 
Pardey et al., 2012 lOFC SCH23390 
Raclopride 
Phenylephrine 
Guanfacine 
DRT  Y 0-400 ↑DD 
↑DD 
No Change 
No Change 
Kheramin et al., 2004 vlOFC 6-OHDA QA w/ 
DRT 
 Y 0-75 ↑DD 
Yates et al., 2014 vlOFC 8-OH DPAT 
Way-100635 
DOI 
Ketanserin 
AD  Y 0-45 ↓DD 
No Change 
No Change 
No Change 
Wischhof et al., 2012 vlOFC DOI 
DOI+LY379268 
T-Maze  Y 10 ↑DD 
No Change 
*Note: Abbreviations: DL(s)= delay length seconds; Post-T=Post-training; Pre-T=Pre-training; FO=Free operant. 
 
Two additional layers influence matters as well. The differential effects of a CDP 
appear to be dependent on the rate of DD (Zeeb et al., 2010). When no cue is used, the 
involvement of the OFC is only tipped towards the immediate reward in steep discounters 
and vice versa when a CDP is used. This possibility explains the numerous null results 
(Mariano et al., 2009; Abela & Chudasama, 2013; Jo et al., 2013; Stopper et al., 2014; 
Churchwell et al., 2009) as well as Zeeb et a., (2010) directly observing this pattern. 
Roesch et al. (2007) also proposed the outcome expectancy signal maybe critical for 
learning about delayed rewards, hence why pre-training lesions tend increase DD 
(Kheramin et al., 2002; 2003; Mobini et al., 2002), and post training lesions, which may 
only disrupt the discounting process, decrease DD (Winstanley et al., 2004b). 
Furthermore all of these different processes may be subserved by different neuronal 
populations (Roesch et al., 2006). These populations may not be anatomically localized 
explaining why subregion is a moderator as well (Mar et al., 2011). In sum, it appears the 
OFC subserves multiple potential roles in DD. Moreover, these roles may differ across 
anatomical subregion. 
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Basolateral Amygdala 
The basolateral amygdala (BLA) is interconnected with other areas implicated in 
DD by preclinical studies. It is reciprocally connected to the OFC (Krettek and Price, 
1997, McDonald, 1991; Cassell & Wright, 1986) and has glutamatergic projections to the 
NAcc and prefrontal cortex (McDonald, 1996; Brinley-Reed et al., 1995). Specifically, it 
projects to both the NAcc core and shell (Wright et al., 1996; Brog et al., 1993), and 
some of these projections bifurcate and send collaterals to the mPFC (Shinonaga et al., 
1994). However it also has independent projections to the mPFC (Shinonaga et al., 1994; 
Gabbott et al., 2006), and in turn the mPFC projects back to the BLA’s primary 
projection neurons (Brinley-Reed et al., 1995; Cassell & Wright, 1986; Gabbott et al., 
2005). The BLA also receives projections from the HPC (Ishikawa & Nakamura, 2006; 
Pitkänen et al., 200) as well as projects back to the HPC (Pikkarainen et al., 1999; 
Pitka̎nen et al., 2000; Krettek & Price, 1997).  
Compared to investigations into other structures, there are fewer studies that have 
looked at the BLA. However, these studies have consistently found the BLA is needed 
for DD. In a DRT with ascending delays and no CDP, excitotoxic BLA lesions caused an 
increase in DD (Winstanley et al., 2004b). Similarly in a T-maze task where subjects had 
to wait outside a goal arm for 15 seconds while not collecting an immediately available 
reward, microinjected muscimol caused increased collection of the immediate reward 
(Churchwell et al., 2009). Electrophysiological recordings indicate the BLA contains 
neurons that encode predicted outcomes and display sustained activity during the delay to 
the reward that increases over the course of the delay (Roesch & Bryden, 2010; Roesch et 
al., 2010). One of several possible explanations put forth by Roesch & Bryden (2010) 
was that this sustained activity may serve to maintain an expectancy of the delayed 
reward until it is received. This interpretation is in keeping with a broader role of the 
BLA in signaling the outcomes associated with various actions (Hatfield et al., 1996; 
Balleine et al., 2003). The BLA has also been implicated in conditioned reinforcement 
via representing value of conditioned stimuli (Cador et al., 1989; Burns et al., 1993; 
Gallagher, 2000). However, the use of a CDP does not appear to be a moderating  
variable for the BLA. Consequently the BLA's possible role in conditioned reinforcement 
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may not play a large role in DD. Rather its ability to generate an expected value 
signal/outcome representation may be more critical. 
 
Table 3: Preclinical Basolateral Amygdala DD Studies 
    Cues   
Study Site Technique Paradig
m 
DS CDP DL(s) Finding 
Winstanley et al., 2004b BLA Post-T. ETL DRT   0, 10, 20, 40, 60 ↑DD 
Churchwell et al., 2009 BLA Muscimol T-Maze   15 ↑DD 
*Note: Abbreviations: DL(s)= delay length seconds; Post-T=Post-training; Pre-T=Pre-training; FO=Free operant. 
Hippocampus  
The hippocampus (HPC) is involved in a variety of functions some of which may 
be important for DD. There is strong evidence that the HPC is involved in working 
memory (Floresco et al., 1997; Seamans et al., 1998; Rawlins and Tsaltas et al, 1983), 
spatial learning and navigation (Moser et al., 1993; Eichenbaum et al., 1999), and 
contextual conditioning (Holland & Bouton, 1999; Anagnostaras et al., 2001). A dorsal 
(dHPC) versus ventral (vHPC) functional and anatomical division has been proposed as 
well (Bannerman et al., 2004). Potentially relevant to DD, the HPC has also been 
suggested to be important for the sequential ordering of events (Fortin et al., 2002) and 
contribute to decision making via representing future outcomes (Johnson et al., 2007; 
Schacter et al., 2007). Hence, HPC function may be important for DD.   
Anatomically, the HPC is interconnected with other areas implicated in DD such 
as the mPFC, OFC, BLA, and NAcc. The HPC projects to the mPFC, specifically the 
prelimbic (PL), and infralimbic (IL) cortices (Jay et al., 1991; Cenquizca & Swanson, 
2007). These cortical efferent connections appear to be glutamatergic (Jay et al., 1992). 
Some evidence indicates that these HPC efferents arise primarily from the vHPC and 
temporal HPC as opposed to its dorsal subdivision based on retrograde tracer studies 
(Verwer et al., 1997). Some of these mPFC projections appear to have collaterals to the 
BLA (Ishikawa & Nakamura., 2006). These collaterals may, or may not, correspond to 
other known HPC projections to the BLA and other amygdala nuclei (Pitka̎nen et al., 
2000). The BLA in return projects back to the HPC (Pikkarainen et al., 1999; Pitka̎nen et 
al., 2000 Krettek and Price, 1977). For the OFC, there is evidence indicating the mOFC 
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receives HPC projections, similar to the mPFC, but the more lateral areas of the OFC 
(lOFC, vOFC, dlOFC) may not be innervated very strongly if at all (Cenquizcca & 
Swanson, 2007; Jay et al., 1989). The vHPC also projects to the NAcc (Groenewegen et 
al., 1987; Brog et al., 1993). Kelley & Domesick (1982) found with anterograde tracing 
of fornix fibers that the projections were limited to the medial NAcc being particularly 
dense in the caudal dorsomedial area of the NAcc (inside the shell). However, tracing 
studies using the subiculum as a point of origin indicate projections cover the whole of 
the NAcc (Groenewegen et al., 1987), and retrograde tracer studies from the central 
NAcc identify the subiculum as a glutamatergic afferent connection to the NAcc (Christie 
et al., 1987). In sum, the HPC is strongly interconnected with other areas implicated in 
DD by preclinical studies. 
Lesioning or inactivating the HPC almost always increases measures of DD. In a 
Y-maze where entry into one arm was associated with delayed continuous reinforcement 
and the other with immediate partial reinforcement17 [p(reward)=.25], HPC aspiration 
lesioned rats showed increased selection of the partially reinforced arm versus sham 
lesioned animals (Rawlins et al., 1985). Moreover, both medial and dorsolateral septal 
lesions increased selection of the immediately available partial reinforcement arm 
(Rawlins et a., 1985). 
McHugh and colleagues (2008) looked into if there was a subregion specificity to 
HPC lesions in addition to using a lesion technique that would spare the fibers of passage. 
In a T-maze DD task, they found complete HPC, vHPC, and dHPC lesioned animals all 
showed greater preference for a low reward option that was not delayed versus a high 
reward, delayed option. Moreover, when equal 10-second delays were placed on each 
reward, all animals displayed a clear preference for the high reward arm suggesting 
magnitude discrimination and spatial navigation were not confounding factors (McHugh 
et al., 2008). The same group then followed up this result with a non-spatial, cued version 
of the T-maze task in which the sooner-smaller and larger-later reward alternated location 
but were always associated with either grey or black and white painted walls, floors, and 
guillotine doors. This method rules out a possible impairment in animals ability to 
                                                 
17 Abela and Chudasama (2013) found vHPC lesions did not affect probability discounting.  
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navigate the maze as a confound. In this alternate T-maze task18, increased DD was still 
observed in HPC lesioned animals versus shams (Mariano et al., 2009).  
 
Table 4: Preclinical Hippocampus DD Studies 
    Cues   
Study Site Technique Paradigm DS CDP DL(s) Finding 
Mariano et al., 2009 cHPC Post-T. ETL Cued T-
maze 
Y 
 
10-15, 30s, 60s ↑DD 
Rawlins et al., 1985 cHPC Pre-T. AL Y-Maze 
  
10 ↑DD 
 
M. 
Septum 
Pre-T. AL Y-Maze 
  
10 ↑DD 
 
DL. 
Septum 
Pre-T. AL Y-Maze 
  
10 ↑DD 
McHugh et al., 2008 dHPC Post-T. ETL T-Maze 
  
10 ↑DD 
 
vHPC Post-T. ETL T-Maze 
  
10 ↑DD 
 
cHPC Post-T. ETL T-Maze 
  
10 ↑DD 
Cheung & Cardinal, 2005 cHPC Post-T. ETL DRT 
  
0, 10, 20, 40, 60 ↑DD 
Abela & Chudasama, 2013 vHPC Pre-T. ETL DRT Y 
 
0, 8, 16, 32 ↑DD 
Abela & Chudasama, 2012 vHPC Muscimol/baclofen DRT Y 
 
0, 8, 16, 32 ↑DD 
 
vHPC Guanfacine DRT Y 
 
0, 8, 16, 32 ↓DD 
 
vHPC SCH 23390 DRT Y 
 
0, 8, 16, 32 -DD 
*Note: Abbreviations: DL(s)= delay length seconds; Post-T=Post-training; Pre-T=Pre-training; FO=Free operant. 
 
Operant based tasks also indicate the HPC is necessary for normal DD behavior. 
In a DRT without DS or a CDP, HPC lesions caused increased DD (Cheung & Cardinal, 
2005). This lesion also caused a decrease in selection of the delayed reward under 0 
second delay conditions, but when the 0 second delay condition was applied to the entire 
session, no difference was observed between HPC lesioned animals and shams (Cheung 
& Cardinal, 2005). Pretraining excitotoxic lesions of the vHPC as well as inactivation 
with a muscimol/baclofen cocktail also caused increased DD on a touchscreen DRT with 
DS but not a CDP (Abela & Chudasama, 2012; 2013). Microinjection of the 
norephinerine α2A receptor agonist guanfacine in to the vHPC, but not the DA D1 
antagonist SCH 23390, decreased DD (Abela & Chudasama, 2012). However caution is 
warranted in interpreting this sole study looking into neurotransmitter specific effects in 
the vHPC on DD. Only ascending delays were used, and lesions of the exact same area, 
vHPC, cause increased premature and perseverative responding on the 5CSRTT (Abela et 
                                                 
18 Described in greater detail in the OFC section.  
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al., 2012). A “false positive/negative” cannot be excluded. Never-the-less, lesion and 
inactivation studies using operant methods show that the vHPC is important for DD.  
Medial Prefrontal Cortex 
The rodent mPFC can be divided into three (or four if the mOFC is considered 
part of the mPFC vs OFC) different sub-regions. However these different regions have 
often been lumped together by researchers. These three regions are the prelimbic (PL), 
infralimbic (IL), and cingulate cortices (Cg). There has been some debate as to what these 
areas translationally correspond to in a human brain. Uylings et al. (2003) argued that the 
rodent medial PFC (mPFC) corresponds to the primate dlPFC based on these areas 
sharing similar subcortical afferent and efferent connections and subserving the same 
“common class functions.” Specifically, both the primate dlPFC and rodent mPFC both 
are involved in working memory as well as monitoring and planning behavior, (Uylings 
et al., 2003). Seamans, Lapish, & Durstewitz (2008) agree with this conclusion in part, 
but focusing on electrophysiological evidence they argue the rat mPFC is more of a 
combination of the primate dlPFC and ACC.  
In addition to numerous other areas of the brain, the mPFC is interconnected with 
areas whose contribution to DD has been investigated in preclinical studies. The PL and 
IL receive a glutamatergic afferents from the vHPC (Jay et al., 1991; 1992; Verwer et al., 
1997; Cenquizca & Swanson, 2007), and recently a monosynaptic projection to the HPC 
from the cingulate region in mice has been identified (Rajasethupathy et al., 2015).  
Additional reciprocal connections are present with the OFC (Sesack et al., 1989). The PL, 
IL, and Cg all receive dense projections from both the mOFC and vOFC with the PL area 
receiving the most innervation (Hoover & Vertes, 2007; 2011). In turn the mPFC projects 
heavily to the mOFC and has some efferent connections with more lateral areas of the 
OFC (Sesack et al., 1989).  Closely associated with the OFC, the BLA is interconnected 
with the mPFC as well. mPFC projections to the BLA form asymmetric synapses onto 
spiny, but not aspiny, neurons (Brinley-Reed et al., 1994). Some of these mPFC-to-BLA 
projections also have collaterals that go to the NAcc (Gabbot et al., 2005). These spiny 
cells are the BLA’s projection neurons (McDonald, 1992). The BLA projections to the 
mPFC synapse onto both pyramidal cell spines as well as basket and chandelier 
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GABAergic interneurons (Gabbot et al., 2006). Finally, the NAcc receives input, but does 
not appear to have a monosynaptic return. The core subregion is innervated by the dorsal 
areas of the PL cortex, and the shell receives inputs from the IL and ventral PL areas 
(Berendse et al., 1992; Brog et al., 1993; Heidbreder & Groenewegen,  2003). While this 
is not an exhaustive list of the mPFC’s afferents and efferents, the highlighted 
connections show how the mPFC, particularly the PL area, is interconnected with other 
structures hypothesized to be involved in DD.  
Lesions and pharmacological inactivations of the mPFC during DD have been 
limited, yielded mixed results, and have alternative explanations for their findings due to 
potential response inhibition and behavioral perseveration confounds. In a T-maze DD 
that included a response inhibition component, muscimol microinjections into the 
mPFC19 caused increased selection of the sooner-smaller reward (Churchwell et al., 
2009). Interestingly, functionally disconnecting the BLA from the mPFC by unilatrealy 
mircroinjecting muscimol into both structures on contralateral sides caused increased 
selection of the smaller immediate reward as well. However, in this task rats had to wait 
outside an arm for 15 seconds while not collecting an immediately available small reward 
in order to receive a larger reward. If the muscimol microinjections caused a response 
inhibition deficit, subjects might not have been able to refrain from collecting the 
immediate reward, skewing the choice behavior without affecting DD per se.  In a DRT 
with no DS, CDP, and only ascending delays, neither Cg1 nor combined PL and IL 
lesions increased DD (Cardinal et al., 2001). However, the PL/IL lesion group appeared 
to no longer adjust their choices as a function of delay. Compared to sham controls, 
PL/IL lesioned animals had decreased preference for the larger reward when there was no 
delay, but increased preference for the larger reward when delays were present. A second 
study looking at PL/IL involvement found reversible inactivation with muscimol 
microinjections failed to effect DD, but they also used a DRT with only ascending delays 
(Feja & Koch, 2014). The DRT with ascending delays used by both studies with null 
results is susceptible to a behavioral perseveration confound which can cause a false 
negative result (Tanno et al., 2014). Given potential response inhibition and behavioral 
perseveration confounds, it is important to note that the mPFC is involved in behavioral 
                                                 
19 Coordinates and representative image suggest PL cortex, but no hit map was provided.  
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flexibility and response inhibition (Ragozzino, 2007, Chudasama & Robbins, 2003; 
Narayanan et al., 2006). Hence, the current lesion and inactivation literature is limited,  
discordant, suffers from plausible alternative explanations, and would benefit from 
additional investigations utilizing DD tasks that do not possess response inhibition and 
behavioral perseveration elements.  
DA neurotransmission in the rodent mPFC appears to play a similar role to the 
hypothesized role for DA in the human dlPFC. As discussed above,20 studies 
investigating the role of allelic variation in COMT suggest that too little or too much 
dopamine in the dlPFC causes increased DD (Boettiger et al., 2007; Paloyelis et al., 2010; 
Smith & Boettiger 2012; Gianotti et al. 2012). This parallels the inverted “U” model of 
prefrontal function where an optimal level of DA neuromodulation is needed (Arnsten, 
2011, Cools and D’Esposito, 2011; Floresco et al., 2013). Rodent preclinical 
investigations show a similar pattern with DA antagonists and agonists microinjected into 
the mPFC (both prelimbic and infralimbic areas; PL & IL) both causing increases in DD.  
Specifically, DA D1 receptor signaling in the mPFC has been shown to be 
implicated in DD. In a DRT without DS or CDP and using ascending delays, 
microinjections of the D1 agonist SKF38393 and the D1 antagonist SCH 23390 into both 
the PL and IL increased DD (Loos et al., 2010). Moreover, D1, D5 and Caly expression 
was positively associated with increased DD (Loos et al., 2010). When a CDP was used 
in a separate study with similar methods, SCH 23390 mPFC21 microinjection caused 
increased DD as well (Pardey et al., 2013). Sonntag et al. (2014) utilized a T-maze 
version of a DD task coupled with a lentiviral vector to increase D1 expression in PL 
glutamtergic neurons. This overexpression of D1 receptors led to an increase in selection 
of the arm containing a small immediate reward as opposed the arm with the large 
delayed reward corresponding to increased DD. However, Yates et al. (2014) found in an 
AD paradigm that microinjecting a D1 agonist and antagonist (SKF81297; SCH23390) as 
well as amphetamine, methylpheidate, and atomoxetine into the mPFC had no effect. 
However some caution is warranted as all three of these reuptake inhibitors are not 
specific to the dopamine transporter (DAT; nor is the DAT even specific to DA). Also, 
                                                 
20 Human Neuroimaging Section 
21 Hit map and coordinates suggest PL but the authors did not specify.  
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examining D1 expression via in situ hybridization with densitometric analysis was 
unrelated to DD on a DRT without DS or a CDP and ascending delays (Simon et al., 
2013), but in situ hybridization is a qualitative technique being used quantitatively, and 
increased mRNA does not necessarily correspond to increased protein levels. 
Collectively, the above studies indicate that increases or decreases in D1 signaling, 
pharmacologically or in terms of receptor expression, cause increases in DD although 
there is a conflicting result.  
DA D2 receptor signaling in the mPFC has also been studied in the context of 
DD. Pardey and collegues’ (2012) DRT with ascending delays and a CDP found 
microinjected raclopride caused increased levels of DD. Quinpirole and eticlopride, DA 
D2 agonist and antagonist respectively, also caused increased DD when microinjected 
into the mPFC during an AD task (Yates et al., 2014). Finally, D2 mRNA levels, 
quantified via in situ hybridization, are negatively correlated with DD on a DRT without 
DS or a CDP (Simon et al., 2013; see above concerns with this methodology). 
Further evidence for mPFC DA involvement was provided by a well-controlled 
microdiaysis study. Rats that completed a DRT without DS or a CDP showed increases in 
mPFC DA and DOPAC from baseline. However the increase in DA was not different 
from a similar increase seen in rats who completed yoked forced choice only and reward 
presentation only versions of the task (Winstanley et al., 2006). Nevertheless that does 
not rule out that DA has no influence on reward valuation or other processes that affect 
DD (Floresco et al., 2008a). 
Given that the majority of studies examining the effects of DA manipulations of 
the mPFC on DD use a DRT, consideration must be given to any possible role that 
increased behavioral perseveration may be playing. As was demonstrated by Tanno et al. 
(2014), in DRT with ascending delays, increases in behavioral perseveration can cause a 
decrease in impulsive choice without necessarily causing decreased DD. This change in 
choice behavior can be observed without a change in the underlying process presumed to 
govern it because the DRT is susceptible to within session carryover effects due to the 
use of multiple delays in a non-random order. Increased behavioral perseveration would, 
in theory, cause the rat to continue to respond on the initially more reinforcing outcome 
in spite of the changing delay. As both Pardey et al. (2012) and Loos et al. (2010) used 
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ascending delays (i.e., the delay to the larger reward became longer as the session 
progressed) if D1 and D2¬ agonists/antagonists were causing increased behavioral 
perseveration, then one would expect to see decreased DD based on the findings of 
Tanno et al. (2014). However the opposite pattern, increased DD, was observed in both 
studies. 
Considering the converse situation, that mPFC DA drug microinjections caused 
decreased behavioral perseveration, additional factors come into play. It could be argued 
that decreasing behavioral perseveration would cause increased DD in a DRT with 
ascending delays as they would be better able to track the changing reward values. 
However this argument assumes that under baseline conditions without pharmacological 
manipulations, subjects are not already tracking the reward values optimally. While this 
situation is possible, it is not likely. The AD paradigm, in which perseveration is not a 
major concern, shows concurrent validity with the DRT suggesting that the DRT does 
provide valid measurement under baseline conditions (Craig et al., 2014).  Therefore, the 
increased DD seen in Loos et al. (2010) and Pardey et al. (2012) is not likely to be due 
solely to decreased behavioral perseveration. 
To date, there are no published reports of electrophysiological recordings of the 
rat mPFC during a DD task. Burton and colleagues (2009) saw a potential anticipatory 
signal in a spatial foraging task. Once animals navigated to a goal zone (changed daily), a 
food pellet was released in one of three separate locations after two seconds. Once 
animals reached the goal zone, the activity in the PL cortex increased in an event related 
manner until delivery of the reward. Interestingly, lesioning of the HPC abolished the PL 
anticipatory activity and instead a short burst of activity was seen upon reward delivery. 
Burton et al., (2009) tested if the PL activity could be explained as “place field” however 
the activity was only weakly related to spatial location. Another study used an alternating 
reward task where rats have to nosepoke for alternating food and water rewards on 
opposite sides of an open field. In this task mPFC22 neurons showed increased activity 
during a delay between nosepoking and reward presentation, but not when the reward 
was presented immediately. Moreover, approximately half of these neurons only 
                                                 
22 Recording electrode was set-up on a Microdrive assembly and with initial coordinates 
suggesting PL; no hit map was provided. 
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displayed increased firing for a specific reward type independent of spatial location; the 
others were indiscriminate based on reinforcer commodity (Miyazaki et al., 2003). One 
possible interpretation of these studies is that the mPFC, specifically the PL, is involved 
in generating an anticipatory signal or outcome representation when the reward is 
delayed.  
 
Table 5: Preclinical Medial Prefrontal Cortex DD Studies  
    Cues   
Study Site Technique Paradigm DS CDP DL(s) Finding 
Cardinal et al., 2001 PL/IL Post-T. ELT. DRT   0, 10, 20, 40, 60 MD 
 Cg Post-T. ELT. DRT   0, 10, 20, 40, 60 No Change 
Feja & Koch, 2014 PL/IL Muscimol DRT Y  0, 10, 20, 40, 60 No Change 
Churchwell et al., 2009 PL Muscimol T-Maze   15 ↑DD 
Loos et al., 2010 PL 
IL 
SKF38393 
SCH 23390 
DRT 
 
Y 
 
Y 
 
0, 5, 20, 40 ↑DD 
↑DD 
Sonntag et al., 2014 PL Lenti-viral ↑D1R T-Maze   5, 10, 15 ↑DD 
Pardey et al., 2013 PL SCH 23390 
Raclopride 
Phenylephrine 
Guanfacine 
DRT  Y 0-400 ↑DD 
↑DD 
No Change 
No Change 
Yates et al., 2014  MPH 
AMPH 
ATO 
SKF81297 
SCH 23390 
Quinpirole 
Eticlopride 
8-OH-DPAT 
Way-100635 
Ketanserin 
AD Y  0-45 No Change 
No Change 
No Change 
No Change 
No Change 
↑DD 
↑DD 
No Change 
No Change 
No Change 
*Note: Abbreviations: DL(s)= delay length seconds; Post-T=Post-training; Pre-T=Pre-training; FO=Free operant; 
MD=Magnitude discrimination disruption. 
 
The mPFC, in particular the PL region, being involved in generating an outcome 
representation of the delayed reward is consistent with studies looking at outcome 
devaluation and contingency degradation. The PL region has been suggested to be 
necessary for goal directed learning (Balleine & O’Doherty, 2010). Rats with PL lesions 
no longer show a devaluation effect after contingency degradation even with limited 
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training when sham animals have yet to develop habitual behavior.  However, IL lesions 
prevented the development of habitual behavior after extended training (Killcross & 
Coutureau, 2003).  
 Potential Interpretation of Delay Discounting Neurobiology Studies 
The human neuroimaging literature's dominate interpretation is a two system 
account where one cool, executive system competes with a hot, impulsive one. In the 
case of the human dlPFC, there is particularly good evidence to support this 
interpretation. The dlPFC exhibits greater BOLD activity when delayed choices are made 
(Hare et al., 2007; McClure et al., 2004; 2007). Furthermore disrupting the dlPFC with 
either TMS or DCS increases the rate of DD (Figner et al., 2010; Hect et al., 2013), and 
COMT genotypes linked to either an excess dlPFC DA in adolescence or deficit in 
adulthood are associated with increased DD statistically mediated by altered dlPFC 
activity (Boettiger et al., 2007; Gianotti et al., 2012; Smith & Boettiger, 2012; Kayser et 
al., 2012).  
Evidence pertaining to delayed reward subjective value representations are 
difficult to reconcile with two system accounts. The most commonly identified impulsive 
system area is the NAcc/VS. Many studies have seen greater NAcc/VS activation when 
individuals make immediate reward choices (Albrect et al., 2011; Hariri et al., 2006; 
McClure et al., 2004; 2007). Greater activity in the NAcc/VS has been shown to be 
related to increased DD, and decreases in DD with age are accompanied by decreases in 
NAcc/VS activity (Christakou et al., 2011). However, it is precisely this structure, in 
addition to several other areas, in which subjective value representations are seen 
(Ballard & Knutson, 2009; Kable & Glimcher, 2007; 2010; Schneider et al., 2014). These 
subjective value representations are problematic because increases in delayed reward 
value, which favor selection of the delayed reward, are related to corresponding increases 
in NAcc/VS BOLD signal. According to two system accounts this increase in NAcc/VS 
activity should cause an increased propensity to choose the immediate reward (Bickel et 
al., 2007). However, this increase in activity is inversely correlated with that outcome in 
this instance.  
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Structural and functional connection studies point out how important the strength 
of connections are to DD, and also raise questions about the existence of two distinct and 
competing neurobehavioral systems. Multiple studies have shown that the functional and 
structural connection between brain regions is associated with the rate of DD both cross 
sectionally and longitudinally (Achterberg, 2016; Christakou et al., 2011; Hampton et al., 
in press; Li et al., 2013; Peper et al., 2013; Peters & Büchel, 2010; van den Bos et al., 
2014; 2015). In the context of two system accounts, one could see how increased 
connection strength between the areas of given neurobehavioral system could be related 
to DD. For example, increased connection strength in between the areas of the impulsive 
system could result in a feed forward mechanism resulting in increased impulsive system 
activity. This increased activity would in turn lead to increased selection of the immediate 
reward. While some of the connections whose strength is associated with DD would 
correspond to intra-system connections (Li et al., 2013), many are inter-system 
connections. Increased structural and functional connectivity between the dlPFC and the 
striatum is associated with decreased DD and increases in the connectivity are related to 
the decrease in DD with age (van den Bos et al., 2014; 2015). Also increased functional 
coupling between the vmPFC and the dlPFC with increases in age is associated with 
decreases in DD (Christakou et al., 2011). One implication is that if these two systems 
exist, they do not operate independently of one another.  
Whether or not two different executive and impulsive neurobehavioral systems 
exist does not mean that there are not “cooler” and “hotter” areas in an interconnected 
network with the NAcc/VS as a final common output pathway. Indeed the animal 
literature supports this idea. The areas implicated in DD in rodent studies (BLA, OFC, 
mPFC, HPC) are all interconnected and all have a common projection to the NAcc 
without a monosynaptic return from the NAcc which projects to other areas including the 
SNpr/pc, VP, and other basal ganglia structures23. As such, the NAcc is well positioned to 
serve as a comparator of different value signals and be a final common output that 
interfaces with the motor system. 
The NAcc/VS being the final common output of this DD network is consistent 
with a number of pieces of evidence. First, the NAcc has long been thought of as an 
                                                 
23 Connections and their citations reviewed at the start of all the prior sections. 
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interface of the limbic and motor systems (Morgenson, 1980). More recently it has been 
proposed to be involved in action selection when outcomes are delayed or uncertain in 
some fashion (Nicola, 2007; Floresco, 2015). Neural activation in the VS on during a DD 
task is directly related to the subjective value of both rewards (Kable & Glimcher; 2010). 
Single unit recordings also indicate that both outcome values are represented in the core. 
NAcc core neurons exhibit increased activity in response to DS that tracks with reward 
value, and show activity immediately before a response that is directionally sensitive 
(Gutman & Taha, 2016; Roesch et al., 2009).  Lesions and inactivation of the NAcc core 
also caused disruptions in magnitude discrimination (Cardinal et al., 2001) and variable 
effects on processing reward magnitude (Cardinal & Cheung, 2005; Galtress & 
Kirkpatrick, 2010). This may be the result of a global disruption in animals’ ability to 
adaptively compare and select an outcome. However, not all studies show this deficit 
with NAcc lesions. Nicola (2007) and Floresco (2015) both suggest that the NAcc action 
selection function may be geared towards outcomes with a degree of uncertainty or delay. 
By contrast the dorsal striatum may facilitate action selection when outcomes are more 
predictable (Nicola, 2007). Hence lesioning the NAcc may disrupt selection of actions 
with delayed outcomes to a greater degree.  
The BLA may be involved, along with the OFC, in the generation of an expected 
value signal for the delayed reward. It exhibits sustained activity during the delay period, 
and lesions and inactivations of the BLA increase DD (Winstanley et al., 2004b; 
Churchwell et al., 2009). Such a role is consistent with a broader role of the BLA in 
signaling the outcomes associated with various actions (Hatfield et al., 1996; Balleine et 
al., 2003), and representing value of conditioned stimuli (Cador et al., 1989; Burns et al., 
1993; Gallagher, 2000). However ultimately very few studies have examined the BLA in 
DD.  
The OFC is clearly intimately involved in DD based on the proclivity with which 
it is identified by human neuroimaging studies and the numerous preclinical results. It is 
also very clear that there are multiple different functions that the OFC is fulfilling. Based 
on the literature reviewed, there is evidence that the OFC is involved in discounting the 
delayed reward, encoding an expectancy signal for the delayed reward, and processes 
cues associated with the delayed reward. All of this is consistent with a more general 
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proposed role for the OFC in signaling the desirability of expected outcomes and a 
generating a common currency value signal of those expected outcomes (Schoenbaum et 
al., 2006; Kringelback, 2005; Montague and Berns, 2002). 
The literature on HPC involvement is anomalous. It is not commonly found in 
human neuroimaging studies unlike the OFC, NAcc, and dlPFC (though some do find it), 
but it has perhaps the most consistent preclinical effects. Across methodological 
variations and paradigms, disrupting the HPC almost always causes an increase in DD 
without disrupting overall task behavior (Abela & Chudasama, 2012; 2013; Cheung & 
Cardinal, 2005; Mariano et al., 2009; Rawlins et al., 1985).  
The other functions the HPC is involved in may provide a clue to its role in DD. 
There is strong evidence that the HPC is involved in working memory (Floresco et al., 
1997; Seamans et al., 1998; Rawlins and Tsaltas et al, 1983). Working memory is 
negativity associated with DD (Shamosh et al., 2008), and increasing working memory 
load increases DD (Hinson et al., 2003). Also the HPC has been proposed to contribute to 
decision making via representing future outcomes which are converted to expected value 
signals by other downstream areas such as the OFC (Johnson et al., 2007; Schacter et al., 
2007). Providing individuals with future episodic tags, to help them generate a 
representation of the delayed reward, decreases DD (Peters & Büchel, 2010). Moreover 
this behavioral manipulation is dependent upon the degree of functional coupling 
between the ACC and the hippocampus/amygdala (Peters & Büchel, 2010). Furthermore, 
these two different functions may be interconnected. Working memory resources may be 
necessary to substantiate a representation of the delayed outcome. 
This role in the generation of outcome representations and working memory may 
be shared by the mPFC. Working memory has been shown to have an inverted U shaped 
dose response function in the rodent mPFC/primate dorsolateral PFC with regard to D1 
receptor stimulation (Goldman-Rakic et al., 2000; Zahrt et al., 1997). This mirrors the 
effects of DA agonists and antagonists microinjected into the mPFC causing increased 
DD (Loos et al., 2010; Pardey et al., 2013; Sonntag et al., 2014; Yates et al., 2014), and 
the hypothesized effect of DA levels on DD in the mPFC’s potential human analog the 
dlPFC (Boettiger et al., 2007; Gianotti et al., 2012; Smith & Boettiger, 2012; Kayser et 
al., 2012). Critically there is direct evidence in the mPFC for this outcome representation. 
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The PL cortex exhibits outcome specific delay period activity (Burton et al., 2009; 
Miyazaki et al., 2003). Also PL lesions block the effect of outcome devaluation 
suggesting they are necessary for outcome directed responding (Balleine and Dickinson, 
1998; Balleine & O’Doherty, 2010; Killcross & Coutureau, 2003).  Interestingly, it is 
also the PL that has the strongest connections to the BLA, OFC, NAcc core, and the HPC 
(Berendse et al., 1992; Brinley-Reed et al., 1995 Cassell & Wright, 1986; Hoover & 
Vertes, 2007; 2011; Gabbott et al., 2006; Shinonaga et al., 1994).  
In sum, it may be the case that a network of areas contributes specific elements to 
delayed reward valuation and decision making. The mPFC, specifically the PL cortex, 
may be involved in generating an outcome representation of the delayed reward. Along 
with a representation generated by the HPC, these potential outcome representations are 
then converted to an expected value signal by the OFC, and potentially the BLA, such 
that different rewards can be compared in a common currency in the NAcc core. The 
OFC and BLA may also process any conditioned reinforcers and cues, and the OFC may 
also account for reward delay by lowering the expected value signal. The NAcc core then 
severs as a mechanism for reward selection and initiation of the motor moment necessary 
to choose a reward. It is also possible that the mPFC and HPC send information directly 
to the NAcc core in addition to any expected value signals the core may receive. Across 
this network there is built in redundancy.  
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EXPERIMENT 1 
Experiment 1: Introduction 
The goal at the outset of experiment 1 was to test the necessity of the rat mPFC 
for DD by inactivating it using designer receptors exclusively activated by designer drugs 
(DREADDs). It was hypothesized that inactivation of the mPFC would result in 
increased DD. Preclinical lesion and inactivation studies investigating the mPFC have 
been discordant indicating both an increase in DD or no change, but the paradigms used 
have response inhibition and behavioral perseveration methodological concerns (Cardinal 
et al., 2001; Feja & Koch 2014; Churchwell et al., 2009). However, DA D1 and D2 
agonists and antagonists microinjected into the mPFC as well as viral mediated changes 
in D1 receptor expression have shown increased DD (Loos et al., 2010;Pardey et al., 
2012;Yates et al., 2014; Sonntag et al., 2014). Electrophysiological recordings where a 
delay is imposed between a response and reward presentation show increased activity 
during the delay period which can be specific to the reward type (Burton et al., 2009; 
Miyazaki et al., 2003). One possible interpretation of these findings is that the mPFC 
maintains a representation of the delayed reward, which is then sent to “downstream” 
areas such as the BLA and OFC to be integrated into a common currency value signal. 
This value signal would then be summated and compared in the NAcc core with a 
corresponding value signal for the immediate reward. If this representation is necessary 
for the generation of the common currency value signal, then disrupting it via decreasing 
the activity of or inactivating the mPFC should in turn disrupt the value signal for the 
delayed reward only. Consequently, the main hypothesis of experiment 1 was that 
inactivation of the mPFC will result in increased DD.  
The same hypothesis can be derived by looking at the literature translationally. 
The studies of DA involvement in DD in the rat mPFC suggest that an optimal level of 
DA is needed following the model of an inverted “U” for prefrontal function. A similar 
body of evidence exists for the primate dlPFC (Boettiger et al., 2007; Gianotti et al., 
2012; Smith & Boettiger, 2012; Kayser et al., 2012). This parallel pattern between the 
human and rat literature suggests the rat mPFC could be used to model the primate 
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dlPFC. Obviously, the rat mPFC does not correspond one-to-one with the human dlPFC. 
However, it is hypothesized that they are related, possibility being divergent evolutionary 
paths from the same ancestral structure (Uylings et al., 2003; Seamans et al., 2008). 
Indeed the functions performed by the primate dlPFC, along with other cortical areas, 
appears to be mediated on a more rudimentary level by the rat mPFC. If these functions, 
whatever they may be, are needed for adaptively delaying gratification, then impairing 
them should increase the rate of DD.  
Using the rat mPFC to model the primate dlPFC, the two system models of DD 
predict that inactivating the rat mPFC will lead to an increase in DD. This derivation 
allows for more “wiggle-room” in what the rat mPFC may actually correspond to in the 
primate brain. Bechara (2005) lists the vmPFC, ACC and dlPFC as executive system 
structures. It has been argued that the rat mPFC actually displays functionality and 
physiology corresponding to the primate ACC and vmPFC in addition to the dlPFC 
(Seamans et al., 2008). Hence, the rat mPFC can be considered an executive system 
structure. Two system accounts postulate that the activity of the executive system is 
pitted against the activity in the impulsive system, and the system with the greater level 
of activity determines whether a delayed or immediate option is chosen. Decreasing the 
activity in the executive system via inactivating a structure should then shift a subjects’ 
pattern of choices to the immediate option. Therefore once again, inactivating the rat 
mPFC should result in increased DD.  
DREADDs are a new tool available to further investigate the neurobiology 
underlying DD (See Urban & Roth, 2015, for an in depth discussion). DREADDs were 
created via mutagenesis of the human muscarinic (hM) receptor, and these novel 
receptors now lack any functional affinity for their endogenous ligand, acetylcholine 
(Armbruster et al., 2007). Rather, they respond to clozapine-N-oxide (CNO), a 
pharmacologically inert and bioavailable clozapine analog and metabolite (Krashes et al., 
2011; Armbuster et al., 2007; Bender et al., 1994; Chang et al., 1998)24. Using a 
recombinant adeno associated virus (rAAV) delivery system, cells can be transfected 
                                                 
24 After the completion of this experiment MacLaren et al., (2016) published a paper indicating 
that CNO and its metabolites are not completely biologically inert. Specifically it is likely that CNO back 
metabolizes into clozapine and N-desmethylclozapine (N-Des). This caveat is discussed in the discussion 
of experiment 1.  
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with a DNA sequence encoding a DREADD receptor. The host cell then expresses the 
DREADD receptor, and if the rAAV is applied locally, CNO can be administered 
systemically to affect changes in only those cells transfected with and expressing the 
DREADD receptor. This allows for brain site specific manipulations with a systemic 
route of administration. Multiple studies have utilized this strategy combined with tying 
expression of the DREADD receptor to a specific promoter, such as Synapsin (Syn), to 
result in neuronal specific expression (Mahler et al., 2014). 
There are multiple different DREADD receptors that have been created via 
mutating different muscarinic receptor subtypes, allowing for selective manipulations of 
different G-protein coupled signaling cascades. Mutagenesis of hM3 resulted in a 
DREADD receptor coupled to Gq (hM3Dq; Urban & Roth, 2015). When hM3Dq is 
expressed in neurons, application of CNO results in depolarization and increased 
excitability, but simply expressing the DREADD receptor did not change basal activity 
levels (Alexander et al., 2009).  The DREADD receptor created from the hM4 receptor 
(hM4Di) is gi linked and associated with a G-protein inward rectifying potassium current 
(GIRK) which induces hyperpolarization (Armbuster et al., 2007).  
Studies of CNO’s pharamacokinetics indicate that it rapidly crosses the blood 
brain barrier, and is quickly eliminated from CNS tissue and the circulatory system. 
Bender et al. (1994) injected NMRI mice (~30g) with 3-4nmol of radiolabeled clozapine 
or CNO into their tail vein. Animals were sacrificed at 2, 5, 10, 20 and 60 minutes post-
injection, and the radioactivity of specific organs/structures was used as an index of CNO 
biodistribution. Maximum CNS signal was seen at 2 and 5 minutes after injection, and 
baseline levels were reached by 10 minutes. In the periphery, blood CNO levels peaked at 
2 minutes and reached baseline levels by 20 minutes. The highest concentrations were 
seen in the kidneys 2 minutes post injection followed by the liver at 5, 10, and 20 
minutes. In summary, CNO reaches the CNS within 2 minutes and is at pre-injection 
levels by 20 minutes in both CNS and blood.  
In contrast to the rapid elimination of CNO, several studies have demonstrated 
prolonged behavioral and electrophysiological effects. In a transgenic mouse line 
expressing the hM3Dq DREADD receptor under the control of the CaMKIIα promoter in 
the cortex, hippocampus, and other areas, administration of 0.3mg/kg CNO resulted in 
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increased motor activity versus controls for a 9 hour period and increased local field 
potential gamma power for 9 hours as well (Alexander et al., 2009). Utilizing an hM4Di 
DREADD and 3mg/kg CNO to inactivate the ventral tegmental area decreased NAcc DA 
release measured by fast scan cyclic voltammetry for over an hour post injection 
(Ferguson et al., 2011). Using dual-recombinase genetic techniques to knock in and 
selectively express to express the hM4Di in serotonergic neurons, administration of 
10mg/kg CNO decreases body temperature within 10 minutes reaching peak effects at 
approximately 1-2 hours (Ray et al., 2011). Finally, activation of an hM4Di  DREADD in 
the motor cortex via systemic CNO injection blocks seizure related activity caused by 
microinjection of the convulsant picrotoxin. Specifically, increased immediate frequency 
and power in the 4-14hz range caused by pilocarpine were reversed within 20 minutes of 
CNO injection, and the reversal lasted through the final timepoint at 70 minutes (Kätzel 
et al., 2014). Hence DREADD receptor activation, via hM3Dq or hM4Di, onsets within 
20 minutes and lasts on a timescale measured in hours.  
Repeated activation of DREADDs also appears to result in continued effects on 
behavior and neural activity. After a 0.3mg/kg dose of CNO combined with an hM3Dq 
DREADD increased local field potential gamma power for 9 hours, a second 
administration 24 hours later and did not see any decrease in effect (Alexander et al., 
2009).  Chronically stimulating parabrachial nucleus calcitonin gene –related peptide 
(PBelo CGRP) neurons with an hM3Dq DREADD receptor and CNO (1mg/kg injection 
every 12 hr for 8 days) caused large and repeated decreases in food intake across days as 
well as a corresponding decreases in body weight. Conversely, chronically inhibiting 
PBelo CGRP neurons after administration of anorexogenic compounds using an hM4Di 
DREADD receptor and the same CNO regime partially rescued the decrease in intake 
and blocked the starvation observed in control animals (Carter et al., 2013). Selectively 
inhibiting serotonergic neurons with hM4Di and a 10mg/kg CNO injection repeatedly did 
show a reduction in effect size with multiple adminstrations, with regards to a decrease in 
body temperature (Ray et al., 2011). However, body regulation temperature is a critical 
homeostatic function subserved by multiple mechanisms. Thus is difficult to infer 
whether this decreasing effect size is due to a loss of function of the hM4Di receptor with 
repeated administrations or a learned conditioned response to mitigate the severe 
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hypothermia which would follow an injection of CNO. Regardless, using DREADDs to 
manipulate neural activity and thus behavior multiple times is a viable experimental 
methodology.  
Experiment 1 sought to test the hypothesis that the mPFC is involved in 
maintaining a representation of the delayed reward that is necessary for DD. In animals 
completing an AA DD task, an hM4Di inhibitory DREADD with a mCherry tag was 
transfected and expressed in the rat mPFC. A dose response of CNO was tested. It was 
hypothesized that activation of the hM4Di DREADD would result in a disruption of the 
potential representation of the delayed reward. This, in turn, would prevent subjects from 
appropriately valuing the delayed reward and cause an increase in DD represented by a 
decrease in indifference points.  
Experiment 1: Methods 
Animals 
Twenty-five male Long Evans rats obtained from Harlan (Indianapolis, IN) 
served as research subjects. All animals were age matched at approximately 50 days at 
the start of the experiment and weighed between 310g and 277g (M=294.52, SD=8.37). 
Throughout the experiment animals had ab libitum access to water and were individually 
housed in polypropylene shoebox cages and were maintained on a 12 hour reverse 
light/dark cycle. Animals were run during dark period in four separate cohorts one time 
per day, 5 consecutive days per week. For all behavioral testing, animals were food 
restricted to 85% of their free feeding weight. 
Apparatus 
Behavioral testing was conducted in modular operant chambers with electrical 
inputs and outputs controlled by an IBM compatible PC (Med-Associates, St. Albans, 
VT; 30 x 30 x 24.4cm). All chambers had a house light, stainless steel bar floor, and were 
enclosed in sound attenuating boxes with exhaust fans for ventilation and masking 
external noise. Chambers were equipped with a nosepoke recess with an internal stimulus 
light and a photocell to record beam breaks. The nosepoke was centered on the front wall 
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2 cm above the floor. A 4,500Hz tone generator was located 18cm above the nosepoke. 
On both sides of the nosepoke recess were retractable levers with stimulus lights 4cm 
above each lever. Opposite the nosepoke was a retractable graduated cylinder tube 
equipped with a lickometer, stainless steel spout containing double ball bearings, and 
rubber stopper. 
Delay Discounting Task 
An AA DD procedure based on Beckwith and Czachowski (2014) was used. 
Training was conducted in a series of stages each with a criterion for advancement. After 
being handled for 4 days, animals received 200 free licks of the sipper tube containing a 
10% sucrose solution (w/v) and then were hand shaped to press either lever for 20 
seconds of access to the sipper tube. During the session the levers remained extended and 
the stimulus lights were illuminated above both levers signaling the availability of 
reinforcement for pressing the lever. Once animals completed 10 trials in less than or 
equal to 20 minutes they moved onto the second stage of training. Here subjects no 
longer received any free licks and responded on an fixed ratio (FR) 1 on either lever for 
10 seconds of access to the sipper tube. To advance subjects were required to complete 
20 trials in less than or equal to 60 minutes.  
In the third stage of training, the levers were retracted to start the session, the 
stimulus lights were extinguished, and the nosepoke’s internal stimulus light was turned 
on.  Animals were hand shaped to nosepoke on an FR1 for extension of the levers, 
turning on the stimulus lights, and extinguishing of the nosepoke’s internal stimulus light. 
Upon pressing either lever all the stimulus lights extinguished, levers retracted, and the 
sipper tube extended into the chamber for 10 seconds. After the sipper tube retracted, a 5 
second inter-trial interval (ITI) was imposed. The nosepokes internal stimulus light 
turned on after the ITI elapsed signaling the start of the next trial. Forced choice trials 
were also introduced in stage 3 of training. If an animal pressed the same lever two 
consecutive times, on the following trial only the opposite lever and stimulus light were 
activated. After animals completed at least 30 trials in 60 minutes the sipper access was 
reduced to 5 seconds and the ITI increased to 25 seconds, and a new a criterion of 40 
trials in 60 minutes was imposed. In the fifth and final stage of training, the sipper access 
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was further reduced to 2 seconds and a 28 second ITI was used. Animals had to have at 
least 3 sessions and at least 40 trials in 60 minutes to advance. During the last 3 sessions 
training, lever preference was assessed for each subject. The stages of training are 
summarized in table 6.  
 
Table 6: Experiment 1 Delay Discounting Training Stages 
Stage Nosepoke Forced Trials Sipper Access (s) ITI (s) Criteria 
1 No No 200 free licks & 20 0 ≥10 trials in 20min 
2 No No 10 0 ≥20 trials in 60min 
3 Yes Yes 10 5 ≥30 trials in 60min 
4 Yes Yes 5 25 ≥40 trials in 60min 
5 Yes Yes 2 28 ≥40 trials in 60min & ≥3 sessions 
*Note: s=seconds; min=min. 
 
Next the 0 second delay (0sD) condition began. The same pattern of chained 
responding occurred. However, a response on the nonpreferred lever from stage 5 of 
training yielded a standard reward of 2 seconds of access to the sipper tube, and a 
response on the preferred lever resulted in the delivery of an adjusting, alternative 
reward. The adjusting, alternative reward started at 1 second of access to the sipper tube, 
but then titrated by .2 second increments based on the subjects choices ranging between 0 
and 3 seconds. Selection of the standard reward caused an increase, and selection of the 
alternative reward caused a decrease on the next trial. The median of the last 20 
alternative reward amounts was taken as an indifference point (IDP). Moreover, a 
variable ITI was implemented ensuring 30 seconds always elapsed between when the 
animal made a selection and when the next trial began preventing subjects from earning 
several alternative rewards in the time it would take to earn one standard reward. To 
advance, animals had to demonstrate magnitude discrimination and complete ≥20 free 
choice trials. Magnitude discrimination was operationally defined as exhibiting an 
average indifference point of 1.5 seconds or greater across 4 days.  
Once all animals met criteria for magnitude discrimination, viral microinjection 
surgeries occurred. After surgeries the 0sD was in place for another two weeks to 
reassess magnitude discrimination. A four second delay (4sD) to the standard reward was 
then implemented for 5 sessions. During the delay to the standard reward, the stimulus 
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light above the delayed lever remained on until the standard reward was delivered (i.e., a 
CDP was used). Next an eight second delay (8sD) was implemented for another 5 
sessions, and then the delay decreased back to 4 seconds for another 5 sessions before the 
CNO injections.  
Viral Microinjection Surgeries 
Rats were anesthetized with isoflurane and placed in a stereotaxic apparatus 
(Benchmark Digital Stereotaxic; myNeurolab, St. Louis, MO), and given 5mg/ml/kg 
ketoprofen (Zoetis Inc., Kalamazoo, MI) via subcutaneous (s.c.) injection, 2.5mg/kg 
Maricane (Hospira Inc., Lake Forest, IL) via s.c. injection at the site of the incision in a 
concentration of 5mg/ml, and Cefazolin (West-Ward Pharmaceutical Corp., Eatontcwn, 
NJ) 30mg/ml/kg via intraperitoneal (i.p.) injection. Then stainless steel guide cannulae 
(26 gauge) with removable wire obturators (33 gauge) extending 1mm beyond the 
cannulae were lowered to into the mPFC (A.P. +3.2mm, M.L. ±.7mm, and D.V. -
3.3mm). The obturators were then removed and stainless steel microinjectors extending 
1mm beyond the cannulae were used to inject 1μl/side of rAAV8-hSyn-hM4Di-mCherry 
(8.3 x 1012 viral molecules/mL; University of North Carolina Vector Core) at a rate of 
.1μl per minute. An additional 10 minutes post microinjection was provided to ensure 
diffusion into the surrounding tissue before removing the microinjectors. Sterile bone 
wax (Surgical Specialties Corp., Reading, PA) was used to repair the skull after 
injections, and the incision was sutured closed.  Post-surgery, animals were held in 
isolation for one week and were given 10ml/kg of sterile saline (s.c.) and wet food to aid 
in recovery. 
Clozapine-N-Oxide Administration 
Clozapine-N-Oxide (CNO; Tocris Bioscience, Bristol, UK) was administered at 
doses 0, 3, and 9mg/kg/ml (i.p.) in 1% Dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. 
Louis, MO) and sterile water with a 30 minute pretreat. Each dose was given for 5 
consecutive days, and was followed by a washout period of 2 days (where no behavioral 
testing occurred). The order of the different doses was administered via a latin square 
65 
 
design. All doses were tested at a delay of 4 seconds to the standard reward. This delay 
was selected to ensure sufficient signal window to detect a decrease in DD.  
Immunohistochemistry 
After behavioral experiments, all animals were transcardialy perfused with 
phosphate buffered saline (1xPBS) and 4% formaldehyde made up from 
paraformaldehyde in 1xPBS no more than 24 hours before perfusions. Brains were 
postfixed in 4% formaldehyde for 24 hours. Brains were then cryoprotected by soaking in 
20% sucrose in 1xPBS for 48-72 hours followed by 30% sucrose in 1xPBS for another 
48-72 hours. Brains were then SNAP frozen in isopentane chilled via dry ice and 
sectioned at 40μm on a cryostat at -20°C.  
Sections were blocked in 5% normal goat serum in 1xPBS (5% NGS) for 1 hour. 
Next sections were incubated for 18 hours in rabbit anti-mCherry (ABCAM ab167453; 
1:500 in 5% NGS) at 4°C on a plate shaker followed by 3x5min washes in 1xPBS. Then 
goat anti-rabbit IgG AlexaFlour594 (ABCAM ab150080; 1:1000 in 5% NGS) was added 
and incubated for 1 hour at room temperature on a plate shaker. Finally sections were 
washed in 1xPBS (3x5min) and rinsed in Milli-Q water before mounting on subbed slides 
and coverslipped with Dako fluorescent mounting medium (Agilent Technologies, Santa 
Clara, CA). Images were subsequently acquired with a Leica LMD 6500 system (Leica 
Microsystems, Buffalo Grove, IL). Hits were dichotomously coded based upon bilateral 
expression of hM4Di-mCherry in the PL cortex (Paxinos & Watson, 1998) when 
experimenters were blind to behavioral results. Animals were not deemed misses if the 
expression of the hM4Di-mCherry extended beyond the bounds of the PL region. 
Electrophysiological Recordings 
Prior to perfusion, a subset of animals underwent electrophysiological recording 
under urethane anesthesia. 64-channel silicon probes (Cambridge Neurotech, Newmarket, 
Suffolk, U.K.) and custom multi-tetrode probes made in house and gold electroplated to 
an impedance of approximately 300kΏ were lowered into the mPFC. Signals were 
amplified and digitized by 64 and 32 channel headstages (Intan, Los Angeles, CA) 
respectively. Raw data (30 kHz) was acquired using an Open Ephys recording system 
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comprised of a multi-channel electrophysiology acquisition board (Open Ephys) and a 
PC computer running Linux with Open Ephys GUI. After lowering the probes, a baseline 
period of 30 minutes was recorded then animals received a vehicle injection (0mg/kg; 
i.p.). 9mg/kg CNO was administered at least 40 minutes after the vehicle injection, and 
recordings continued for another 120 minutes. Single units were identified, automatically 
spike sorted, and manually refined in phy (Rossant et al., 2016). Finally, spike 
timestamps were exported using Matlab, binned in 5 minute increments, and z-score 
transformed to limit unit to unit variability. 
Data Analysis 
For behavioral data, normality assumptions were tested via visual inspection of 
histograms and q-q plots as well as Shapiro-Wilks tests. If normality and homogeneity of 
variance assumptions were violated, log10 transformations were used for right skewed 
data, and for left skews the data were reflected, anchored at 1, and log10 transformed. If 
data transformations were unable to normalize the data, non-parametric tests were used. 
Primary data analysis was conducted using repeated measures analysis of variance 
(ANVOA) with factors of dose (0-, 3-, & 9mg/kg) and day (1-5). Main effects of dose 
were followed up with paired samples t-tests with Dunnett’s corrected alpha levels 
(α=.05/2 comparisons=.025) with 0mg/kg serving as the control condition. Main effects 
of day were followed up with polynomial trend analysis. Curve fitting started with 
centered, 0 order functions and worked up until a more complex function no longer 
provided a significantly better fit. Dose by day interactions were followed up by 
examining the effect of day inside of each dose with polynomial trend analysis and by 
examining the effect of dose inside each day with Dunnett’s corrected paired sample t-
tests inside of each day (α=.05/(2x5 comparisons)=.005). 
Experiment 1: Results 
The final n after all sources of attrition was 11 animals who exhibited bilateral 
expression of the hM4Di-mCherry in the PL cortex (hits). For sources of attrition, 1 
animal failed to learn how to lever press, 6 animals died as a result of surgical 
complications, and 7 animals did not express hM4Di-mCherry bilaterally in the PL 
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Cortex (misses). Figure 1B displays the range of expression in hits which included the 
mOFC (8/11), IL (2/11), and Cg1 (7/11) areas. Inside the 7 animals classified as misses, 
animals had bilateral expression limited to the MO cortex (5/7), unilateral expression in 
the PL cortex (1/7), and unilateral expression in the VO cortex (1/7).  
 
Figure 1: Experiment1 hM4Di Expression A) Representative images of hM4Di 
expression. B) Combined expression map across all animals classified as hits. The area of 
expression was visual drawn for each subject, made partially transparent and then 
overlaid.  Diagrams are adapted from Paxinos and Watson (1998). 
 
Among animals classified as hits, both before (Mdn=5, Mode=4, Range=6) and 
after (Mdn=4, Mode=4, Range=1) surgeries the majority of subjects took 4-5 sessions to 
reach magnitude discrimination criteria. Pre-surgery the distribution was right skewed 
with one extreme outlier two SD beyond the mean and post-surgery only one subject took 
more than the minimum number of sessions giving rise to a near uniform distribution. A 
Wilcoxon signed rank’s test indicated that after surgery subjects took fewer sessions to 
reach magnitude discrimination criteria, Z=-1.983, p=.047. Excluding the extreme outlier 
reduced this effect to a trend, Z=-1.730, p=.084. IDPs when animals met magnitude 
discrimination criteria did not differ before (M=1.96, SD=.39) or after surgery (M=2.13, 
SD=.47), t(10)=-.845, p=.418. However post-surgery increasing the delay to the standard 
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reward decreased IDP, F(2,20)=44.345, p<.001. Specifically Bonferroni corrected paired 
sample t-test revealed that increasing the delay to 4, t(10)=7.2, p<.001, as well as 8 
seconds, t(10)=7.954, p<.001, decreased indifference points relative to the 0sD condition. 
Moreover the 8sD had lower indifference points compared to the 4sD, t(10)=3.187, 
p=.010. In a specific a priori planned comparison to determine if IDPs were stable across 
time, the IDPs at the 4sD both before and after a week of the 8sD condition were 
compared with a uncorrected paired sample t-test and no difference was found, 
t(10)=.360, p=.727. A hyperbolic equation (Mazur, 1987) was fit to the mean IDPs 
through the determination of the 8sD. The best fitting k value was .1768 with a standard 
error of 0.02494. The model fit the data extremely well with an R2 value of 0.98.  
 
Figure 2: Experiment 1 Magnitude Discrimination and Baseline Indifference Points 
(IDP). A) Boxplots of the number of sessions animals required to reach magnitude 
discrimination criteria. The arrow indicates the outlier that was excluded in the second 
analysis where the indicated significant difference dropped to a trend. *p<.05 on 
Wilcoxon signed rank test. B) Mean (±SEM) IDP plotted as a function of pre- vs. post-
surgery and delay. The break in the x-axis is used to separately represent the second 
determination of a 4 second delay to the standard reward.  
 
Indifference points (IDP), the main dependent variable, were normally distributed. 
A main effect of dose, F(2,20)=5.5, p=.018, was observed, but effects of day, 
F(4,40)=0.4, p=.797, and the interaction of dose by day, F(8,80)=1.3, p=.278, were not 
significant. Dunnett’s corrected paired samples t-test revealed that only the 9mg/kg dose, 
t(10)=2.8, p=.018, was significantly different from the 0mg/kg dose. The same repeated 
measures ANVOA was conducted in animals classified as misses (n=7) as well. In 
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misses, no significant effects of dose, F(2,12)=0.5, p=.594, day, F(4,24)=0.3, p=.897, or 
an interaction of dose by day, F(8,48)=0.6, p=.775, were observed.   
 
Figure 3: Experiment 1 Indifference points (IDP) in animals classified as hits. 
Mean (±SEM) IDP in seconds graphed by dose. *p<.05 on Dunnett’s test.  
 
The delayed lever preference inside the last 20 free choice trials, termed the 
indifference point choice ratio (IDP CR), was normally distributed. A 2 way repeated 
measures ANOVA found no effect of dose, F(2,20)=1.7, p=.205, day, F(4,40)=0.4, 
p=.829, or dose by day interaction, F(8,80)=1.1, p=.352. Additionally, one-sample t-tests 
were conducted inside each dose using 0.5 as a test value. IDP CR was not significantly 
different from a hypothetical population value of 0.5 at either the 0mg/kg, t(10)=0.3, 
p=.744, 3mg/kg, t(10)=0.8, p=.430, or 9mg/kg dose, t(10)=1.9, p=.085. Mean values are 
reported in table 7.  
The time it took to complete a session in minutes was not affected by dose, 
F(2,20)=2.3, p=.131, but was by day, F(4,40)=2.6, p=.049. There was a trend towards a 
day by dose interaction, F(8,80)=2.0, p=.054. Trend analysis following up the effect of 
day revealed, that there was a negative linear trend across all days that failed to reach 
significance, F(1,53)=1.8, p=.188, nor did Dunnett’s follow up tests find any significant 
effects. Following up the trending interaction, there were no significant linear trends 
inside any dose. Only, inside the first day was the 3mg/kg dose trending towards 
increased time after corrections for multiple comparisons, t(10)=3.5, p=.005. 
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Figure 4: Experiment 1 Session Time. A) Mean (±SEM) session time in minutes 
collapsed across dose and plotted as a function of day along with the regression line and 
95% confidence band. B) Mean (±SEM) session time in minutes plotted separately by 
dose as a function of day with regression lines. †(grey) trend for 3mg/kg vs. 0mg/kg 
inside day.  
 
The number of free choice trials completed were left skewed, and the median 
number of trials for all doses approached 60 trials (0mg/kg: Mdn=60, Range =16.60; 
3mg/kg: Mdn=58.2, Range=22.40; 9mg/kg: Mdn=57.2, Range=19.20). Data 
transformations failed to correct for the deviation from normality. Friedman’s tests 
showed a trend towards an effect of dose, χ2(2)=5.25, p=.072, and an effect of day,  
χ2(4)=16.794, p=.002. Dunnett’s corrected Wilcoxin signed rank tests using day 1 as the 
control condition showed days 2, Z=-2.521, p=.012, and 4 , Z=-2.521, p=.012, had a 
greater number of trials completed. Forced choice trials were normally distributed and 
centered around 18 trials (Table 7). No effect of dose was observed, F(2,20)=.0.5, p=.64. 
There was no significant effect of day, F(4,40)=0.8, p=.53. Finally, there was no 
interaction of dose and day, F(8,80)=0.5, p=.84, for forced choice trials.  
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Figure 5: Experiment 1 Free Choice Trials. A) Boxplots of free choice trials as a 
function of dose. B) Boxplots of free choice trials as a function of day. *significantly 
different from day 1 on Wilcoxin signed ranks with a Dunnett’s corrected alpha. 
 
Median trial initiation latencies from each session (TIL) were right skewed and 
were normalized by log10 transforming them. The log10 TIL exhibited an effect of dose, 
F(2,20)=4.8, p=0.019, an effect of day, F(4,40)=3.7, p=.012, and a dose by day 
interaction, F(8,80)=2.4, p=.025. After correcting for multiple comparisons, significantly 
greater log10 TIL were seen in the 3mg/kg dose, t(10)=4.5, p=.001, and a trend towards 
greater log10 TIL in the 9mg/kg dose, t(10)=2.4, p=.036, versus 0mg/kg. Trend analysis 
following up the effect of day revealed a linear decrease across days that approached 
significance, F(1,53)=2.9, p=.09. Following up the day by dose interaction, inside eace 
dose, a linear function best described the change across days. However, only the 3mg/kg, 
F(1,53)=3.1, p=.09, and 9mg/kg, F(1,53)=3.8, p=.056, approached and trended toward a 
significant negative change across days. Compared to 0mg/kg, Dunnett’s testing inside of 
each day revealed the 3mg/kg dose induced significantly increased log10 TIL on day 1, 
t(10)=4.5, p=.001, as well as a trend on day 4, t(10)=3.0, p=.014. Meanwhile the 9mg/kg 
dose trended towards increased log10 TIL on day 1, t(10)=3.0, p=.013, and day 2, 
t(10)=2.5, p=.033.  
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Figure 6: Experiment 1Trial Initiation Latencies (TIL). A) Boxplots of untransformed 
TIL by dose. B) Boxplots of untransformed TIL by day. C) Boxplots of untransformed 
TIL by both day and dose. D) Mean (±SEM) log10 TIL by dose. *Significantly different 
versus 0mg/kg on Dunnets corrected paired sample t-tests; *(grey) trend vs. 0mg/kg. E) 
Mean (±SEM) log10 TIL plotted as function of day with the besting fitting regression 
line and 95% confidence band. F) Mean (±SEM) log10 TIL plotted separately by dose as 
a function of day. † Significantly difference between 0mg/kg and 3mg/kg on Dunnets 
corrected paired sample t-test †(grey) trend for 3mg/kg vs. 0mg/kg. ‡(grey) trend 9mg/kg 
vs. 0mg/kg. 
 
Free choice latencies from each session (CL) exhibited a mild right skew. Median 
CL inside each dose were 1.08 (Range=.94), 1.00(Range=1.41), and 1.11(Range=0.85) 
for the 0-, 3-, and 9mg/kg doses respectively. Log10 transforming CL corrected the 
deviation from normality. However log10 CL did not show effects of dose, F(2,20)=0.3, 
p=.73, day,  F(4,40)=1.7, p=.16, and dose by day, F(8,80)=1.4, p=.22. Untransformed 
mean values are reported in table 7.  
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The number of licks animals earned was distributed normally. Main effects of 
dose, F(2,20)=3.8, p=.039, and day, F(4,40)=3.7, p=.012, as well as a dose by day 
interaction, F(8,80)=2.2, p=.033, were significant. Follow-up paired samples t-test 
revealed that there were fewer licks at the 3mg/kg dose versus the 0mg/kg dose, 
t(10)=4.5, p=.001, but not the 9mg/kg dose, t(10)=1.7, p=.12. Across all doses, the effect 
of day was best characterized by a linear function, a=924.7, b1=19.45. However, the 
slope was not significantly different from zero, F(1,53)=1.3, p=.27. Inside each day, there 
were significant effects of the 3mg/kg dose at days 1, t(10)=3.8, p=.003, and 5, t(10)=4.3, 
p=.002. Polynomial trend analysis found that the 3mg/kg dose’s effect across days was 
best described by a quadratic function, a=982.5, b1=24.58, b2=50.04. The 0mg/kg, 
F(1,53)=0.1, p=.78, and 9mg/kg, F(1,53)=1.8, p=.19, doses were best described by a 
linear function across days, but neither reached significance.  
 
Figure 7: Experiment 1 Licks. A) Mean (±SEM) licks graphed as a function of dose. B) 
Mean (±SEM) licks collapsed across dose and plotted by day along with a regression line 
and 95% confidence band. C) Mean (±SEM) licks separately plotted by dose as a 
function of day. Regression lines correspond to the best fitting polynomial. †p<.05 
3mg/kg vs. 0mg/kg Dunnett’s test within each day.  
 
Intake of 10S in milliliters (ml) was normally distributed. A main effect of dose, 
F(2,20)=5.9, p=.009, was observed. Effects of day, F(4,40)=2.0, p=.114,  and dose by 
day, F(8,80)=1.8, p=.097, were not significant. Dunnett’s test revealed 9mg/kg dose, 
t(10)=4.3, p=.002, decreased intake relative to the 0mg/kg dose. Mean values are graphed 
in figure 8.  
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Figure 8: Experiment 1 Intake of 10% sucrose (10S) in milliliters. Mean (±SEM) intake 
in ml as a function of dose. *p<.05 vs. 0mg/kg dose on Dunnetts corrected paired sample 
t-test.  
 
Table 7: Experiment 1 Secondary Variables. Mean (±SEM) 
Variable 0mg/kg 3mg/kg 9mg/kg 
IDP CR 0.49(0.02) 0.48(0.03) 0.54(0.02) 
Session Time (minutes) 51.14(1.64) 53.32(1.51) 52.68(1.65) 
Forced Choice Trials 18.62(0.75) 18.06(0.83) 17.98(0.90) 
Choice Latencies  1.13(0.08) 1.16(0.13) 1.17(0.09) 
 
For the electrophysiological recordings, 30 individual units were identified. Firing 
rates were assessed in 5 minute bins and the spikes per bin was z-score transformed 
inside each unit to account for disparate baseline firing rates (zSpikes). To grossly 
examine if CNO administration affected zSpikes, a repeated measures ANOVA was 
conducted collapsing across bin on condition (vehicle, baseline, 9mg/kg CNO). This 
analysis found a main effect of condition, F(2,58)=8.419, p<.001. Paired sample t-tests 
with Bonferroni corrected alpha levels (α=.017) found that the CNO condition differed 
from both the vehicle, t(29)=3.628, p=.001, and baseline conditions, t(29)=2.722, p=.011, 
which did not differ from each other, t(29)=-.607, p=.548.  
A hierarchical multiple regression was then conducted with z-score transformed 
firing rates across all bins as the outcome variable. Steps 1-3 progressively included CNO 
(CNO vs. baseline/vehicle), bin (centered), and a CNO by bin interaction in that order. 
Congruent with the results of the ANOVA, dummy coded CNO predicted a significant 
amount of variance in firing rates across all bins, β=-.275, p<.001, in the first step, such 
that firing rates were lower with CNO on board. In the second step, there was a 
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significant increase in R2 up from .076 to .204, F(1, 1137)=183.767, p<.001. CNO 
remained significant predictor, β=.271, p<.001, and bin also significantly predicted a 
unique amount of variance, β=-.653, p<.001. Including the interaction term in the third 
step, again resulted in a significant increase in the amount of variance explained, 
F(1,1136)=35.187, p<.001. However neither CNO, β=-.025, p=.718, nor bin, β=-.020, 
p=.864, predicted unique variance from the interaction term, β=-.446, p<.001.  
To follow up the interaction, bin was regressed onto zSpikes separately after CNO 
administration and during vehicle and baseline. For the baseline/vehicle regression, the 
model failed to significantly predict variation in zSpikes, F(1,418)=.026, p=.872. 
However, the CNO model did explain a significant amount of variance, 
F(1,718)=243.084, p<.001, with bin showing a negative relationship with zSpikes, β=-
.503, p<.001.  In sum, when CNO was on board zSpikes were lower compared to 
baseline and vehicle. Under baseline/vehicle conditions zSpikes displayed no significant 
linear trend, but under CNO zSpikes tended to decrease across bins. Both model and 
predictor level statistics from the hierarchical multiple regression are reported in table 8, 
and mean zSpikes as a function of condition and condition by time are graphed in figure 
9. 
Table 8: Experiment 1 All Units Regression Analysis.  
 Model Statistics  Predictor Statistics 
Step R F p Predictor β b p 
1 .275 93.185 <.001 Constant -- .355 <.001 
    CNO -.275 -.563 <.001 
2 .452 183.767 <.001 Constant -- -.350 <.001 
    CNO .271 .554 <.001 
    Bin -.653 -.059 <.001 
3 .478 35.187 <.001 Constant -- .334 .012 
    CNO -.025 -.051 .718 
    Bin -.020 -.002 .864 
    CNO x Bin -.446 -.068 <.001 
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Figure 9: Experiment 1 All units z-score transformed firing rates. A) Mean 
(±SEM) z-score transformed spikes per 5 minute bin. *significantly different on paired 
sample t-tests with Bonferroni corrected α for multiple comparisons.  
 
Visual inspection individual unit activity revealed that some neurons actually 
increased their firing rate in response to CNO administration. Visually neurons were then 
categorized into increasing (7), decreasing (17), and unstable/no change categories (6). 
Inside unstable/no change units the RMANOVA collapsing on bin found no effect of 
condition, F(2,10)=1.518, p=.266, but for increasing units there was an effect of 
condition, F(1,6)=13.231, p<.001.Bonferroni corrected paired samples t-tests found that 
under CNO, firing rates were higher than during vehicle, t(6)=3.804, p=.009, and 
baseline, t(6)=4.848, p=.003, conditions which were not different from each other, 
t(6)=1.325, p=.233.  Finally, inside decreasing units the RMANVOA found an effect of 
condition, F(2,32)=27.663, p<.001. Post hoc testing with Bonferroni corrected paired 
sample t-tests revealed that z score transformed firing rates were significantly lower with 
CNO on board compared to both vehicle, t(16)=7.503, p<.001, and baseline, t(16)=5.275, 
periods which were not different from each other, t(16)=-0.101, p=.921. 
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Figure 10: Experiment 1 Visual Classification Means A) Pie chart of the proportion of 
units classified in each subgroup. B) Mean (±SEM) z-score transformed firing rates 
(zSpikes) based on condition inside decreasing units. C) Mean (±SEM) zSpikes inside 
increasing units. D) Mean (±SEM) zSpikes inside unstable no change units. *Significant 
different on Bonferroni corrected paired sample t-test.  
 
Linear regressions were carried out for each visual classification under separately 
under both CNO and vehicle/baseline (collapsed together) conditions. For unstable/no 
change units there were no significant linear trend under vehicle/baseline conditions, 
F(1,12)=0.02494, p=.8771, nor under CNO conditions, F(1,22)=3.481, p=.0755. For 
decreasing neurons there was no linear for vehicle/baseline, F(1,12)=.7542, p=.4022, but 
there was a significant linear decrease across bin after CNO administration, 
F(1,22)=181.0, p<.001. For increasing units, there was no vehicle/baseline trend, 
F(1,12)=3.228, p=.0976, and under CNO conditions there was a clear non-linear pattern. 
A centered second order polynomial which predicted and initial increase followed by a 
decrease provided a significantly better fit than a linear function, F(1,21)=67.28, p<.001.  
 
78 
 
 
Figure 11: Experiment 1 Visual Classification Time Course A-C) Individual units z-
score transformed firing rates (zSpikes) plotted as a function of 5 minute bin for units 
classified as unstable/no change (A), decreasing (B), and increasing (C). D-F) Mean 
(±SEM) zSpikes plotted as a function of 5 minute bin for units classified as unstable/no 
change (D), decreasing (E), and increasing (F). Regression lines correspond to the best 
fitting linear function except for increasing units under CNO conditions where the best 
fitting quadratic function is graphed.  
To verify that multiple different responses to CNO were present, a principal 
component analysis was conducted with the z-score transformed firing rates in each bin 
serving as the input variables. The first seven components were retained explaining 
86.8% of the overall variance. The first (P.C.1), second (P.C.2), and third principal 
components explained 33.3%, 23.2%, and 10.2% of the variance individually. For the 
first component, the five largest loadings were the z-score transformed firing rates at 75-
80 (.909), 60-65(.867), 55-60(.854), 65-70(.847), and 70-75 (.847) minutes post CNO 
injection. Two different groups of units were identified by plotting P.C.1 versus P.C.2 
and using a single straight line was used to create two different groupings of units termed 
C1 and C2. C1 was comprised of 21 units. Previously C1 units had classified as 
decreasing (17), increasing (1), and unstable/no change (3). C2 was comprised of 9 units 
previously classified as increasing (6) and unstable/no change (3).  
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Figure 12: Experiment 1 PCA classification of single unit firing rates. A) Principal 
component 2 (P.C.2) plotted as a function of principal component 1 (P.C.1) with 
marginal histograms. The drawn classification line divides C1 units from C2 units. B) Pie 
chart showing the breakdown of the number of units classified as C1 versus C2.  
C1 units show the same pattern as the overall data set and the visually identified 
decreasing units. Inside the vehicle/baseline period there was not a significant linear 
trend, F(1,292)=.4411, p=.507, and inside the CNO period there was a significant 
negative linear trend, F(1,502)=308.7, p<.001. For C2 units, there was no significant 
linear trend in the vehicle/baseline period, F(1,124)=.7192, p=.398, and similar to the 
visually identified increasing neurons a clear non-linear pattern was observed after CNO 
administration. A centered second order polynomial provided a better fit than a linear 
function for CNO bins, F(1,21)=59.90, p<.001. The nonlinear function predicted an 
increase in firing rates followed by a decrease similar to visually identified increasing 
units.  
 
Figure 13: Experiment 1 PCA Classifcation Z-score transformed firing rates. A) Mean 
(±SEM) z-score transformed spikes inside 5 minute bins for C1 units. B) Mean (±SEM) 
z-score transformed spikes inside 5 minute bins for C2 units. 
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Experiment 1: Discussion 
Prior literature implicated the mPFC in being involved in DD and necessary in 
valuation of delayed rewards. Based on this, rats were transfected with the inhibitory 
DREADD construct AAV8-hSyn-hM4Di mCherry in the mPFC and CNO was 
administered to subjects while they completed an AA DD task with DS and a CDP. It 
was hypothesized that this would result in a decrease in IDPs corresponding to an 
increase in DD. However, the opposite result was observed with CNO administration 
causing an increased in IDP (i.e., decreased DD). Subsequent electrophysiological 
confirmation of the hM4Di-mCherry’s ability to decrease neural activity revealed that 
while the overall effect and the majority of neurons firing rates decreased, a subgroup of 
neurons actually increased firing rates after CNO administration. This pattern raises the 
possibility that a disinhibition effect occurred on pyramidal cell neurons, and the 
functional output of the mPFC to other structures actually increased. This possible 
increase in the functional output of the mPFC may be what resulted in a decrease in DD.  
To determine if the surgery alone and transfection of the virus would disrupt 
behavior on the task, several factors were examined. First if the viral microinjection 
globally disrupted behavior on the task, it may take animals longer to complete 
magnitude discrimination post-surgery. However, this was not the case, and in fact the 
opposite pattern was true with animals trending towards taking fewer sessions to attain 
magnitude discrimination criteria post-surgery. Moreover, once delays were added to the 
standard reward animals exhibited the expected delay dependent decrease in IDPs. This 
decrease fitted the hyperbolic model of DD (Mazur, 1987) very well, and the obtained k 
values (M=0.177) were approximate to ones obtained and previously published for Long 
Evans rats in the same paradigm with minor procedural differences (M=.169; Beckwith & 
Czackowski, 2014). Finally after animals completed the 8sD a second week of the 4sD 
was run before testing CNO and compared to the first week at the 4sD that began two 
weeks prior. No difference was found. All in all, this evidence suggests that neither the 
viral microinjection surgery, nor any possible constitutive activity of the hM4Di-mCherry 
construct affected animals behavior on the task. 
IDPs dose-dependently increased in response to CNO administration in a manner 
that was anatomically specific. In animals classified as hits, injection of 9mg/kg CNO 
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caused an increase in IDP. However in animals classified as misses, no effect was present 
indicating that bilateral transfection of the mPFC with hM4Di-mCherry is necessary for 
the effect. Furthermore, IDP CR, the choice ratio in the last 20 trials, was not affected by 
any factor, and it did not significantly differ from 0.5 under any dose. The IDP CR 
findings suggest that animals were not prevented from reaching indifference, ruling out a 
possible alternative explanation. As a result, the increase in IDPs only in hits indicates 
activation of the hM4Di-mCherry construct causes a decrease in DD, presumably via 
inactivating/disrupting the mPFC.  
To verify the action of the hM4Di-mCherry construct to decrease neural activity, 
recordings of mPFC activity were carried out in rats under urethane anesthesia. Across all 
identified units, the mean level of activity decreased sharply after CNO administration, 
but did not vary during baseline or after a vehicle injection. Further examination of the 
data revealed individual unit differences in the response to CNO. While the majority of 
neurons showed a decrease in firing post CNO, a subgroup showed the opposite effect. 
Specifically a subgroup of neurons, identified both visually and via PCA, showed an 
increase in neural activity which lasted for over 75 minutes before returning to and 
ultimately dropping below baseline levels.  
This increase in firing in a subset of neurons may be explainable by the mPFC’s 
cytoarchitecture and the promoter used for the hM4Di-mCherry construct. Using a hSyn 
promoter would result in the expression of the hM4Di-mCherry in both the mPFC’s 
pyramidal cells and its GABAergic interneurons (Gabbot et al., 1997). Activating the 
hM4Di-mCherry with CNO would cause a hyperpolarization in both cell types. As the 
GABAergic interneurons inhibit the pyramidal cells (Gabbot et al., 2006), inhibition of 
the GABAergic cells could result in a disinhibition of pyramidal cells. The increase in 
firing only by a subset of neurons may represent a disinhibition of the pyramidal cells. 
The eventual decrease in firing seen with extended time may be due to direct inhibition 
on the pyramidal cells via CNO-hM4di eventually overcoming this disinhibition. 
Pyramidal cell disinhibition may explain why IDPs changed in the opposite 
direction versus what was expected. One potential implication of these two possible 
opposing forces on pyramidal cell activity (inhibition and disinhibition) is that they may 
“tune” pyramidal cell activity to favor strong inputs. If an input has enough strength to 
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overcome the direct inhibition of the hM4Di-mCherry, then it may then be favored due to 
disinhibition of the pyramidal cell. The mPFC exhibits delay period activity (Burton et 
al., 2009; Miyazaki et al., 2003), and it is hypothesized that this activity encodes a 
representation of the delayed reward which is then sent to other structures for valuation. 
The principal projection neurons of the mPFC are the glutamatergic pyramidal cells 
(Gabbott et al., 2005). Hence disinhibition of these cells would be predicted to actually 
increase the strength of this representation sent to downstream regions.  
It is not unreasonable that a stronger representation of the delayed reward would 
drive behavior to a greater degree and have more value attributed to the delayed reward. 
Classically, increasing the representation of a future reward in preschool children by 
showing them an image of it increased their ability to abstain from collecting a mutually 
exclusive less desirable reward immediately during a waiting period (Mischel & Moore, 
1973). Having individuals complete a DD task where delayed reward amounts were 
presented alongside an episodic tag describing their planned activities on the day of its 
receipt also causes a decrease in DD (Peters & Büchel, 2010). Increasing working 
memory/cognitive load would be expect to impair one’s ability to represent the delayed 
reward. Accordingly, participants who have to remember a series of digits or have 
consider more options in a DD task also exhibit increased DD (Hinson et al., 2003). 
Hence, activation of the hM4Di DREADD receptor expressed in the mPFC may have 
disinhibited the pyramidal cells and strengthened a representation of the delayed reward 
which in turn caused a decrease DD.  
Alternatively, activation of the hM4Di-mCherry may have caused animals to 
switch to a simpler decision making strategy. Animals may have no longer factored delay 
into the valuation of the standard reward. Indeed inactivation and lesioning of the mPFC 
disrupts interval timing behavior (Dietrch & Allen 1998; Kim et al., 2009). If animals 
could no longer accurately perceive and thus factor the delay to the standard reward into 
their decision, choices would be based upon the magnitude of the rewards because no 
other factor systematically varied between the two choices. Focusing solely on the 
magnitude of the rewards would result in animals favoring the standard alternative. 
However adoption of this simpler strategy, should decrease the difficulty of the decision.  
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As less difficult decisions should take less time, a decrease in choice latency should 
accompany the adoption of the simpler choice strategy. Such a decrease in choice latency 
was not observed. 
The largest caveat to the main results is the now known back metabolism of CNO 
into clozapine with the implication being that systemic CNO injections are not 
completely biologically inert. MacLaren et al. (2016) tested a dose response of CNO in 
several behavioral and neurochemical assays. In a pre-pulse inhibition task, 1mg/kg CNO 
was found to decrease the initial startle magnitude at higher decibels, but had no effect on 
percent inhibition. Also, CNO at 2 and 5mg/kg were unable to affect percent inhibition 
nor block PCP and scopolamine induced decreases in percent inhibition. On locomotor 
behavior, 1, 2, and 5mg/kg CNO had no effects in isolation, but 5mg/kg CNO was able to 
reduce, but not abolish, the increase in distance travelled due to 1.5mg/kg amphetamine 
administration. NAcc fast-scan cyclic voltammetry under conditions of urethane 
anesthesia also revealed that neither 2- nor 5mg/kg CNO was unable to alter DA release 
caused by electrical stimulation of the VTA, but it reduced the DA release caused by such 
stimulation when d-amphetamine (1.5mg/kg) was on board. Finally HPLC was used to 
quantify blood plasma levels of CNO, clozapine, and N-Des after CNO administration. 
After a 5mg/kg injection of CNO clozapine and N-Des were detectable at 30, 90, 180, 
and 360 minutes post injection (MacLaren et al., 2016). As a frame of reference for 
MacLaren et al.’s (2016) effects, clozapine robustly decreases startle magnitude and 
increases percent inhibition (7.5 & 10mg/kg; Feifel et al., 2011), blocks PCP induced 
decreases in prepulse inhibition, (12mg/kg; Leng et al., 2003; 5mg/kg; Bakshi et al., 
1994) decreases locomotor behavior (0.5mg/kg; Pinar et al., 2015), and completely 
blocks the increase in locomotor behavior caused by 2.5mg/kg amphetamine injections 
(all doses 0.31-2.5mg/kg clozapine; O’Neill & Shaw, 1999). 
Critically this raises the implication that CNO, either directly or via back 
metabolizing into clozapine, caused the decrease in DD and not activation of the hM4Di-
mCherry construct by CNO. Clozapine is a second generation, atypical antipsychotic 
medication, and is one of the few effective treatments for treatment-resistant 
schizophrenia (Remington et al., 2016; Wenthur & Lindsley, 2013). There is dispute over 
exactly why clozapine works in treatment resistant schizophrenia probably because of 
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clozapine’s multiple mechanisms of action (Wenthur & Lindsley, 2013). Like typical 
antipsychotic medications, it acts as an antagonist at the D2 receptor, though it has a 
lower affinity that typical antipsychotics (Lako et al., 2013; Naheed & Green, 2001; 
Fakkra & Azorin, 2012). Clozapine also acts at the D1, D4, 5-HT2A,  5-HT1A, 5-HT2c, α1-
adreneric, histamine H1 and muscarinic m1 receptors (Meltzer, 1989; Meltzer, 1992, 
2002).  In spite of its multiple mechanisms of actions, its antagonistic effects on D2 and 
5-HT2A receptors are often discussed, and clozapine’s antagonism of these two receptor 
systems is believe to underlie its therapeutic effects and decreased extrapyramidal side 
effects (Iversen et al., 2008).  
To the best of my knowledge there are no published studies examining 
clozapine’s effects in a DD task, human, rodent, or otherwise. However there have been 
studies examining the role of DA and 5-HT receptor systems in DD. Examining this 
literature may provide some insight into what effects clozapine might have on DD. 
Notably, much of this work has been completed in the DRT task. This task is susceptible 
to false negatives for increases in DD and false positives for decreases in DD; 
nevertheless, an increase in DD can still be interpretable in this task25.  
Global serotonin depletion tends to increase DD, at least in animals. Systemic 
injection of para-chlorophenyl-alanine methyl ester (pCPA), a 5-HT synthesis inhibitor, 
decreases selection of the delayed reward on a T-maze task (Denk et al., 2005; Bizot et 
al., 1999). Similarly, 5-7-DHT infused into the median raphe increased DD on an AD 
task with a CDP as well in a T-maze paradigm (Wogar et al., 1993; Bizot et al., 1999). In 
contrast with these findings, a pair of studies using a DRT with ascending delays failed to 
find an effect of intracerebroventricular 5,7-DHT (Winstanley et al., 2003; 2004a). Given 
that only DRTs with ascending delays show no effect, and 5-HT depletion also tends to 
increase premature responding on the 5-CSRTT, though not perseverative responding 
(Dalley & Roiser, 2012), it is probable these null results for global 5-HT depletion may 
be due to the DRT behavioral perseveration confound (Tanno et al., 2014), and global 
serotonin depletions actually increase DD.  
Non-selectively increasing 5-HT signaling systemically appears to decrease DD 
on T-maze tasks but not on DRTs. The selective serotonin reuptake inhibitors zimelidine, 
                                                 
25 See discussion of this topic in the introduction.  
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citalopram, and indalpine (Bizot et al., 1988) as well as fluoxetine and fluvoxamine 
decrease DD on a T-maze task (Bizot et al., 1999). On a DRT, citalopram fails to change 
DD (Evenden & Ryan, 1996). Also chronic fluoxetine had no effect on an AD with DS 
and a CDP (Logue et al., 1992). Tricyclic antidepressants, which among other actions 
also block serotonin reuptake, follow this same pattern where on T-mazes they decrease 
DD (clomipramine, desipramine; Bizot et al., 1988) but have no effect on DRTs 
(imipramine; Evenden and Ryan, 1996). Finally the monoamine oxidase inhibitor 
nialamide (Bizot et al., 1988) and the serotonin releaser dexfenfluramine (Poulos et al., 
1996) have both been seen to decrease DD on a T-maze.  
Looking at the 5-HT1 receptor family, differential, sometimes opposite, effects on 
DD pending their specific target and the dosage used exist. 8-OH-DPAT, a 5-HT1A 
agonist, at a low dose (.1mg/kg) caused a reduction in immediate reward selection but a 
higher dose (.3mg/kg) respectively caused decreased and increased selection of the 
delayed reward under no delay and maximum delay conditions on a DRT (i.e., disrupted 
behavior globally; Evenden & Ryan 1999). In T-maze DD tasks, 8-OH-DPAT caused 
decreased DD in one study (0.015-.5mg/kg; Bizot et al., 1999). Another group found 
opposite dose dependent effects with the low doses (0.006 & 0.031mg/kg) causing 
increased DD and the high dose causing decreased DD (0.062mg/kg) in a T-maze task 
(Poulos et al., 1996).  However, an AD task with DS but no CDP found the opposite 
effect with 8-OH-DPAT causing increased DD for a highly palatable delayed solution 
(supersaccharin) versus an immediately available sucrose solution ( .3 & 1mg/kg; Blasio 
et al., 2012). In a DRT, Flesionoxan, a 5-HT1A agonist, increased choice of the immediate 
reward including when the larger reward wasn’t delayed, and Eltoprazine, 5-HT1A/1B 
agonist, has no effects (van den Berg et al., 2006). Thus activating 5-HT1A receptors has 
discordant effects across paradigms, opposite dose dependent effects inside the same 
paradigm, and has been shown to disrupt magnitude discrimination.  
Partial agonists and antagonists for the 5-HT1A receptor tend to increase DD on T-
maze tasks but antagonists fail to do so on DRTs. The 5-HT1A partial agonists buspirone, 
ipsapirone, and MDL-73005EF all increase DD in a T-maze DD task (Bizot et al., 1999) 
and buspirone also increases DD on a DRT with no DS or CDP (Liu et al., 2004).  WAY-
100635, a 5-HT1A antagonist also causes an increase in DD in a T-maze (Bizot et al., 
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1999). Though WAY-100635 does not affect DD on a DRT with ascending delays 
(Evenden & Ryan, 1999; Liu et al., 2004), but this task has concerns about potential false 
negatives for increasing DD perhaps explaining why results differ based on task (Tanno 
et al., 2014). Finally, the 5-HT1/2 antagonist metergoline caused a reduction in DD in a 
DRT (Evenden & Ryan, 1996). However, its effects are not limited to the 5-HT1 receptor 
but also include effects on the 5-HT2 receptor. 
 For the 5-HT2 receptor family, agonists selective for the 5-HT2A receptor increase 
DD, but antagonists selective for this receptor do not have any effects. Also, blocking the 
5-HT2c receptor may decrease DD, but the only evidence for this comes from DRTs with 
ascending delays. The 5-HT2A/2C agonist DOI
26 has been seen to modestly increase DD in 
a DRT with ascending delays (Evenden & Ryan, 1999), an AD paradigm (Blasio et al., 
2012), and a T-maze task (Hadamitzky et al., 2009). The increase seen in the T-maze task 
appears to be dependent on signaling via the 5-HT2A receptor as coadminstraion of 
ketanserin, a selective 5-HT2A antagonist blocked the increase in DD, but ketanserin alone 
had no effect on DD in the T-maze (Hadamitzky et al., 2009). Independently ketanserin 
has also been seen not to affect DD on a DRT with ascending delays and no CDP 
(Paterson et al., 2012; Talpos et al., 2006). For the 5-HT2C receptor, SER-082, a 5-HT2c/2b 
antagonist, causes a decreased DD in DRTs (Paterson et al., 2012; Talpos et al., 
2006). Finally the non-subtype selective 5-HT2 antagonist Ritanserin did not affect DD on 
a DRT (Evenden & Ryan 1999). In sum, it appears activating 5-HT2A receptors can 
increase DD, but antagonizing this receptor has no effects on DD. 5-HT2c/2b antagonism 
may either decrease DD or cause increase behavioral perseveration.  
 Clozapine’s other main mechanism of action is via antagonizing the DA D2 
receptor, though it still has some effects on D1 receptors (Meltzer, 1989; Meltzer, 1992, 
2002). The DA system has long been implicated in impulsivity and DD, in large part 
because the frontline treatment for disruptive behavior disorders characterized by 
impulsivity such as ADHD are semi-selective mono-amine reuptake inhibitors such as 
amphetamine (Castle et al., 2007). Moreover, DA agonist therapy for Parkinson’s disease  
                                                 
26 (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropan 
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may increase DD (Milenkova et al., 2011; Foerde et al., 2016; Antonelli et al., 2014). 
Fortunately, multiple preclinical studies have examined DA specific manipulations on a 
systemic level27.  
Non-specifically increasing DA has been seen to decrease DD or disrupt behavior 
globally, but all findings have come from a single paradigm, the DRT. The selective 
DAT inhibitor GBR-12909 in a DRT with DS and no CDP has been seen to either not 
effect (Koffarnus et al., 2011) or decrease DD (van Gaalen et al., 2006). In this same 
paradigm apomorphine, a non-selective DA agonist, tends to disrupt choice at the 0sD 
indicating impaired magnitude discrimination and a general disruption of choice behavior 
(Koffarnus et al., 2011).  
Non-specific DA antagonists tend to increase DD; though, a discordant finding 
exists. The D1/D2 antagonist flupenthixol has been seen to cause an increased in DD in 
both an AA paradigm with DS and a CDP (Wade et al., 2000), and DRTs both with and 
without a CDP (Floresco et al., 2008b; Cardinal et al., 2000). Interestingly, flupenthixol’s 
effect had a significantly larger effect when a CDP was used versus when it was not 
(Cardinal et al., 2000). In an AD paradigm with DS and no CDP, Fluphenazine caused a 
decrease in DD in spontaneously hypertensieve rats, but not in Wistar-Kyoto or Sprague-
Dawleys (Wooters & Bardo, 2011). 
Looking at D1 specific agonists and antagonists, manipulations tend to increase 
DD but also disrupt magnitude discrimination, especially at higher doses. Administration 
of SKF 81297 in a DRT with DS but no CDP increases selection of the immediate 
reward, even when the larger reward is not delayed (Koffarnus et al., 2011). The D1 
antagonist SCH 23390 has been more widely studied than SKF 81297. In DRTs with DS 
but no CDPs, it tends to increase DD at lower doses, but at higher doses it also decreases 
choice of the larger reward when it isn’t delayed (Koffarnus et al., 2011; van Gaalen et 
al., 2006; Tian et al., 2006). In an AA paradigm SCH 23390 was found not to affect 
indifference points (Wade et al., 2000).  
                                                 
27 The effects of amphetamine, and other non/semi-selective monoamine reuptake inhibitors will 
not be reviewed here for multiple reasons including their lack of specificity for the DA reuptake 
transporter. This is not due to a belief that their effects do not exist or lack importance. Amphetamine’s 
effects on DD in rodent studies are highly discordant. There is a strong possibility multiple moderating 
factors exist (Slezak et al., 2009; Tanno et al., 2010; Cardinal et al., 2000). Such an undertaking would be 
an extensive review paper in and of itself and is deemed beyond the current scope.  
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 Agonists of D2-like receptors also tend to disrupt performance globally or have 
no effect. 7-OH-DPAT, a D3 agonist, increases selection of the immediate reward at all 
delays including when the larger-later reward is not delayed (DRT; van den Bergh et al., 
2006). The D2 agonist sumanirole has no observable effect on DD in a DRT with DS and 
no CDP (Koffarnus et al.., 2011). Pramipexole, a mixed D2/D3 agonist, increased 
immediate reward selection on a DCT with DS and a CDP during a short delay condition 
but not during a long delay condition, but its use in a DRT by the same researchers causes 
a “flattening” of choice behavior where it increases and decreases immediate reward 
selection at the no delay and longest delay condition respectively such that choice 
behavior no longer varies as a function of delay (Madden et al., 2010). However the D4 
partial agonist ABT-724 causes a modest increase DD in a DRT (Koffarnus et al., 2011).  
 The effects of D2 antagonists on DD tend to have no effects or globally disrupt 
behavior unless a CDP is used. When a CDP is used D2 antagonists tend to increase DD. 
Eticlopride does not affect choice behavior on a DRT with DS and no CDP (van Gaalen 
et al., 2006). Both PG01037, a D3 preferring antagonist, and L-741,626, a D2 preferring 
antagonist, on a DRT with DS but no CDP decrease delayed reward selection overall 
including when it is not delayed (Koffarnus et al., 2011). The typical antipsychotic 
haloperidol increases DD on a T-maze which can be argued to have a CDP (Denk et al., 
2005), has no effect on a DRT without DS or CDP (Evenden & Ryan, 1996), increases 
immediate reward selection but also disrupts magnitude discrimination on a DRT with 
DS but not a CDP (Koffarnus et al., 2011), and in a DRT with DS and a CDP it increases 
DD selectively (Boomhower & Rassmussen, 2014). Finally raclopride administered in an 
AA task with DS and a CDP increased DD (Wade et al., 2000).  
While no receptor selective drug can truly mimic clozapine’s polypharmacology, 
examination of clozapine’s two main mechanisms of action, antagonizing D2 and 5-HT2A 
receptors, suggests clozapine may not affect DD or at least change it in the opposite 
direction observed in the current study (a decrease in DD). 5-HT2A receptor antagonists 
seem not to effect DD, and D2 receptor antagonists tend to have no effects or globally 
disrupt behavior unless a CDP is used wherein an increase in DD is usually observed. 
Indeed in a study that has very similar methods to the current body of work (DS, CDP, 
AA task), raclopride causes an increase in DD (Wade et al., 2000). Based on these two 
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mechanisms, CNO back metabolizing into clozapine would be predicted to either have no 
effect on DD or increase DD, and not be a likely alternative explanation for the current 
findings. While much of this work has been conducted in the DRT which is susceptible to 
false positives for a decrease in DD, a susceptibility to false negatives for decreases has 
not been demonstrated. Consequently it is may be relatively safe to infer that clozapine’s 
two main pharmacodynamic mechanisms do not result in increased DD.  
To recapitulate, CNO has been shown to back metabolize into clozapine, and 
injections of CNO influence behavior and stimulated VTA DA release when 
amphetamine is administered but not without amphetamine (MacLaren et al., 2016). This 
raises the possibility that activation of the hM4Di-mCherry receptor in the mPFC may 
not be responsible for the observed increase in IDPs (i.e., decreased DD). There are three 
pieces of evidence which argue against this possibility. First, clozapine’s two main 
mechanisms of action, antagonizing the D2 and 5-HT2A receptors, appear to either 
increase DD or have no effect. Second, in AA task upon which the current task was 
directly based and matches almost exactly, clozapine has no effect on DD when tested in 
mice (1.32 & 5mg/kg; Halcomb & Grahame, personal communication). Finally, animals 
classified as misses did not exhibit any change in IDPs. If CNO administration were 
causing a decrease in IDPs, it would be expected to do so in all animals, not just animals 
that have hM4Di-mCherry expressed bilaterally in the PL cortex and surrounding areas. 
As the decrease in IDP was only seen in animals classified as hits, it strongly suggests 
that activation of the hM4Di-mCherry in the PL cortex caused the increase in 
IDPs/decrease in DD.  
There is some indication that activating the hM4Di-mCherry caused a small 
decrease in motivation, vigilance, and/or attention. The 3mg/kg dose trended towards 
increased session completion times on the first day, and the number of trials completed 
showed a trend towards an effect of dose with CNO tending to decrease trial completion. 
However both effects were relatively small, but the effect on trials may have been limited 
by a ceiling effect at the 0mg/kg dose. A decrease in motivation or vigilance is also 
corroborated by the TIL. Activation of the hM4Di-mCherry construct caused increased 
TIL with the median TIL increasing by several seconds. However a large decrease in 
motivation would have affected CL as well, and no differences in CL were observed. 
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Unlike TIL, CL are not subject to a large attentional demand because the animal is 
already attenuating to the task and the overall timeframe they have to pay attention for is 
relatively short.  By contrast, in order to have shorter TIL, an animal must maintain 
sustained attention without action during a long ITI (>20 seconds) in which nothing 
occurs. As a dependent variable influenced by both attention and motivation versus 
motivation but not attention was affected, it suggests that an attentional deficit was 
induced. Although, a small motivation deficit cannot be excluded. Indeed a decrease in 
attention cannot completely account for the decrease in trial completion. Nevertheless, 
decreased attentional capacity following mPFC disruption is supported by lesions and 
glutamateric antagonist microinjections of/into the mPFC causing attentional deficits on 
the 5-CSRTT (Maddux & Holland, 2011; Pozzi et al., 2011; Murphy et al., 2005).  
Interestingly TIL showed a dose by day interaction in which the 3 and 9mg/kg, 
but not the 0mg/kg dose showed a decrease across days. This could represent some form 
of tolerance to the effects of hM4Di activation or a habituation to any possible 
interoceptive sensations arising from mPFC inactivation. Session completion time 
showed a similar, but far less robust pattern where the 3mg/kg dose trended towards 
elevated time only on the first day, but it is important to note that if animals are taking 
longer to initiate trials, then it should take them longer to complete the session with all 
other factors being equal. Licks also showed a dose by day interaction with the 3mg/kg 
dose causing decreased licks on the 1st and 5th days.  
There is some minimal support in the literature for decreasing effects of 
DREADD receptor activation with multiple CNO administrations. Inhibiting serotonergic 
neurons repeatedly to cause a decrease in body temperature has been shown to provide 
diminishing effects with repeated administration (Ray et al., 2011). However body 
temperature regulation is a critical homeostatic function, and a conditioned compensatory 
response is a plausible explanation for this effect. Other studies have not seen anything 
resembling tolerance or habituation. Change in gamma power does not reduce with a 
second administration (Alexander et al., 2009), and chronic inhibition of PBelo CGRP 
neurons causes large, repeatable decreases in food intake to the point of starvation (Carter 
et al., 2013).  
91 
 
Regardless, how this potential tolerance or habituation effect may alter decision 
making and DD is an important consideration. The strongest “tolerance” effects, 
represented by a dose by day interaction were driven by the 3mg/kg dose which did not 
affect IDPs. Two of the three variables, TIL and session time completion, are fairly 
distant and unrelated to the actual “choice,” and critically no effect of day or dose by day 
was seen or even trending for IDPs. Consequently, if tolerance to the effects hM4Di were 
present, they failed to cause systematic variation in IDPs.  
Counter to expectations based on an increase in IDP, activation of the DREADD 
receptor decreased licks and intake of 10S. The increased IDP should result/be a 
consequence of greater sipper access per trial. This increase in access to the sipper tube 
should in turn result in increased licks and intake. However a decrease in trial completion 
was observed as well. Completing fewer trials would reduce the total sipper access time 
and potentially offset any gains resulting from increased sipper access per trial. Moreover 
if animals were in fact less motivated, they may simply drink less per unit of access time. 
Another point to consider is that the decrease in licks was only significant at the 3mg/kg 
dose in which there were not significant effects on IDP.  
In sum, activation of the hM4Di-mCherry DREADD receptor caused a dose 
dependent change in IDPs as well as several secondary variables. However, the changes 
in the secondary variables did not covary with the changes in IDPs, but they do suggest a 
small decrease in motivation and attention that does not approach problematic levels. 
Electrophysiological confirmation of the DREADD receptors mechanism of action led to 
the unexpected finding that some neurons increase their firing rate in response to 
activation of hM4Di via CNO. This unexpected result is consistent with a disinhibition 
effect and may explain the other unexpected finding. IDP increased versus decreased as 
was hypothesized. It is possible that hM4Di-mCherry activation actually strengthened a 
representation of the delayed reward via “tuning” the mPFC to favor strong signals.  
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EXPERIMENT 2 
Experiment 2: Introduction 
Experiment 2’s goal was to build upon and differentiate between experiment 1’s 
possible interpretations. Complete inactivation of the rat mPFC via microinjection of 
tetrototoxin (TTX), a very potent and efficacious voltage gated sodium channel blocker, 
was used as an experimental manipulation. It is possible that the decrease in indifference 
points seen in experiment 1 was due to a disinhibition of pyramidal cell output caused by 
incomplete inactivation of the mPFC. This new manipulation that completely silences the 
mPFC should prevent this from occurring. It also has the advantage of not using systemic 
CNO injections combined with the DREADD virus, working around the largest caveat 
from experiment 128. If it is truly the pyramidal cell output to other structures that is the 
critical element for the functional effects of a representation of the delayed reward, then 
complete inactivation of their activity should increase DD. Conversely if the results 
indicate a decrease in DD, this would speak to the other prior interpretations of 
experiment 1 (i.e., disruption in time perception; simpler decision strategy).  
TTX is a voltage gated sodium channel blocker most commonly known as the 
poison in Japanese puffer fish and is classified as guanidinium toxin (Narahashi, 2008; 
Fozzard & Lipkin, 2010; Moczydlowski, 2013; Bane et al., 2014). It is a small polar 
molecule with a dioxa-adamantane carbon skeleton with a cyclic guanidinium moiety and 
numerous hydroxyl groups (Moczydlowski, 2013; Bane et al., 2014). TTX’s positively 
charged guanidinium moiety interacts ionically with the negatively charged carboxylate 
groups on the extracellular pore loops of voltage gated sodium channels (Stevens et al., 
2011; Bane et al., 2014). This interaction results in occlusion of voltage gated sodium 
channel’s pore with a 1:1 stoichiometry and blocks Na+ passage through the channel 
(Fozzard & Lipkind, 2010; Moczydlowski, 2013, Bane et al., 2014). TTX application 
                                                 
28 This serendipitous advantage was not initially planned. At the time this experiment was initially 
designed and the committee last met in early September of 2016, the MacLaren et al. (2016) paper was not 
yet in press. It became available for early access in mid-October of 2016 after animals had been trained and 
surgeries were underway.  
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results in a complete loss of voltage-dependent sodium current across neuronal 
membranes, and full loss of action potentials (Kaneda et al., 1989). Hence, TTX is a 
highly potent and efficacious sodium channel blocker that completely silences neural 
activity.  
There is timecouse data on TTX’s duration of action indicating a timescale of 
hours, but there are no biotransformation studies, possibly because it is lethal at very 
small doses. In animals undergoing multi-unit recording in the hypothalamus under 
urethane anesthesia, TTX microinjection caused a full suppression of spike activity 
within 6 minutes which lasted “many hours” and up to 10 hours post injection in one 
subject when recordings were stopped (Harlan et al., 1983). When injected into the dorsal 
midbrain of conscious, both 10ng and 3.3ng of TTX per hemisphere inhibited lordosis 
reflex in female rats after 10 minutes with no decrease in effect until 4 hours post 
injection and no significant effects after 12 hours post injection (Rothfeld et al., 1986). 
Synchronized lever pressing-drinking behavior was impaired immediately by 10ng TTX 
microinjections into the motor cortex. Animals only began lever pressing again after 3 
hours, had lingering effects on some variables for 24 hours, and trends towards effects 
were present up to 2-3 days post injection (Zhuravin et al., 1994). In sum, TTX appears to 
have an onset of effects within 10 minutes which does not degrade for at least several 
hours, and trace effects may be present for several days.  
When it is microinjected into the CNS, TTX diffusion remains localized (1-2mm 
diameter from point of injection). Zhuravin and Bures (1991) microinjected 10ng of TTX 
directly into, 1mm away from, and 1.5mm away from the Edinger-Westphal nucleus and 
then measured the resulting pupil dilation. When microinjected directly into the nucleus, 
75% of maximal effects was seen by 6 minutes. At the next timepoint (40 minutes), 
maximum pupil dilation was observed that lasted until 90 minutes before effects began a 
slow decline. When the injection was 1mm away from the nucleus, the onset of effects 
was right-shifted by 8 minutes, but the decline of effects occurred at the same time-points 
as the 0mm condition. At 1.5mm away, only 50% of maximum dilation was seen after 
120 minutes (Zhuravin & Bures, 1991). In a more complex behavioral paradigm, 
microinjection of TTX (5ng/side) blocked conditioned-cue reinstatement of cocaine 
seeking when microinjected into the PL cortex but not the adjacent infralimbic cortex 
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(McLaughlin & See, 2002). Consequently, microinjection of TTX in the 10-5ng range 
can produce dissociable changes in behavior in adjacent brain areas and the high end of 
that range produces submaximal effects 1.5mm from the site of injection.  
Experiment 2: Methods 
Animals 
Thirty-two male Long Evans rats were obtained from Envigo29 (Indianapolis, IN) 
were used as research subjects. Animals began experimental procedures at approximately 
50 days of age, and weighed between 273g and 327g (M=297.9, SD=14.2). Animals were 
housed in polypropylene shoebox cages under a 12 hour reverse light/dark cycle. 
Animals had ab libitum access to water throughout, and were food restricted to 85% of 
their free feeding weight. All behavioral sessions were run during the dark phase. 
Apparatus and Delay Discounting Task 
Experiment 2 used the same operant chambers as experiment 1 with no 
modifications. Similarly, the same DD paradigm, along with the subsequent training was 
employed. After animals demonstrated magnitude discrimination, cannulation surgeries 
occurred. Then magnitude discrimination was reassessed. Following successful 
redetermination of magnitude discrimination in all subjects, the 4sD was in place for 6 
sessions before the first sham microinjections. All microinjections were tested at a delay 
of 4 seconds.  
Surgeries 
Rats underwent isoflurane anesthesia, placed in a stereotaxic apparatus 
(Benchmark Digital Stereotaxic; myNeurolab, St. Louis, MO), and were administered 
5mg/kg/ml Carprofen in sterile saline (s.c.) and .1ml of 5mg/ml Maricane at the site of 
the incision. Stainless steel guide cannulae (26 gauge) were lowered to 1mm above the 
mPFC (A.P. +3.2mm, M.L. ±.7mm, and D.V. -2.mm; from brain). Three cranial screws 
                                                 
29 Between the completion of experiment 1 and start experiment 2 Huntingdon Life Sciences, and 
Harlan Laboratories merged to form Envigo.  
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combined with cranioplastic cement were used to hold the cannulae in place. Finally, 
removable wire obturators (33 gauge) extending the full length of the cannulae were 
inserted. Obturators were checked daily and replaced at need. Post-surgery, animals were 
given 10ml/kg of sterile saline (s.c.) and wet food to aid in recovery. 
Microinjection Procedures 
Microinjections occurred over the course of five weeks. Each week had three no 
injection days (normal sessions) followed by microinjections occurring on days 4 and 5 
of each week. The same type of microinjection was given both days in a particular week. 
Sham microinjections occurred on weeks 1, 3, and 5 (i.e., before, after, and between all 
experimental conditions). Microinjections (.5μL/side) of TTX (10ng/μL; 5ng/side; 
Sigma-Aldrich, St. Louis, MO) and aCSF (Fisher Scientific) were microinjected on 
weeks 2 and 4 in a counterbalanced order (order 1= TTX week 2 & aCSF week 4; order 2 
aCSF week 2 & TTX week 4).  
For all microinjections, animals were gently restrained and placed in a 27cm x 
17cm x 12cm clear acrylic holding tub. Obturators were removed, and 33 gauge stainless 
steel microinjectors extending 1mm beyond the end of the cannula were inserted. Over 
the course of 1 minute, a volume of .5μl was injected. Afterwards, microinjectiors were 
left in place for an additional minute to allow for diffusion. Then obturators were 
replaced, and animals underwent a 10 minute waiting period in their homecages before 
beginning operant sessions. For sham micorinjections, everything occurred exactly as 
previously described, except sham wire microinjectors that did not extend beyond the 
cannulae were used, and no solution was injected. 
Histology 
Animals were given 100-150mg/kg sodium pentobarbital (i.p.) and placed into a 
deep plane of anesthesia before being transcardially perfused with 1xPBS followed by 
10% formalin (Fisher Scientific). Brains were extracted and post-fixed in 10% formalin 
for 24 hours and soaked in 30% sucrose for 72-96 hours before being SNAP frozen in 
isopentane chilled via dry ice.  
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Brains were sectioned on a cryostat at -20°C, collected in PBS, and then mounted 
on subbed microscope slides. Sections were stained with cresyl violet by immersion in a 
33mg/ml cresyl violet acetate-Milli-Q water solution followed by 70% ethanol and Milli-
Q water rinses. Images were acquired via light microspy on a Leica LMD 6500 system 
(Leica Microsystems, Buffalo Grove, IL). Cannula placement was determined by the 
most ventral extent of tissue damage. Hits, defined by placement within the PL area 
(Paxinos & Watson, 1998), were dichotomously coded when experimenters were blind to 
behavioral results.  
Data Analysis  
For behavioral data, normality assumptions were tested via visual inspection of 
histograms and q-q plots as well as Shapiro-Wilks tests. If normality and homogeneity of 
variance assumptions were violated, log10 transformations were used for right skewed 
data, and for left skews the data was reflected, anchored at 1, and log10 transformed. If 
data transformations were unable to normalize the data, non-parametric tests were used, 
Wilcoxon signed rank’s tests & Freidman’s ANOVA. For the non-paramtetric tests the 
normal approximations were used.  
Primary data analysis was conducted using repeated measures analysis of variance 
(ANVOA) with factors of TTX and session. Interactions were followed up with 
Bonferroni corrected student t-tests. To examine week to week variation a RMANOVA 
was first conducted for data from sham microinjection, no injection, all microinjection 
sessions, and all sessions with factors of week and session using Bonferroni corrected 
paired samples t-tests as post hoc tests.   
Experiment 2: Results 
The final n for the main analysis, TTX microinjection sessions versus aCSF 
microinjection sessions, was 12 animals.  Two animals failed to learn to lever press, and 
one animal failed to meet magnitude discrimination resulting in 29 microinjection 
surgeries. Among these animals, 16 animals were classified as hits, 12 were misses, and 1 
animal died as a result of surgery. Figure 14 displays a hit map for all 16 hits. Inside the 
16 hits, 4 animals did not meet performance criteria during all TTX and aCSF sessions. 
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These animals were approximately evenly distributed between the two orders (5 order 1 
TTX first, 7 order 2 aCSF first), χ2(1)=.333, p=.564. Inside sham sessions only 2 of the 
animals failed to reach performance criteria across all sessions, and on no injection days 
only one animal failed to reach performance criteria during all sessions. Any animal that 
did not meet performance criteria across all sessions for a particular analysis was 
excluded from only that analysis. This left final n’s of 12, 14, and 15 respectively for 
analyzing TTX effects in comparison to aCSF, comparing sham injections week to week, 
and comparing no injection sessions week to week. 
 
Figure 14: Experiment 2 Cannula placement. Top Left) Pie chart showing the 
number of animals in each order used in the main analysis. Bottom Left) Representative 
image of cannula placement created by stitching adjacent 5x images together. Right) Hit 
map showing cannula placements.  
 
Inside all animals classified as hits, the number of sessions required to reach 
magnitude discrimination both before (Mdn=4, Range=9) and after (Mdn=4, Range=4)   
was heavily right skewed by several extreme outliers. A Wilcoxon signed ranks test 
found no pre- vs. post-surgery difference with the vast majority of animals demonstrating 
magnitude discrimination within the minimum number of sessions required, Z=-.071, 
p=.943. Similarly, IDPs when animals met magnitude discrimination criteria did not 
differ before (M=2.09, SD=.38) or after surgery (M=2.05, SD=.47), t(15)=.222, p=.827. 
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However increasing the delay to the standard reward to 4 seconds decreased IDPs 
(M=1.34, SD=.56) compared to the post-surgery 0sD, t(15)=3.434, p=.004. Fitting to the 
mean group IDP, the best fitting k value was 0.12 with a standard error of the estimate of 
0.01, and a strong model fit, R2=.99. Figure 15 displays the baseline IDPs both pre- and 
post-surgery. 
 
Figure 15: Experiment 2 Baseline Indifference Points (IDP). Mean IDP (±SEM) 
both pre- and post-surgery. A hyperbolic equation, whose slope is defined by k (Mazur, 
1987), was fitted to the post-surgery data.  
 
In the main analysis IDP were normally distributed across all aCSF and TTX 
microinjection sessions. The RMANOVA found no effects of TTX, F(1,11)=.007, 
p=.936, session, F(1,11)=.337, p=.573, nor an interaction of TTX and session, 
F(1,11)=1.523, p=.243. Whether IDP were stable across sham session was examined with 
a RMANOVA with factors of week (3 levels) and session (2 levels). This analysis 
revealed a main effect of week, F(2,26)=4.498, p=.021, but not session, F(1,13)=.008, 
p=.932, nor an interaction of week by day, F(2,26)=.247, p=.783. Overall IDP tended to 
decrease across weeks, but Bonferroni corrected paired samples t-tests failed to pull out 
any significant pairwise differences. As a potential effect of time could possibly obscure 
the effect of TTX, between subject analyses were conducted comparing the effect of TTX 
and aCSF with a mixed ANOVA with factors of session (2) and TTX (2). During the first 
week of TTX versus aCSF microinjections there was no effect of session, F(1,10)=.015, 
p=.904, or TTX, F(1,10)=.004, p=.953, but there was a trend towards a TTX by session  
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interaction, F(1,10)=4.809, p=.053. During the second week of microinjections there 
were no effects of session, F(1,10)=.619, p=.450, TTX, F(1,10)=.002, p=.964, nor an 
interaction of the two, F(1,10)=1.788, p=.211. 
To investigate the possibility that IDP simply tended to increase across time, 
several analysis were conducted testing the effect of time. Subjects were excluded based 
on performance in a pairwise fashion for each analysis resulting in a final n of 10 for each 
analysis. First the week to week change on all microinjection sessions collapsed across 
type (sham, TTX, aCSF) was examined with a RMANOVA with factors of week (5) and 
session (2). A trend towards an effect of week, F(4,36)=2.617, p=.051, but not session, 
F(1,9)=2.617, p=.937, or week by session, F(4,36)=.628, p=.645, was present. Next, a 
RMANOVA on no injection sessions was conducted with factors of week (5) and session 
(3). This analysis revealed no effects of either week, F(4,52)=.730, p=.576, session, 
F(2,26)=.858, p=.436, nor their interaction, F(8,104)=1.497, p=.167. Finally looking at 
all sessions (no injection, sham, TTX, and aCSF) simply as a function of week (5) and 
session (5) found no significant effects of week, F(4,36)=1.081, p=.380, session, 
F(4,36)=.085, p=.987, or week by session, F(16,144)=1.568, p=.085.   
The IPD CRs were normally distributed. A RMANOVA found no effect of TTX, 
F(1,11)=.178, p=.681, session, F(1,11)=.590, p=.458., nor their interaction, F(1,11)=.006, 
p=.941. Analysis of sham microinjections found no effect of week, F(2,26)=.653, p=.529, 
session, F(1,13)=.001, p=.973, nor their interaction, F(2,26)=.594, p=.559. One sample t-
tests compared the mean IDP CR on each session to a test value of .5. On the first, 
M=.52, SD=.28, t(11)=-.256, p=.803, and second, M=.56, SD=.26, t(11)=-.823, p=.428, 
sessions of aCSF and the first, M=.49, SD=.16, t(11)=.271, p=.791, and second, M=.52, 
SD=.19, t(11)=-.387, p=.706, sessions of TTX IDP CRs did not differ from .5. The same 
pattern was seen after sham microinjections, p>.05, on all sessions.  
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Figure 16: Experiment 2 Indifference Points (IDP). A) Mean IDP (±SEM) collapsed 
across session from the within subject analysis comparing TTX to aCSF microinjections. 
B) Mean IDP (±SEM) after sham microinjections as a function of week and collapsed 
across session. *Indicates a main effect of week. C) Mean IDP (±SEM) from the between 
subject analysis after TTX or aCSF microinjections. The left side displays data after the 
first round of microinjections. The right side displays data after the second round of 
microinjections. D) Mean IDP (±SEM) after all microinjections regardless of type as a 
function of week. E) Mean IDP (±SEM) from no injection days as a function of week. F) 
Mean IDP (±SEM) as a function of session regardless of condition.  
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The total time it took for subjects to complete a session in minutes was heavily 
left skewed and bounded by 60 minutes on the right side of the distribution. Data 
transformations failed to correct for the deviations from normality and non-parametric 
statistics were used. A Wilcoxon signed rank test found no effect of TTX compared to 
aCSF microinjections, Z=-1.177, p=.239, and a Friedman’s test found no week to week 
variation after sham microinjections, χ2(2)=1.564, p=.458. Mean values for session time 
are reported in table 9.  
The number of free choice trials inside each session were left skewed and 
transformations were unable to correct for the deviation from normality. A Wilcoxon 
signed ranks test revealed a trend for TTX microinjection (Mdn=48, Range=24) to 
decrease the number of trials completed compared to aCSF microinjections (Mdn=57.25, 
Range=22), Z=-1.859, p=.063. A Friedman’s test failed to find any week to week 
variation after sham microinjections, χ2(2)=1.366, p=.505. 
 
 
Figure 17: Experiment 2 Free Choice Trial Completion. Boxplots of the number of free 
choice trials completed as a function of microinjection solution. *(grey) trend for aCSF 
vs. TTX. 
 
Trial initiation latencies (TIL) were right skewed. Log 10 transformation 
corrected for the deviation from normality and parametric statistics were carried out on 
the transformed values. The log 10 transformed TILs showed an effect of TTX, 
F(1,11)=10.212, p=.009, but not session, F(1,11)=2.737, p=.126, or an interaction of 
TTX and session, F(1,11)=.662, p=.433.  Analysis of sham microinjections found that  
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TIL did not vary from week to week, F(2,26)=2.251, p=.125, but did change across 
sessions, F(1,13)=9.459, p=.009. There was no interaction between session and week, 
F(2,26)=.283, p=.756.  
 
 
Figure 18: Experiment 2 Trial Initiation Latencies (TIL). A) Boxplots of untransformed 
TIL as a function of microinjection. B) Boxplots of untransformed TIL after sham 
microinjections as a function of session. C) Mean (±SEM) Log10 transformed TIL as 
function of microinjection **p<.01 main effect of TTX. D) Mean (±SEM) Log10 
transformed TIL after sham microinjections as function of session. **p<.01 main effect 
of session.  
 
Free trial CL were normally distributed. A RMANOVA found no effects of TTX, 
F(1,11)=.015, p=.904, session, F(1,11)=.075, p=.790, nor of TTX by session, 
F(1,11)=.408, p=.536. Analysis of sham microinjection data found an effect of week, 
F(2,26)=3.535, p=.044, but not session, F(1,13)=.031, p=.863. An interaction of week 
and session was present, F(2,26)=4.085, p=.029. Although week 3 tended to have lower 
CLs, comparing the week to week mean CLs with Bonferroni corrected paired sample t-
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tests failed to find any significant pairwise differences. However, the second session of 
week 3 exhibited shorter choice latencies that the second session of week 5, t(13)=-3.800, 
p=.002, and the first session of week 5 had significantly shorter CL that the second 
session of week 5, t(13)=-3.689, p=.003. Analysis of sessions in which no injection 
occurred found no significant effects [Week: F(4,56)=1.001, p=.415; Session: 
F(2,28)=1.009, p=.378; Week x Session: F(8,112)=1.000, p=.440], and examining all 
sessions irrespective of injections found no effects [Week: F(4,56)=.996, p=.418; 
Session: F(4,56)=.978, p=.427; Week x Session: F(16,224)=1.000, p=.457]. Mean CL 
values as a function of injection are displayed in table 9, and the week by session 
interaction for sham microinjections is graphed in figure 19. 
 
 
Figure 19: Experiment 2 Choice Latencies (CL). Mean (±SEM) CL after sham 
microinjections as a function of week and session.*significantly different from Week 5 
session 2 on paired sample t-test with Bonferroni corrected alpha level.  
 
The intake of 10S in milliliters (ml) was normally distributed in spite of two 
strong outliers on TTX administration days. In the main analysis no effects of TTX, 
F(1,11)=.246, p=.629, session, F(1,11)=.562, p=.469, or TTX by session, F(1,11)=.003, 
p=.957, were observed. Examining intake after sham microinjections30 also found no 
significant effects of week, F(2, 24)=2.468, p=.106, session, F(1,12)=1.003, p=.336, nor 
week by day, F(2,24)=2.528, p=.101. Mean intake is reported in table 9.  
                                                 
30 Note: An additional animal was excluded due to a missing data point on the second session of 
week 1. 
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The number of licks animals earned was non-normally distributed after TTX 
microinjections, and log transformations failed to correct for this deviation from 
normality. A Wilcoxon signed rank test revelaed that after TTX microinjection 
(Mdn=617.5; Range=629) the number of licks decreased compared to after aCSF 
microinjection (Mdn=880.8; Range=820), Z(-2.197), p=.028. However, a Friedman’s test 
failed to find a week to week variation after sham microinjections, χ2(2)=.167, p=.92. 
 
Figure 20: Experiment 2 Licks. Boxplots of the total number of earned licks as a 
function of microinjection. *p<.05 Wilcoxon signed rank test 
 
Table 9: Experiment 2 Secondary Variables. Mean (±SEM) 
Variable Sham aCSF TTX 
Session Time (minutes) 54.4(1.5) 54.2(1.9) 54.7(1.8) 
Choice Latency (seconds; CL) 1.22(.07) 1.13(.20) 1.13(.27) 
Intake 10% Sucrose (milliters; 10S) 9.0(0.8) 9.0(0.9) 9.6(1.1) 
Experiment 2: Discussion 
The findings of experiment 1 in the context of prior literature suggest that hM4Di 
DREADD receptor activation in the mPFC may actually strengthen a representation of 
the delayed reward via a disinhibition mechanism. If this representation is critical for DD 
and proper valuation of the delayed reward, then its complete abolishment with a very 
efficacious manipulation should increase the rate of DD. To this end, TTX was 
microinjected into the mPFC of rats performing an AA DD task. However, contrary to 
predictions, no significant change in DD behavior was observed. As such the results of 
experiment 2 suggest that a possible representation of the delayed reward in the mPFC 
and the mPFC in general, is not critical or necessary for DD. 
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Animals quickly learned the AA task and displayed typical DD behavior as 
evidenced by their rapidly reaching magnitude discrimination criteria and exhibiting 
decreased IDP with increases in delay to the standard reward.  Moreover, IDP CR were 
not altered or different from .5 under any condition. Microinjections of TTX compared to 
aCSF, in both within and between groups analyses, caused no systematic difference in 
IDP. However, there was a week-to-week change on sham microinjection days. As 
intracerebral microinjections damage the target structure, the effect in shams could be 
due to progressive damage being done to the mPFC. However such progressive damage 
would be expected to cause increased DD across all conditions and not just after sham 
injections, and this pattern was not observed. On no injection sessions there was not an 
effect of week, and when all sessions irrespective of condition were examined there were 
no differences between sessions. Consequently progressive damage being done to the 
mPFC causing an increase in DD appears to be an unlikely scenario. 
Similar to experiment 1, disrupting the mPFC appears to have caused a decrease 
in motivation and/or sustained attention. Once again, there was a trend towards decreased 
trial completion with TTX microinjections suggesting decreased motivation. Also, TIL 
were increased with TTX, but TTX did not affect CL suggesting a decrease in rats ability 
to sustain attention. Further paralleling experiment 1, neither of these decreases were to 
problematic levels. Free choice trial completion decreased from just under 60 trials 
(Mdn=57.25) to just under 50 trials (Mdn=48). The effects on TIL and free choice trial 
completion do appear to be larger in experiment 2 versus 1. This difference may reflect 
the greater efficacy of TTX at decreasing neural activity compared to hM4Di activation. 
Critically this finding shows that the TTX microinjections had behavioral effects and 
services as a quasi-manipulation check.  
There was some unique variation in CL as a function of session and week inside 
sham microinjections, but its meaning and interpretation is not readily apparent. Week 1 
had a relative elevation of CL while week 3 a general reduction. Finally in week 5 the 
second session had a sharp increase. The increase in CL on week 1 may be due to animals 
first time experiencing the microinjection procedure. The decrease on week 3 thus may 
represent that animals have habituated to the procedure. The subsequent rise on week 5’s 
second session is much more anomalous, and has no readily apparent explanation.  
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In sum, the results of experiment 2 replicate the decrease in motivation and 
attention with mPFC disruption. They also discredit the idea that the mPFC is necessarily 
involved in the valuation of the delayed reward and critical for DD. TTX, which 
completely abolishes neural activity, when microinjected into the mPFC produces no 
detectable change in IDP. Importantly, the current results do not suggest that the mPFC is 
not sufficient to sustain or manipulate delayed reward valuation and DD.  
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GENERAL DISCUSSION AND CONCLUSIONS 
Prior investigations of the rat mPFC’s involvement in DD suggested that the 
mPFC may generate an outcome representation of the delayed reward. The PL cortex 
exhibits outcome specific delay period activity (Burton et al., 2009; Miyazaki et al., 
2003) and is necessary for outcome directed responding (Balleine & Dickinson, 1998; 
Balleine & O’Doherty, 2010; Killcross & Coutureau, 2003). Finally, the lesion and 
inactivation studies in the literature have been limited and suffer from potential response 
inhibition and behavioral perseveration confounds (Cardinal et al., 2001; Churchwell et 
al., 2009; Feja & Koch, 2014), leaving a hole to fill in the literature.  
If the mPFC and this potential delayed reward outcome representation is 
necessary for appropriately attributing value to the delayed reward, then inactivating the 
mPFC should increase DD. To test this hypothesis, two experiments were conducted. 
Activation of an hM4Di inhibitory DREADD receptor and microinjections of the voltage 
gated sodium channel blocker TTX were used to site-specifically disrupt the mPFC while 
animals completed an AA DD task. This task does not suffer from the same potential 
response inhibition and behavioral perseveration confounds that prior lesion and 
inactivation studies possessed. In experiment 1, activation of the hM4Di receptor caused 
a decrease in DD, the opposite of what was predicted. This finding was coupled with a 
potential disinhibition effect on a subpopulation of mPFC neurons. The potential 
disinhibition effect raises the possibility that an outcome representation of the delayed 
reward was actually strengthened. Experiment 2 microinjected TTX to ensure no 
disinhibition effect would be possible, and the mPFC would be completely silenced. In 
this case, no effect on DD was observed. Combined, these results indicate that altering 
mPFC activity is sufficient to alter DD, but the mPFC and any outcome representation it 
may generate are not necessary for adaptively valuing the delayed reward.  
One likely interpretation is that the rat mPFC plays a secondary or modulatory 
role in DD. If the rat mPFC was a primary contributor to DD and necessary for delayed 
reward valuation, inactivating it with TTX microinjections should have increased DD, 
but this manipulation did not alter indifference points. The implication is that the mPFC 
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is not critical for attributing value to and choosing delayed rewards. However, DA 
agonist and antagonist mPFC microinjections increasing DD (Loos et al., 2010; Pardey et 
al., 2013; Sonntag et al., 2014; Yates et al., 2014), and activating the hM4Di DREADD 
receptor decreasing DD show that when you alter mPFC function, versus simply 
abolishing it, you can change DD. Hence the mPFC is capable of altering DD, and is 
likely to play a secondary, or perhaps situation-specific role.  
The rat HPC is thought to play a very similar role to the one originally 
hypothesized for the mPFC. Namely, the HPC has been proposed to contribute by 
representing future outcomes which are converted to expected value signals by other 
downstream areas such as the BLA and the OFC (Johnson et al., 2007; Schacter et al., 
2007). HPC lesion and inactivation studies do show that the HPC is necessary for DD in 
rats more consistently than any other structure (Abela & Chudasama, 2012; 2013; 
Cheung & Cardinal, 2005; Mariano et al., 2009; Rawlins et al., 1985). Consequently, the 
HPC may be the primary contributor to delayed outcome representations that the mPFC 
supports and backs up.  Ironically, evidence of this secondary role for the mPFC is 
provided by studies showing the mPFC exhibits outcome specific delay period activity 
(Burton et al., 2009; Miyazaki et al., 2003). Lesioning the HPC abolishes the PL cortex’s 
delay period activity (Burton et al., 2009).  
The mPFC may be recruited when the animal is challenged or when the outcome 
representation needs to be strengthened. The HPC and mPFC have overlapping efferent 
projections to the OFC (Cenquizcca & Swanson, 2007; Sesack et al., 1989), BLA 
(Gabbot et al., 2005; Ishikawa & Nakamura, 2006), and NAcc core (Groenewegen et al., 
1987; Berendse et al., 1992). The HPC may send the outcome representation to these 
areas where it is converted to an expected value signal (Johnson et al., 2007; Schacter et 
al., 2007). Then the expected value signals are then compared in the NAcc core, action is 
selected/the choice is made, and the action necessary to achieve the chosen outcome is 
initiated. The mPFC’s role may be to act as a secondary amplification step wherein it 
receives the outcome representation, amplifies it, and then sends it to the OFC, BLA, and 
NAcc. In this fashion, these value attribution areas receive a greater outcome 
representation signal overall via one input from the HPC and then a second, possibly  
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amplified, representation from the mPFC. This bolstering of the outcome representation 
may be needed when there are particular barriers to overcome such as when the delay is 
particularly long.  
This possible secondary outcome representation role for the mPFC can explain 
the results of both experiments 1 and 2. In experiment 1, the decrease in DD was 
accompanied by a potential disinhibition of the mPFC pyramidal cells. If the mPFC’s 
pyramidal cells did in fact have their inputs tuned to stronger signals, an outcome 
representation from the HPC that normally drives activity might be favored (Burton et al., 
2009). This effect could functionally mimic the mPFC amplifying the outcome 
representation and then sending an artificially strengthened outcome representation to 
downstream valuation areas. Accordingly, the greater outcome representation received by 
areas such as the OFC and BLA could result in a greater expected value signal. Such a 
greater value signal would be expected to facilitate choice of the delayed alternative. By 
contrast, removing this polysynaptic pathway for the outcome representation by silencing 
the mPFC with TTX may have limited effect. Such an amplification mechanism many 
not be necessary under nominal conditions, or the HPC is normally capable of 
compensating for the loss of the mPFC. Consequently, no change in DD would be 
observed.  
A stronger outcome representation causing a greater expected value signal and 
subsequently decreased DD is critical to this new hypothesis. In support of this processes 
being possible, episodic future tags decrease DD (Peters & Bu̎chel, 2010). Specifically 
when individuals are presented with text describing what they plan to do on the day the 
delayed reward would be delivered, their choices shift towards the delayed alternative. In 
theory, such an episodic tag would aid in the generation of outcome representations, and 
the effect of the episodic tags was moderated by functional coupling strength between the 
hippocampus/amygdala and the ACC (Peters & Bu̎chel, 2010).  
An alternative secondary role for the mPFC in DD may be contributing additional 
working memory resources. The mPFC is involved in working memory (Zahrt et al., 
1997), and working memory may have a causal relationship with DD. The rate of DD is 
inversely related to working memory in healthy adults (Shamosh et al., 2008). MAD 
scores on an AD task in rats are related to working memory assessed via a delayed 
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matching to position task (Renda et al., 2014). A more direct causal role is supported by 
increasing working memory load, by having participants remember a series of digits or 
by offering more options, increasing DD (Hinson et al., 2003), and working memory 
training decreases DD in treatment seeking stimulant addicts (Bickel et al., 2011). Also, 
both DD (Boettiger et al., 2007; Gianotti et al., 2012; Smith & Boettiger, 2012; Kayser et 
al., 2012) and working memory (Goldman-Rakic et al., 2000; Zahrt et al., 1997) have 
been shown to exhibit an inverted “U” shaped dose response function for DA in the 
rodent mPFC/primate dlPFC. Both dopamine agonists and antagonists microinjected into 
the rat mPFC, as well as altering receptor expression with a lenti virus,  increase DD 
mirroring a similar inverted “U” shape function (Loos et al., 2010; Pardey et al., 2013; 
Sonntag et al., 2014; Yates et al., 2014). In sum there is a case to be made for the mPFC 
affecting DD via working memory.  
 However, TTX microinjections would cause a similar if not greater working 
memory impairment as DA agonist and antagonist microinjections. This manipulation 
should have caused increased DD as well. One possible explanation for why TTX 
microinjections did not centers on the length of the delay used in the current study: four 
seconds. Compared to other discounting studies, 4 seconds is a very short delay (Loos et 
al., 2010; Pardey et al., 2013). With such a short delay, the HPC may be able to 
completely fulfill all of the outcome representation demands on working memory. 
However, the mPFC and HPC may both be necessary at longer delays. In support of this 
interpretation, independent mPFC and HPC inactivations do not increase errors on a 
spatial delayed non-matching to position task with short delays (10 seconds), but 
inactivation of both structures simultaneously increases errors (Churchwell & Kesner, 
2011). Conversely at long delays (10 minutes) inactivation of either structure or 
functionally disconnecting them increased errors (Chuchwell & Kesner, 2011). 
Consequently the four second delay to the standard reward may not have been long 
enough for TTX to increase DD.  
Delay length does account for results in the mPFC and DD literature to a 
moderate degree. Studies which have shown that inactivating the mPFC (Churchwell et 
al., 2009) and injecting dopaminergic drugs increases DD (Loos et al., 2010; Pardey et 
al., 2013) have used longer delays of at least 15 seconds. Yates et al., (2014) found D2, 
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but not D1 antagonists, increased DD in an AD task. The baseline MAD scores were 
approximately 10 seconds which correspond to a longer delay on most AA tasks in rats 
(Beckwith & Czackowski, 2014; Richards et al., 1997) and a shorter delay on DRT tasks 
(Loos et al., 2010 Pardey et al., 2013). Of the null results, the two lesion studies did use 
longer delays, but they also used DRTs with only ascending delays so there is a 
legitimate concern these studies may be a false negatives for increased DD (Cardinal et 
al., 2001; Feja & Koch, 2014). One study did find a result with a shorter delay; 
overexpressing D1 receptors with a lenti-viral vector caused an increase in DD at a delay 
of 5 seconds in a T-maze (Sonntag et al., 2014). In sum, delay length does explain some, 
but not all, mPFC DD results.  
However there are several holes in the relationship between DD and working 
memory as well as in the working memory explanation. Spatial working memory 
assessed in an eight arm radial arm maze does not correlate with DD on a DRT (Della-
hagedorn, 2006). Also the working memory training that decreased DD, did not change 
working memory raising questions as to what exactly about the training actually affected 
DD (Bickel et al., 2011). With regards to the current experiments, whether or not 
disinhibiting mPFC pyramidal cells could cause increased working memory to decrease 
DD does not appear to have a clear mechanism. Increasing the working capacity of a 
network is likely a much more complex process than simply amplifying a signal that is 
already being sent.  
Assuming that the rat PL/IL cortices primarily correspond to the human dlPFC, 
two system accounts of DD would predict that their inactivation would cause an increase 
in DD. In experiment 1, the opposite effect was found. However, it is possible the output 
of this structure was increased. As the dlPFC and other executive system areas likely 
would need an effector structure of some type, increasing the output of a structure via 
disinhibiting its projection neurons, may functionally equate to increasing its activity 
level. In this case, two system accounts would predict the observed decrease in DD 
(Bickel et al., 2007; Bechara et al., 2005). However, the results of experiment 2 are 
completely incongruent with two system accounts. Silencing an executive system area  
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should decrease activity in the executive system and result in an increase in DD (Bickel 
et al., 2007; Bechara et al., 2005). In this sense, the current results detract from two 
system accounts. 
The interpretation that the rat mPFC may serve a secondary role in outcome 
representation to the HPC is also discordant with the human literature. Disrupting the 
dlPFC with either TMS or DCS increases the rate of DD (Figner et al., 2010; Hect et al., 
2013). These results suggest, independent of any larger theory of DD, that the dlPFC is 
critical for delayed reward valuation.  
However when fitting the current results in with human neuroimaging studies, it 
is important to consider what the rat mPFC may correspond to from a translational 
standpoint. Given that the primate brain is unique in its amount and differentiation of 
neocortical development; both strucutres may be derived from a common ancestor but 
underwent a divergent evolutionary path where human cortical areas underwent extensive 
expanding, differentiation, and parceling into more specific subregions. Hence the rat 
mPFC may be considerably closer to an ancestral structure that areas such as the dlPFC 
evolved from. As such, one could consider the essential functions mediated by the human 
dlPFC to be subserved by the rat mPFC at a lower lever in addition to the functions of 
other cortical structures such as the cingulate cortex. There is some evidence of this as 
that rat mPFC performs the same common class functions as the human dlPFC (Uylings 
et al., 2003). 
As the rat mPFC may correspond to the human dlPFC but not be as advanced, it 
may not be as influential on rat behavior as it is on human behavior. Consequently, the 
current findings not matching up with two system accounts of the neurobiology of DD is 
far from a death blow to these conceptualizations. it may simply be a species difference. 
Also as the human neocortex underwent extensive development and expanding, it may 
have wrested the primary role in delayed outcome representation from the HPC. This 
could explain why, despite being consistently shown to be necessary for DD in rodent 
studies (Abela & Chudasama, 2012; 2013; Cheung & Cardinal, 2005; Mariano et al., 
2009; Rawlins et al., 1985), the HPC does not take center stage in human neuroimaging 
studies with some studies not even identifying it as important (McClure et al., 2004; 
2007; Kable & Glmicher 2010).  
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In summary, these findings extend those of prior studies by showing that the 
mPFC is able to affect the rate of DD, but it is not a necessary contributor to DD under 
certain conditions. Critically showing that the mPFC is not necessary for DD was 
accomplished in a task, unlike prior studies, that has no response inhibition or behavioral 
perseveration confounds. These results detract from the hypothesis that the mPFC 
generates a necessary outcome representation of the delayed reward. However, it does 
not preclude the mPFC from producing such a representation sufficient to increase 
delayed reward value. Rather it suggests that it may be possible to amplify this 
hypothesized representation to decrease DD. The current body of work is unable to 
address if under different conditions, such a longer delay to the larger-later reward, the 
mPFC is necessary to properly value the delayed reward; nor, is it able to confirm if the 
mPFC plays a secondary role to a structure such as the HPC. Future research should 
attempt to determine if the mPFC is critical at longer delays as well as if HPC-mPFC 
interactions are needed at longer delays to confer value to the delayed reward.  
Limitations & Future Directions  
Like any other study, there are limitations to the current body of work. First, the 
effects of hM4Di activation and TTX microinjections into the mPFC were only tested at a 
single delay. It is entirely possible that different results could be obtained at a longer or 
shorter delay. Indeed the differential effects of mPFC inactivation on working memory 
based on the delay (Chuchwell & Kesner, 2011) suggest that a longer delay may have 
yielded a significant result in experiment 2. Along the same lines, the current study is not 
able to detect if the sensitivity to reinforcer magnitude or magnitude discrimination was 
disrupted by the acute manipulations. Another methodological element to the AA DD 
task was the use of a CDP. Using a CDP is not a bad practice but doing so likely alters 
which neural mechanisms are engaged. Different results could possibility be obtained if a 
CDP was not used. That being said, delayed rewards often have predictive cues and 
conditioned reinforcers in real life, but not always. Consequently the current investigation 
is limited in that it did not also include a group without a CDP. Furthermore the  
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electrophysiological techniques and data analysis used are unable to determine if the 
different responses to CNO occurred in different populations of neurons, such as the 
disinhibition occurring in pyramidal cells and not interneurons.  
Both of the manipulations used in experiments 1 and 2 have limitations. For 
experiment 1, CNO may back metabolize into clozapine (MacLaren et al., 2016). It is 
possible that this occurred in the current study. Three pieces of evidence suggest that if it 
did occur, it did not alter DD. First and foremost, there was no change in DD in misses 
who received the same dose of CNO, but did not have hM4Di-mCherry expressed in the 
PL cortex bilaterally. Clozapine’s main mechanisms of action are antagonism of 5-HT2A  
and D2 receptors. Selective antagonists for both of these receptors do no alter DD, and 
finally when tested in mice, clozapine does not affect DD on an AA task (Halcomb & 
Grahame, personal communication). Also the spread of the hM4Di-mCherry 
encompassed several areas of the mPFC. The effects of transfecting a single area, such as 
the only the PL cortex, may be different than the whole area. For experiment 2, TTX 
microinjections also have drawbacks. TTX will not spare the fibers of passage. 
Consequently, TTX would impair any projections that are simply traveling through the 
mPFC. Microinjections also do permanent damage to the target structure altering its 
functionality. Consequently there was a limit to how many times TTX microinjections 
could be delivered.  
The extent to which a rat’s neurobiology relates to a humans is another limitation. 
The rat brain’s areas are not a one-to-one match with the human brain. This is particularly 
true of cortical structures. The rat lacks many neocortical areas that the human brain 
possesses, including the dlPFC. While the mPFC appears to correspond to the primate 
dlPFC based on anatomical connections and the “common class functions” it subserves 
(Uylings et al., 2003) and a combination of the dlPFC and ACC based on 
electrophysiological evidence (Seamans et al., 2008), it is ultimately not the human 
dlPFC. Consequently, the current findings may not necessarily generalize to the human 
dlPFC.  
One possible interpretation of the current findings is that the mPFC plays a 
secondary role to the HPC and that it may only be necessary when a longer delay is used. 
However the current study is unable to substantiate this hypothesis. Future work should 
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look to determine if the mPFC is critical at longer delays, and if mPFC-HPC 
communication is needed at longer delays as well. Also, if the mPFC does truly play a 
secondary role to the HPC, the importance of different HPC efferents to DD is worth 
investigating. Conceptualizations of HPC contribution to decision making involve 
sending an outcome representation to downstream areas which then generate an expected 
value signal (Johnson et al., 2007; Schacter et al., 2007). This outcome representation 
could be sent to the OFC, BLA, or directly to the NAcc. However, if the NAcc is truly 
the final common output of the entire circuity, conversion to an expected value signal 
may need to occur in advance of the NAcc. To test this hypothesis, functional 
disconnection studies breaking HPC to BLA and HPC to OFC connections would be 
needed.  
The current conceptualization of the neurobiology of DD centers around the 
NAcc core being a final common output pathway that compares expected value signals 
and helps initiate motor behavior to select an outcome. Consequently, the inputs to the 
NAcc core should be examined with the use of functional disconnection studies. 
Particular areas which may be important inputs to the NAcc for DD are those suggested 
to generate expected value signals, the OFC and the BLA.  
Another area that deserves further investigation is the dorsal striatum as a number 
of human neuroimaging results have implicated it, and it likely plays a role in action 
selection similar to the NAcc (Nicola, 2007). Frontostriatal WMI between the dorsal 
striatum and the dlPFC is related to increased DD (Hampton et al., in press). Increased 
fMRI BOLD in the head of the caudate nucleus and putamen is seen when DD choices 
involve a long versus short delay (Wittman et al., 2007). Also, individuals with α-
synuclein gene duplication before the development of Parkinson’s disease have normal 
caudate volume and no difference between controls on DD, but once symptoms begin to 
onset, caudate volume is decreased, DD is increased, and caudate volume is negatively 
correlated with the rate of DD. Accordingly, the dorsal striatum needs some attention 
from preclinical investigations.  
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Adriani, W., Boyer, F., Gioiosa, L., Macrí, S., Dreyer, J.-L., Laviola, G. (2009) Increased 
impulsive behavior and risk proneness following lentivirus-mediated dopamine 
transporter over-expression in rats’ nucleus accumbens. Neuoscience. 159:47-58. 
Ainslie, G. (1975) Specious Reward: A Behavioral Theory of Impulsiveness and Impulse 
Control. Psychological Bulletin. 82(4): 463-496. 
Ainslie, G. (1992). Picoeconomics: The strategic interaction of successive motivational 
states within the person. New York: Cambridge University Press. 
Ainslie, G.W. (1974) Impulse Control in Pigeons. Journal of the Experimental Analysis 
of Behavior. 21: 485-489.  
Albert, P.R., Lembo, P., Storring, J.M., Charest, A., Saucier, C. (1996) The 5-HT1A¬ 
receptor: signaling, desensitization, and gene transcription. 
Neuropsychopharmacology. 14(1):19-25. 
117 
 
Albrecht, K., Volz, K.G., Sutter, M., Laibson, D.I., von Cramon, D. Y. (2011) What is for 
me is not for you: brain correlates of intertemporal choice for self and other. Scan. 
6:218-225. 
Alexander, G.E., Crutcher, M.D. (1990) Functional architecture of basal ganglia circuits: 
neural substrates of parallel processing. Trends in neurosciences. 13:266–271 
Alexander, G.M., Rogan, S.C, Abbas, A.I., Armbruster, B.N., Pei, Y., Allen, J.A., 
Nonneman, R.Jl., Hartmann, J., Moy, S.S., Nicolelis, M.A., McNamara, J.O., 
Roth, B.L. (2009) Remote control of neuronal activity in transgenic mice 
expressing evolved g protein-coupled receptors. Neuron. 63:27-39. 
Anagnostaras, S.G., Gale, G.D., Fanselow, M.S. (2001) Hippocampus and contextual fear 
conditioning: recent controversies and advances. Hippocampus. 11:8-17. 
Anderson, J. R. (1990). Cognitive psychology and its implications. WH Freeman/Times 
Books/Henry Holt & Co. 
Anderson, K.G., Diller, J.W. (2010) Effects of acute and repeated nicotine administration 
on delay discounting in Lewis and Fischer 344 rats. Behavioral Pharmacology. 
21(8): 754-764. 
Anker JJ, Perry JL, Gliddon LA, CarrollME (2009) Impulsivity predicts the escalation of 
cocaine self-administration in rats. Pharmacology Biochemistry and Behavior. 
93:343–348. 
Antonelli, F., Ko, J.H., Miyasaki, J., Lang, A.E., Houle, S., Valzania, F., Ray, N.J., 
Strafella, A.P. (2014) Dopamine-agonists and impulsivity in parkinson’s disease: 
impulsive choices vs. impulsive actions. Human brain mapping. 35(6): 2499–
2506. 
Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S., Roth, B.L. (2007) Evolving the lock 
to fit the key to create a family of G protein-coupled receptors potently activated 
by an inert ligand. PNAS. 104(12):5163-5168. 
Arnsten, A.F.T.( 2011) Catecholamine influences on dorsolateral prefrontal cortical 
networks. Biological Psychiatry. 69:e89-e99. 
Baker, F., Johnson, M.W., Bickel, W.K. (2003) Delay discounting in current and never-
before cigarette smokers: Similarities and differences across commodity, sign, 
and magnitude. Journal of Abnormal Psychology. 112(3):382-392. 
118 
 
Bakshi, V.P., Swerdlow, N.R., Geyer, M.A. (1994) Clozapine antagonizes phencyclidine-
induced deficits in sensorimotor gating of startle response. Journal of 
pharmacology and experimental therapeutics. 271:787-794. 
Ballard, K., Knutson, B. (2009) Dissociable neural representations of future reward 
magnitude and delay during temporal discounting. NeuroImage. 45:143-150. 
Balleine B.W., Killcross, A.S., Dickinson, A. (2003) The effects of lesions of the 
basolateral amygdala on instrumental conditioning. Journal of neuroscience. 
23(2):666–675 
Balleine, B.W., O’Doherty, J.P. (2010) Human and rodent homologies in action control: 
corticostriatal determinants of goal-directed and habitual action. 
Neuropsychopharmacology. 35(1): 48–69. 
Bane, V., Lehane, M., Dikshit, M., O’Riordan, A., Furey, A. (2014) Tetrodotoxin: 
Chemistry, toxicity, source, distribution, and detection. Toxins. 6:693-755. 
Bannerman, D.M., Rawlins, J.N., McHugh, S.B., Deacon, R.M., Yee, B.K., Bast, T., 
Zhang, W.N., Pothuizen, H.H., Feldon, J. (2004) Regional dissociations within 
the hippocampus—memory and anxiety. Neuroscience and Biobehavioral 
Reviews. 28:273–283. 
Basar, K., Sesia, T., Groenewegen, H., Steinbusch, H.W., Visser-Vandewalle, V., Temel, 
Y. (2010) Nucleus accumbens and impulsivity. Progress in Neurobiology. 92:533-
557. 
Bechara, A. (2005) Decision making, impulse control and loss of willpower to resist 
drugs: a neurocognitive perspective. Nature Neuroscience. 8(11): 1458-1463.  
Beckwith, S.W., Czackowski, C.L. (2014) Increased Delay Discounting Tracks with A 
High Ethanol-Seeking Phenotype and Subsequent Ethanol Seeking but not 
Consumption. Alcoholism: Clinical and Experimental Research. 38(10):2607-
2614 
Bender, D., Holschbach, M., Stocklin, G. (1994) Synthesis of n.c.a. carbon-11 labelled 
clozapine and its major metabolite clozapoine-N-oxide and comparison of their 
biodistribution in mice. Nuclear medicine and biology. 21(7):921-925. 
 
119 
 
Berendse, H.W., Galis-de Graaf, Y., Groenewegen, H.J., 1992. Topographical 
organization and relationship with ventral striatal compartments of prefrontal 
corticostriatal projections in the rat. Journal of comparative neurology. 316:314–
347. 
Berendse, H.W., Groenewegen, H.J., (1990) Organization of the thalamostriatal 
projections in the rat, with special emphasis on the ventral striatum. Journal of 
comparative neurology. 299:187–228. 
Berridge, K.C. (2007) The debate over dopamine’s role in reward: the case for incentive 
salience. Psychopharmacology. 191:391-431 
Berridge, K.C., Robinson, T.E., (1998) What is the role of dopamine in reward: hedonic 
impact, reward learning, or incentive salience? Brain research reviews. 28:309–
369. 
Bezzina, G., Cheung, T.H.C., Asgari, K., Hampson, C.L., Body, S., Bradshaw, C.M., 
Szabadi, E., Deakin, J.F.W., Anderson, I.M. (2007) Effects of quinolinic acid-
induced lesions of the nucleus accumbens core on inter-temporal choice: a 
quantitative analysis. Psychopharmacology. 195:71-84. 
Bickel, W.K., Jarmolowicz, D.P., Mueller, E.T., Koffarnus, M.N., Gatchalian, K.M. 
(2012) Excessive discounting of delayed reinforcers as a trans-disease process 
contributing to addiction and other disease-related vulnerabilities: Emerging 
evidence. Pharmacology and Therapeutics. 134:287-297 
Bickel, W.K., Miller, M.L., Yi, R., Kowal, B.P., Lindquist, D.M., Pitcock, J.A. (2007) 
Behavioral and neuroeconomics of drug addiction: Competing neural systems and 
temporal discounting processes. Drug and Alcohol Dependence. 90S: S85-S91. 
Bickel, W.K., Yi, R., Landes, R.D., Hill, P.F., Baxter, C. (2011) Remember the Future: 
Working Memory Training Decreases Delay Discounting Among Stimulant 
Addicts. 69(3):260-265. 
Bickel. W.K., Odum, A.L., Madden, G.J. (1999) Impulsivity and cigarette smoking: 
delay discounting in current, never, and ex-smokers. Psychopharmacology. 146: 
447-454. 
 
120 
 
Bizot, J.C., Thiebot, M.H., Le Bihan, C.L., Soubrie, P., Simon, P. (1988) Effects of 
imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. 
Possible implication in the behavioral mechanism of action of antidepressants. 
Journal of Pharmacology and Experimental Theraputics. 246(3):1144-1151. 
Boettiger, C.A., Mitchell, J.M., Tavares, V.C., Robertson, M., Joslyn, G., D’Esposito, M., 
Fields, H.L., (2007) Immediate Reward Bias in Humans: Fronto-Parietal 
Networks and a Role for the Catechol-O-Methyltransferase 158val/val Genotype. 
The Journal of Neuroscience. 27(52):14838-14391 
Boomhower, S.R., Rassmussen, E.B. (2014) Haloperidol and rimonabant increase delay 
discounting in rats fed high-fat and standard-chow diets. Behavioral 
Pharamacology. 25(8): 705–716. 
Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011). 
Economic costs of excessive alcohol consumption in the U.S., 2006. American 
Journal of Preventive Pedicine, 41(5), 516-524.  
Brinley-Reed, M., Mascagni, F., McDonald, A.J (1995) Synaptology of prefrontal 
cortical projections to the basolateral amygdala: An electron microscopic study in 
the rat. Neuroscience Letters. 202:45-48. 
Brog, J.S., Salyapongse, A., Deutch, A.Y., Zahm, D.S., (1993) The patterns of afferent 
innervation of the core and shell in the ‘‘accumbens’’ part of the rat ventral 
striatum: immunohistochemical detection of retrogradely transported fluorogold. 
Journal of comparative neurology 338:255–278. 
Broos, N., Diergaarde, L., Schoffelmeer, A. N., Pattij, T., & De Vries, T. J. (2012). Trait 
Impulsive Choice Predicts Resistance to Extinction and Propensity to Relapse to 
Cocaine Seeking: A Bidirectional Investigation. Neuropsychopharmacology, 1-10 
Burgos-Robles, A., Bravo-Rivera, H., Quirk, G.J. (2013) Prelimbic and infralimbic 
neurons signal distinct aspects of appetitive instrumental behavior. PLoS One. 
8(2):e57575. 
 
 
 
121 
 
Burns, L.H., Robbins, R.W., Everitt, B.J. (1993) Differential effects of excitotoxic lesions 
of the basolateral amygdala, ventral subiculum, and medial prefrontal cortex on 
responding with conditioned reinforcement and locomotor activity potentiated by 
intra-accumbens infusions of D-amphetamine. Behavioural Brain Research. 
55:167–183. 
Burton, B.G., Hok, V., Save, E., Poucet, B. (2009) Lesion of the ventral and intermediate 
hippocampus abolishes anticipatory activity in the medial prefrontal cortex of the 
rat. Behavioural Brain Research. 199:222-234. 
Burwell, R.D., Amaral, D.G. (1998) Perirhinal and postrhinal cortices of the rat: 
interconnectivity and connections with the entorhinal cortex. Journal of 
comparative neurology. 391:293–321 
Cador, M., Robbins, T.W., Everitt, B.J. (1989) Involvement of the amygdala in stimulus-
reward associations: interaction with the ventral striatum. Neuroscience. 30:77–
86. 
Cardinal RN, Parkinson JA, Hall J, Everitt BJ (2002) Emotion and motivation: the role of 
the amygdala, ventral striatum, and prefrontal cortex. Neuroscience Biobehavioral 
Reviews. 26:321–352 
Cardinal, R.N., Cheung, T.H.C. (2005) Nucleus accumbens core lesions retard 
instrumental learning and performance with delayed reinforcement in the rat. 
BMC Neuroscience. 6:9 
Cardinal, R.N., Pennicott, D.R., Sugathapala, C.L., Robbins, T.W., Everitt, B.J. (2001) 
Impulsive choice induced in rats by lesions of the nucleus acccumbens core. 
Science. 292:2499-2501 
Cardinal, R.N., Robbins, T.W., Everitt, B.J. (2000) The effects of d-amphetamine, 
chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of 
signaled and unsignalled delayed reinforcement in rats. Psychopharmacology. 
152:362-375. 
Carter, M.E., Soden, M.E., Zweifel, L.S., Palmiter, R.D. (2013) Genetic identification of 
a neural circuit that suppresses appetite. Nature. 503:111-116 
 
122 
 
Cassell M.D., Wright, D.J. (1986) Topography of projections from the medial prefrontal 
cortex to the amygdala in the rat. Brain Research Bulletin. 17:321-333. 
Castle, L., Aubert, R.R., Khalid, M., Epstein, R.S. (2007) Trends in medication treatment 
for ADHD. Journal of Attention Disorders. 10(4):335-342. 
Cenquizca, L.A., Swanson, L.W. (2007). Spatial organization of direct hippocampal field 
CA1 axonal projections to the rest of the cerebral cortex. Brain Research 
Reviews.56(1):1–26. 
Chang, H.T, Kitai, (1985) Projection neurons of the nucleus accumbens: an intracellular 
labeling study. Brain Research. 347:112-116. 
Chang, W.H., Lin, S.K., Lane, H.Y., Wei, F.C., Hu, W.H., Lam, Y.W., Jann, M.W. 
(1998) Reversible metabolism of clozapine and clozapine N-oxide in 
schizophrenic patients. Progress in neuro-psychopharmacology & biological 
psychiatry. 22:723–739. 
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., … 
Weinberger, D. R. (2004). Functional analysis of genetic variation in catechol-O-
methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in 
postmortem human brain. American Journal of Human Genetics, 75(5), 807–21.  
Cheung T.H.C., Cardinal, R.N. (2005) Hippocampal lesions facilitate instrumental 
learning with delayed reinforcement but induce impulsive choice in rats. BMC 
Neuroscience. 6:36. 
Christakou, A., Brammer, M., Rubia, K. (2011) Maturation of limbic corticostriatal 
activation and connectivity associated with developmental changes in temporal 
discounting. NeuroImage. 54:1344-1354.  
Christie, M.J., Summers, R.J., Stephenson, J.A., Cook, C.J., Beart, P.M. (1987) 
Excitatory amino acid projections to the nucleus accumbens septi in the rat: a 
retrograde transport study utilizing d[3H]aspartate and [3H]GABA. Neuroscience. 
22(2):425-439. 
Chudasama, Y., Robbins, T.W. (2003) Dissociable contributions of the orbitofrontal and 
infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: 
further evidence for the functional heterogeneity of the rodent frontal cortex. 
Journal of Neuroscience. 23(25):8771-8780.  
123 
 
Churchwell, J.C., Morris, A.M., Heurtelou, N.M., Kesner, R.P. (2009) Interactions 
between the prefrontal cortex and amygdala during delay discounting and 
reversal. Behavioral Neuroscience. 123(6):1185-1196. 
Claus, E. D., Kiehl, K. a, & Hutchison, K. E. (2011). Neural and behavioral mechanisms 
of impulsive choice in alcohol use disorder. Alcoholism, clinical and experimental 
research, 35(7), 1209-19.  
Cools, R., D’Esposito, M. (2011) Inverted-U-shaped dopamine actions on human 
working memory and cognitive control. Biological Psychiatry.69:e113-e125. 
Counotte, D.S., Spijker S., Van de Burgwal, L.H., Hogenboom, F., Schoffelmeer, 
A.N.M., De Vries, T.J., Smit, A.B., Pattij, T. (2009) Long-Lasting Cognitive 
Deficits Resulting from Adolescent Nicotine Exposure in Rats. 
Neuropsychopharmacology. 34: 299-306 
Craig, A.R., Maxfield, A.D., Stein, J.S., Renda, C.R., & Madden, G.J. (2014) Do the 
adjusting-delay and increasing-delay tasks measure the same construct: delay 
discounting? Behavioural Pharmacology. 25(4):306-315 
Cyders, M.A., Coskunpinar, A. (2011) Measurment of constructs using self-report and 
behavioral lab tasks: Is there overlap in nomothetic span and construct 
representation for impulsivity? Clinical Psychology Review. 31:965-982. 
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Poulos, C.X., Parker J.L., Anh Lê, D. (1998) Increased Impulsivity After Injected 
Alcohol Predicts Later Alcohol Consumption in Rats: Evidence for “Loss-of-
Control Drinking” and Marked Individual Differences. Behavioral Neuroscience. 
112(5): 1247-1257. 
Poulos, C.X., Parker, J.L., Le, A.D. (1996) Dexfenfluramine and 8-OH-DPAT modulate 
impulsivity in a delay-of-reward paradigm: implications for a correspondence 
with alcohol consumption. Behavioural Pharmacology. 7:395-399. 
Pozzi, L., Baviera, M., Sacchetti, G., Calcagno, E., Balducci, C., Invernizzi, R.W., Carli, 
M. (2011) Attention deficit induced by blockade of D-aspartate receptor in the 
prefrontal cortex is associated with enhanced glutamate release and cAMP 
response element binding protein phosphorylation: role of metabotropic glutamate 
receptors 2/3. Neuroscience. 176:336-348. 
Preston, R.J., Bishop, G.A., Kitai, S.T. (1980) Medium spiny neuron projection from the 
rat striatum: An intracellular horseradish peroxidase study. Brain Research. 
183:253-263. 
Puluc E., Trotter, P.D., Thomas, E.J., McFarquhar M., Juhasz, G., Sahakian, B.J., Deakin, 
J.F.W., Zahn, R., Anderson, I.M., Elliott, R. (2014) Temporal discounting in 
major depressive disorder. Psychological Medicine. 44(9): 1825-1834. 
Rachlin, H., & Green, L. (1972). Commitment, Choice, and Self-Control. Journal of 
Experimental Analysis of Behavior, 17(I), 15-22.  
140 
 
Rachlin, H., Raineri, A., & Cross, D. (1991). Subjective Probability and Delay. Journal of 
Experimental Analysis of Behavior, 55(2), 233-244. 
Ragozzino, M.E. (2007) The contribution of the medial prefrontal cortex, orbitofrontal 
cortex and dorsomedial striatum to behavioral flexibility. Annals of the New York 
Academy of Sciences. 1121:355-375. 
Rajasethupathy, P., Sankaran, S., Marshel, J.H., Kim, C.K., Ferenczi, E., Lee, S.L., 
Berndt, A., Ramakrishnan, C., Jaffe, A., Lo, M., Liston, C., Deisseroth, K. (2015) 
Projections from neocortex mediate top-down control of memory retrieval. 
Nature. 526:653-659. 
Rawlins, J.N., Feldon, J., Butt, S. (1985) The effects of delaying reward on choice 
preference in rats with hippocampal or selective septal lesions. Behavioural Brain 
Research. 15:191-203. 
Rawlins, J.N., Tsaltas, E. (1983) The hippocampus, time, and working memory. 
Behavioural Brain Research. 10:233-262. 
Ray, R.S., Corcoran, A.E., Bbrust, R.D., Kim, J.C., Richerson, G.B., Nattie, E., Dymecki, 
S.M. (2011) Impaired respiratory and body temperature control upon acute 
serotonergic neuron inhibition. Science. 333:637-642. 
Reimers, S., Maylor, E.A., Stewart, N. Chater, N. (2009) Associations between a one-
shot delay discounting measure and age, income, education and real-world 
impulsive behavior. Personality and Individual Differences. 47(8):973-978. 
Remington, G., Lee, J., Agid, O., Takeuchi, H>, Foussias, G., Fervaha, G., Burton, L., 
Powell, V. (2016) Clozapine’s critical role in treatment resistant schizophrenia: 
ensuring both safety and use. Expert Opinion on Drug Saftey. 15(9):1193-1203. 
Renda, C.R., Stein, J.S., & Madden, G.J. (2014) Impulsive Choice Predicts Poor Working 
Memory in Male Rats. PlosOne. 9(4)e93263. 
Richards, J. B., Mitchell, S. H., de Wit, H., & Seiden, L. S. (1997). Determination of 
discount functions in rats with an adjusting-amount procedure. Journal of the 
Experimental Analysis of Behavior, 67(3), 353–66. 
 
 
141 
 
Richards, J.B., Ishiwari, K., Hauskneckt, K., Salamone, J.D. (2002) Effects of nucleus 
accumbens dopamine depletion on the value of delayed rewards in rats. Program 
No. 481.15. 2002 Neuroscience Meeting Planner. Orlando, FL: Society for 
Neuroscience, 2002. Online. 
Richards, J.B., Zhang, L., Mitchell, S.H., de Wit, H. (1999) Delay or probability 
discounting in a model of impulsive behavior: effect of alcohol. Journal of the 
Experimental Analysis of Behavior. 17: 121-143.  
Roesch M.R., Takahashi, Y., Gugsa, N., Bissonette, G.B., Schoenbaum, G. (2007) 
Previous Cocaine Exposure Makes Rats Hypersensitive to Both Delay and 
Reward magnitude. Journal of Neuroscience. 27(1): 245-250. 
Roesch, M.R., Bryden, D.W. (2011) Impact of size and delay on neural activity in the rat 
corticostriatal system. Frontiers in neuroscience. 5:1-13. 
Roesch, M.R., Calu, D.J., Burke, K.A., Schoenbaum, G. (2007) Should I stay or should I 
go? Transformation of time-discounted rewards in orbitofrontal cortex and 
associated brain circuits. Annuals of the New York Academy of Sciences. 
1104:21-34. 
Roesch, M.R., Calu, D.J., Esber, G.R., Schoenbaum, G. (2010) Neural correlates of 
variations in event processing during learning in basolateral amygdala. Journal of 
Neuroscience. 30(7):2464-2471. 
Roesch, M.R., Singh, T., Brown, P.L., Mullins, S.E., Schoenbaum, G. (2009) Ventral 
striatal neurons encode the value of the chosen action in rats deciding between 
differently delayed or sized rewards. Journal of Neuroscience. 29(42)13365-
13376. 
Roesch, M.R., Taylor, A.R., Schoenbaum, G. (2006) Encoding of time-discounted 
rewards in orbitofrontal cortex is independent of value representation. Neuron. 
51:509-520. 
Rossant, C., Kadir, S.N., Goodman, D.F., Schulman, J., Hunter, M.L., Saleem, A.B., 
Grosmark, A., Belluscio, M., Denfield, G.H., Ecker, A.S., Tolias, A.S., Solomon, 
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